KOL | Rikard HolmdahlNational and Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China | Medical ... |
CV Kol pour Rikard Holmdahl
| Year | |
|---|---|
| 2022 | National and Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China Medical Inflammation Research, MediCity Research Laboratory, University of Turku, Turku, Finland |
| 2021 | The Second Affiliated Hospital of Xi’an Jiaotong University (Xibei Hospital), Xi’an, China Department Medical Biochemistry and Biophysics, Division Medical Inflammation Research, Karolinska Institute, 171 77 Stockholm, Sweden;, (M.A.);, (X.C.);, (B.X.);, (G.F.L.);, (M.Y.B.);, (Y.H.);, (L.B.) Division of Medical Inflammation Research, Dept. of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden |
| 2020 | Dept. of Medical Inflammation Research, Section of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm Section for Medical Inflammation Research, BMCI11, Lund University, Lund, Sweden National & Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital, Xi'an Jiaotong University, 710004 Xi’an, China Karolinska Institutet |
| 2019 | Section for Medical Inflammation Research, Department of Medical Biochemistry and Biophysics, Karolinska Institute, Solnavägen 9, 171 65, Solna, Sweden Center for Medical Inflammation Research, Southern Medical University, Guangzhou, China R. Holmdahl and C.I. Svensson contributed equally to this paper. |
| 2018 | School of Pharmaceutical Science, Southern Medical University, Guangzhou, China Medical Inflammation Research, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm 17177, Sweden. Electronic address: Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden Medicity Research Laboratory, University of Turku, Turku, Finland |
| 2017 | Karolinska Institutet Division of Medical Inflammation Research Stockholm Sweden Center for Medical Immunopharmacology Research, Southern Medical University, 510515 Guangzhou, China. Medicity Research Laboratory, University of Turku, Turku, Finland, . |
Rikard Holmdahl: Statistiques d'influence
Rapport d'exécution
| Concept | World rank |
|---|---|
| peripheral cells alphachains | #1 |
| ncf1mutation | #1 |
| keratinocytes dth reaction | #1 |
| disease affinity | #1 |
| cia comp | #1 |
| antibody response cii | #1 |
| bb2bb3 regulation | #1 |
| mabs monoclonal arthritis | #1 |
| arthritis chronic | #1 |
| chronic stage arthritis | #1 |
| aq molecule | #1 |
| 339 polymorphism | #1 |
| glycosylated determinant peptides | #1 |
| animal models polychondritis | #1 |
| disease cd8 deficiency | #1 |
| disease monitoring rats | #1 |
| cia ul1 | #1 |
| antibodies pc4 | #1 |
| oia induction | #1 |
| mechanism autoimmune | #1 |
| monoclonal cartilage cattle | #1 |
| collageninduced arthritis | #1 |
| lew avridineinduced arthritis | #1 |
| cii peptides | #1 |
| mice cii epitopes | #1 |
| mem lglutamine | #1 |
| arthritis epitopes | #1 |
| hladrβ10402 | #1 |
| ztmrhd | #1 |
| c3hnb h2p | #1 |
| glut4dependent glucose transport | #1 |
| congenic c57bl mice | #1 |
| ncf1 sle | #1 |
| vpba pnipaam | #1 |
| lewis rat cia | #1 |
| cia locus | #1 |
| terpenes toll | #1 |
| ncf4 gene | #1 |
| cii heterologous cii | #1 |
| response splenocytes | #1 |
| rats antibody response | #1 |
| b10dr4ncf1 mice cii | #1 |
| type collagens rats | #1 |
| ciipeptide cells | #1 |
| psa mip | #1 |
| acute arthritis neutrophils | #1 |
| dendritic cells collagen | #1 |
| pregq2 | #1 |
| cii anticd4 treatment | #1 |
| pia model rats | #1 |
| dominant susceptibility loci | #1 |
| disease c4bp | #1 |
| pristaneinduced arthritis pia | #1 |
| cii disease | #1 |
| ncf1 | #1 |
| serum chromosome | #1 |
| nox2 agonists | #1 |
| cii260‐270 | #1 |
| oxidases receptors | #1 |
| cia21 lymph nodes | #1 |
| evokes peptide | #1 |
| constant light order | #1 |
| mutant p47phox | #1 |
| eae2 locus | #1 |
| epitopes vivo | #1 |
| controlling collagen | #1 |
| mice anticd4 treatment | #1 |
| tlr3 expression flss | #1 |
| synovium pia rats | #1 |
| nodq nod | #1 |
| eae3 chromosome | #1 |
| experimental arthritis articular | #1 |
| ncf1 genes | #1 |
| ciispecific antibodies | #1 |
| pinealectomy exposure | #1 |
| cii immunization | #1 |
| ftirm mice | #1 |
| hladr1transgenic mice | #1 |
| autoimmunogenic hydrocarbon oils | #1 |
| fecq4 | #1 |
| ncf4 nox2 complex | #1 |
| lewis rats pepsin | #1 |
| genes congenic | #1 |
| pristane stimulation | #1 |
| riiis segment chromosome | #1 |
| oestradiol suppression | #1 |
| pristaneinduced arthritis | #1 |
| nfr origin | #1 |
| tlr3 pristane | #1 |
| inflammatory phase arthritis | #1 |
| antitlr3 antibody | #1 |
| dapia6 | #1 |
| mice ncf1 | #1 |
| rats antibody cartilage | #1 |
| mice functional ncf1 | #1 |
| b10q mice ncf1 | #1 |
| collagen reactivity cxi | #1 |
| collagen langerhans cells | #1 |
| g6pi peptide | #1 |
| function ncf1 gene | #1 |
| skg mutation | #1 |
| treatment physiological doses | #1 |
| oxidative burst inducers | #1 |
| igg response cii | #1 |
| visual signs arthritis | #1 |
| human immunopeptidome lung | #1 |
| eae2 chromosome | #1 |
| dapia3 | #1 |
| mice l012 | #1 |
| haplotype ltab | #1 |
| cia21 | #1 |
| animal genes cia | #1 |
| peritonitis sod3 | #1 |
| rp autoimmune disease | #1 |
| f1 males influence | #1 |
| ncf1m1j mice ncf1 | #1 |
| rat congenic data | #1 |
| fpr1 agonist neutrophils | #1 |
| positional identification | #1 |
| eae2 resistant locus | #1 |
| rheumatoid collagen | #1 |
| b10q | #1 |
| cia b10q | #1 |
| nod incidence | #1 |
| mgpi325 | #1 |
| cii cells | #1 |
| glycosylation hla | #1 |
| mice th1 cytokines | #1 |
| pia eae | #1 |
| cia7 chromosome | #1 |
| partial advanced intercross | #1 |
| lys264 | #1 |
| pia11 | #1 |
| chromosome cia | #1 |
| cxiia | #1 |
| rheumatoid arthritis complexity | #1 |
| citrullinated collagen arthritis | #1 |
| pia cia | #1 |
| role major epitopes | #1 |
| mutation ptdins3pbinding site | #1 |
| hybridomas multispecific antibodies | #1 |
| effects cia | #1 |
| nzb dth | #1 |
| ppt medium | #1 |
| pristane cell death | #1 |
| female preponderance development | #1 |
| cii polymer | #1 |
| nss1 | #1 |
| tcell congenic arthritis | #1 |
| human cii cartilage | #1 |
| severity cia | #1 |
| caia gene segments | #1 |
| increase ncf1 | #1 |
| cii u1 | #1 |
| locus cia development | #1 |
| h‐2q | #1 |
| rheumatoid arthritis cia | #1 |
| dth nzb | #1 |
| genetic crossbreeding | #1 |
| emulsions induction | #1 |
| spleen cluster | #1 |
| arthritis ul1 | #1 |
| elevated th17 cells | #1 |
| double deficiency qa2 | #1 |
| ciispecific | #1 |
| csfspecific | #1 |
| il10 mmc | #1 |
| rheumatoid arthritis cii | #1 |
| ros ncf1 | #1 |
| dnp epitopes lysine | #1 |
| mice burkholderia cepacia | #1 |
| cii caia | #1 |
| rat cii response | #1 |
| h2q haplotype | #1 |
| monoclonal arthritis arthritis | #1 |
| cia compdeficient mice | #1 |
| decreasing activation | #1 |
| pepsin arthritis | #1 |
| enhanced autoimmunity | #1 |
| normal cartilage arthritis | #1 |
| citc1iiip | #1 |
| antibody responses cii | #1 |
| congenic mice vdr | #1 |
| collagen‐induced arthritis | #1 |
| findings new therapy | #1 |
| region eae2 | #1 |
| chick cii cii | #1 |
| antibody ciic1 | #1 |
| immune response mbp | #1 |
| rt1f haplotype | #1 |
| immunization mouse cii | #1 |
| expression liver receptor | #1 |
| cia22 | #1 |
| aq molecules | #1 |
| cell recognition cii | #1 |
| cells arthritogenicity | #1 |
| arthritogenic mabs | #1 |
| eae2 eae3 | #1 |
| arthritis suppression | #1 |
| b10qnfr | #1 |
| fibroblast induced arthritis | #1 |
| ros continental ancestry | #1 |
| function nox2 | #1 |
| arthritis caia | #1 |
| cix cii | #1 |
| effects fab2 | #1 |
| pia rats arthritis | #1 |
| qtl animal genes | #1 |
| immunization heterologous peptide | #1 |
| inbred dba prolactin | #1 |
| arthritogenic mab ciic1 | #1 |
| congenic cia40 | #1 |
| collagen‐induced | #1 |
| injection lewis rat | #1 |
| etoposide topoisomerase antagonist | #1 |
| caia lps | #1 |
| illness terpenes | #1 |
| cii antigen presentation | #1 |
| liver histone deacetylase | #1 |
| animal models arthritis | #1 |
| pparγ cbrh7919 cells | #1 |
| increased incidence cia | #1 |
| cix disease | #1 |
| chronic arthritis development | #1 |
| respiratory burst severity | #1 |
| lpscaia | #1 |
| formation arthritis | #1 |
| da1u rat liver | #1 |
| ciiglycopeptides | #1 |
| sle‐prone mrl | #1 |
| ncf1 p47phox | #1 |
| dth dba 1 | #1 |
| clec4b ncf1 | #1 |
| dth nzb mice | #1 |
| cia12 | #1 |
| tracheolaryngeal | #1 |
| post‐partum exacerbation | #1 |
| antigenic adjuvant | #1 |
| cia12 pia4 | #1 |
| rabeximod | #1 |
| experimental arthritis antibodies | #1 |
| cells heterologous cii | #1 |
| arthritis transfer | #1 |
| neonatal mortality milk | #1 |
| cia model strains | #1 |
| cii response | #1 |
| collagen antibody arthritis | #1 |
| autoimmune diseases identification | #1 |
| induce arthritis | #1 |
| transgenic nadph | #1 |
| h2q mice | #1 |
| reduced oxidative burst | #1 |
| cell recognition carbohydrates | #1 |
| type collagen cia | #1 |
| psoriasis spread | #1 |
| mice mutated cii | #1 |
| dth mice trait | #1 |
| tolerance arthritis protection | #1 |
| citrullinated type | #1 |
| function single | #1 |
| ros nox2 complex | #1 |
| frequency chronic arthritis | #1 |
| estrogen manifestations | #1 |
| nodq nod nodp | #1 |
| cii vaccination | #1 |
| beta 10b mrl | #1 |
| gene ncf1 | #1 |
| act389949 agonist | #1 |
| manifestations lupus disease | #1 |
| immune cartilage | #1 |
| critical restriction site | #1 |
| pia cia13 pia7 | #1 |
| cia lysine | #1 |
| tlr expression synovium | #1 |
| nonglycosylated epitope | #1 |
| rat cb10 cb11 | #1 |
| arthritis tlr3 | #1 |
| cii swr mice | #1 |
| hufcgammariia | #1 |
| experimental arthritis autoimmune | #1 |
| olive oil arthritis | #1 |
| mcaia | #1 |
| t‐cell epitope cii260‐270 | #1 |
| gia expansion | #1 |
| male mice arthritis | #1 |
| cb268 cii | #1 |
| cell determinants cii | #1 |
| ncf1 mutation | #1 |
| heterologous cii cells | #1 |
| mice cryogels | #1 |
| cia5 region | #1 |
| ifn signature mice | #1 |
| daiu | #1 |
| h2p mice cia | #1 |
| cells mouse cii | #1 |
| cii260 | #1 |
| cia2 cia9 | #1 |
| impact etoposide | #1 |
| hg6pi325 | #1 |
| induction phase cia | #1 |
| animal histocompatibility | #1 |
| day cii immunisation | #1 |
| cia eae39 | #1 |
| chronic arthritis rats | #1 |
| rats hfdmets | #1 |
| melatonin cia | #1 |
| ncf1 polymorphisms | #1 |
| arthritis rat strains | #1 |
| h2w17 | #1 |
| models rheumatoid arthritis | #1 |
| arthritis susceptibility rats | #1 |
| kupffer cells mir144 | #1 |
| existence periodontitis | #1 |
| chronic active arthritis | #1 |
| pc4 pc117 | #1 |
| arthritis collagen | #1 |
| carbohydrates cii | #1 |
| 2 months beta | #1 |
| pia cix | #1 |
| ncf1m1j mice | #1 |
| nox2 complex ncf4 | #1 |
| cii cartilage | #1 |
| cia mtx | #1 |
| susceptible collagen | #1 |
| cii histocompatibility complex | #1 |
| citrullinated type collagen | #1 |
| cells caia | #1 |
| cia congenic arthritis | #1 |
| cholera toxin study | #1 |
| extraarticular cartilage | #1 |
| ncf1 m1j | #1 |
| 4 histone deacetylases | #1 |
| muscle nox2 | #1 |
| cxi | #1 |
| damage type collagen | #1 |
| b10q1 | #1 |
| arthritis loci | #1 |
| cells rat cii | #1 |
| function p47phox | #1 |
| fpr act389949 | #1 |
| b10qnss1 | #1 |
| citrulline collagen | #1 |
| cia11 | #1 |
| bqncf1m1j | #1 |
| partial advanced | #1 |
| anti comp | #1 |
| nox2 complex addition | #1 |
| nadph activation | #1 |
| fecq3 locus | #1 |
| chromosome caia | #1 |
| cii rats | #1 |
| anticii autoantibodies | #1 |
| cii acpa | #1 |
| mumt mice oestrogen | #1 |
| models collagen | #1 |
| cxi arthritis | #1 |
| selected anti‐t‐cell | #1 |
| mice b10q | #1 |
| arthritis autoimmune | #1 |
| therapeutic cleavage | #1 |
| encephalomyelitis arthritis | #1 |
| insulitis nodq | #1 |
| presence mhv | #1 |
| inflammation living mice | #1 |
| phenotypes ncf1m1j mice | #1 |
| susceptibility collageninduced arthritis | #1 |
| synthetic peptides cii | #1 |
| arthritis naive mice | #1 |
| h2g7 haplotype nod | #1 |
| citrullinated collagen | #1 |
| anticlever1 antibody treatment | #1 |
| cii chronic | #1 |
| concentrations mouse cii | #1 |
| region ncf1 | #1 |
| anticii antibody response | #1 |
| mucosal tolerance cii | #1 |
| hfdmets expression | #1 |
| aq class | #1 |
| differential susceptibility cia | #1 |
| phytol arthritis | #1 |
| caia induced | #1 |
| tcell hybridomas cells | #1 |
| polyi pia rats | #1 |
| cii256−270 | #1 |
| nod nss1 | #1 |
| compia | #1 |
| ncf1 mutant mice | #1 |
| antibodies citrullinated peptide | #1 |
| mice mutated type | #1 |
| mhc influence | #1 |
| haplotypes h2q | #1 |
| ncf1 spread | #1 |
| induced arthritis | #1 |
| mannan joints | #1 |
| loci arthritis | #1 |
| ros mip | #1 |
| nasal treatment ctbcii | #1 |
| beta 812 | #1 |
| autoantibodies cartilage | #1 |
| susceptibility collagen | #1 |
| rats rt1 | #1 |
| comp disease monitoring | #1 |
| qa2 natural mutations | #1 |
| ftirm ciic1 | #1 |
| chromosome f1 males | #1 |
| surface redox levels | #1 |
| rt1l haplotypes | #1 |
| targeted mutation ncf4 | #1 |
| w33t | #1 |
| dependent autoimmune arthritis | #1 |
| tolerance immunodominant | #1 |
| disease development effects | #1 |
| nox2complex | #1 |
| autoimmunity mineral oils | #1 |
| ncf1m1j mutation | #1 |
| mannan immune | #1 |
| ncf1 mice wt | #1 |
| cii ecm | #1 |
| animal epitopes injections | #1 |
| presentation arthritis | #1 |
| superovulation rate | #1 |
| rat comp arthritis | #1 |
| c3hnb mice | #1 |
| arthritis gene regions | #1 |
| experimental carcinogens | #1 |
| cii 6 | #1 |
| development collagen | #1 |
| ability gut protection | #1 |
| autoimmune diseases cnvs | #1 |
| pristaneprimed cells | #1 |
| cii 256270 peptide | #1 |
| rat cii arthritis | #1 |
| injection adjuvant oils | #1 |
| cb11 fragment | #1 |
| striking phenotypic similarities | #1 |
| pc4 pc8 | #1 |
| backcrosses nzb mice | #1 |
| epitopes cb11 fragment | #1 |
| lnchc cholesterol metabolism | #1 |
| arthritis multiple | #1 |
| h2w3 | #1 |
| authors hgpi325339 peptide | #1 |
| caia effects | #1 |
| defined polymeric adjuvant | #1 |
| sialadenitis nodq | #1 |
| cii | #1 |
| arthritis arthritis loci | #1 |
| ncf1 copy variation | #1 |
| bond requirements | #1 |
| arthritis driven | #1 |
| antigen presentation cii | #1 |
| development chronic arthritis | #1 |
| homologous cii | #1 |
| inflammatory phase cia | #1 |
| clever1 type macrophages | #1 |
| arthritis monoclonal arthritis | #1 |
| qtl positional cloning | #1 |
| endos hydrolyzed igg | #1 |
| disease genotype immunoglobulin | #1 |
| features arthritis | #1 |
| diagnostic accuracy acpa | #1 |
| animal models complexity | #1 |
| mice ros | #1 |
| arthritogenic mabs cii | #1 |
| congenic arthritis | #1 |
| homologous type pia | #1 |
| cia13 pia7 | #1 |
| breeding capacity | #1 |
| animal models acpa | #1 |
| large numbers hybridomas | #1 |
| anticii antibodies | #1 |
| cia21 cia22 | #1 |
| cii259 | #1 |
| autologous cii | #1 |
| arthritis darkness | #1 |
| exacerbation arthritis | #1 |
| dominant traits | #1 |
| rats ncf1 | #1 |
| arthritis humans | #1 |
| denidritic cells | #1 |
| sialadenitis arthritis | #1 |
| oxidative burst disease | #1 |
| cia molecular basis | #1 |
| emerging glyco‐based strategies | #1 |
| vivo treatment | #1 |
| animal genetic predisposition | #1 |
| mediating arthritis | #1 |
| rats pia | #1 |
| rat rt1ba genes | #1 |
| eae mtx | #1 |
| cii severity | #1 |
| cia oia | #1 |
| cd43expressing cells | #1 |
| cii cell | #1 |
| socalled collagen antibody | #1 |
| macrophages hladr1transgenic mice | #1 |
| regulates severity | #1 |
| rats mhc genes | #1 |
| b10qacb | #1 |
| peptide agonist fmlf | #1 |
| glycosylated epitope structures | #1 |
| immunological transmitter | #1 |
| protein expression genes | #1 |
| suggestive locus chromosome | #1 |
| vivo monoclonal | #1 |
| ciif4 cartilage explants | #1 |
| acpa general population | #1 |
| swr nfr | #1 |
| hydrocarbon oil structure | #1 |
| arthritis monoclonal | #1 |
| deficient neonatal | #1 |
| mab ecm | #1 |
| cii induced | #1 |
| strains nodq | #1 |
| arthritis rat | #1 |
| mhc genetic region | #1 |
| rt1u lew1w | #1 |
| major cii | #1 |
| disease arthritis | #1 |
| collageninduced arthritis loci | #1 |
| engagement fcgammar | #1 |
| arthritis qtl chip | #1 |
| eae39 control disease | #1 |
| cii epitopes | #1 |
| cathelicidin expression blood | #1 |
| loci cia2 | #1 |
| pia4 chromosome | #1 |
| cia31 | #1 |
| eae strains severity | #1 |
| cell specificity cii | #1 |
| 256 270 | #1 |
| pia3 chromosome | #1 |
| experimental collagen type | #1 |
| ncf1deficient mice | #1 |
| qtl chip | #1 |
| induction cii | #1 |
| caia kgf | #1 |
| role eosinophilia | #1 |
| lymphocytes collagen | #1 |
| induced relapsing | #1 |
| disease th1 immunity | #1 |
| models rheumatoid | #1 |
| melatonin release pinealectomy | #1 |
| arthritis mhc | #1 |
| chromosome congenic strains | #1 |
| antibodies cii | #1 |
| epitope cartilage | #1 |
| fecq4 fragment | #1 |
| sensitive wkymvm | #1 |
| sterically privileged | #1 |
| ifnbeta deficiency | #1 |
| dimethyl6n | #1 |
| arthritis cell | #1 |
| loci sialadenitis | #1 |
| elisagenetyping | #1 |
| collagen epitopes | #1 |
| arthritis protection | #1 |
| 2 nox2 | #1 |
| cartilage explants mabs | #1 |
| mediate pulmonary inflammation | #1 |
| pia rheumatoid arthritis | #1 |
| copy variation ncf1 | #1 |
| ala261gly262 | #1 |
| l012 vivo imaging | #1 |
| 237 females | #1 |
| dba 1jpfp | #1 |
| substrains ztmrhd | #1 |
| synovial membranes joints | #1 |
| autologous peptide cells | #1 |
| ciic1scfv | #1 |
| clec4b activation | #1 |
| b10q mice authors | #1 |
| enhanced autoimmunity arthritis | #1 |
| congenic strains cia | #1 |
| riiis alleles eae2 | #1 |
| collagen iiinduced arthritis | #1 |
| peptides aq | #1 |
| deficient ncf1 | #1 |
| pristane hydrocarbon oils | #1 |
| cia13 | #1 |
| rats severity | #1 |
| rheumatoid disease models | #1 |
| specificity ros rns | #1 |
| psicoch2 | #1 |
| alphachains cell surface | #1 |
| rt1bβ | #1 |
| acpas specificity | #1 |
| cartilage explants m2139 | #1 |
| epitopes collagen | #1 |
| polymorphism autoimmune diseases | #1 |
| cartilage antibody | #1 |
| cia induced arthritis | #1 |
| blocking arthritis | #1 |
| mice chronic arthritis | #1 |
| c3hq mice cii | #1 |
| dancf1da rats | #1 |
| c57bl 10q | #1 |
| acute phase arthritis | #1 |
| inbred strains cia | #1 |
| cells autologous cii | #1 |
| susceptibility cia | #1 |
| cia il10 | #1 |
| polyi arthritis | #1 |
| cii256270 | #1 |
| rheumatoid drug evaluation | #1 |
| ncf1 knockout | #1 |
| cii comp | #1 |
| cii immunization mice | #1 |
| data act389949 | #1 |
| arthritis encephalomyelitis | #1 |
| rs201802880 | #1 |
| stromal cells osteoclasts | #1 |
| cells galactosylated peptide | #1 |
| b10riii | #1 |
| nodq×b10q | #1 |
| dth dominant hypersensitivity | #1 |
| genetic regions | #1 |
| spe acute phase | #1 |
| immunization type | #1 |
| differences ncf1 | #1 |
| glycoprotein alpha1microglobulin | #1 |
| tolerance induction cii | #1 |
| reproductive performance identification | #1 |
| cia40 | #1 |
| ncf1 ncf1m1j mutation | #1 |
| caia acute arthritis | #1 |
| h2p h2q haplotype | #1 |
| arthritis estrogen | #1 |
| rats phytol | #1 |
| h2p cia | #1 |
| pathogenesisis | #1 |
| cii lewis | #1 |
| pristane primed | #1 |
| tolerance collagen | #1 |
| cii cxi | #1 |
| celldependent disease | #1 |
| 270 peptide | #1 |
| fab2 ciic1 | #1 |
| cxb10qf2 | #1 |
| cia animal models | #1 |
| lew1w rt1u | #1 |
| oxazolone inflammatory response | #1 |
| u1 epitope | #1 |
| functional selective fpr1 | #1 |
| day acute arthritis | #1 |
| plcpip | #1 |
| ym1 alternative activation | #1 |
| scarce clinical samples | #1 |
| ros rheumatoid humans | #1 |
| mhc class injections | #1 |
| ifnbeta arthritis | #1 |
| inability collagen | #1 |
| caia cia | #1 |
| arthritis injection | #1 |
| autoimmune response cii | #1 |
| b10qc5δ | #1 |
| bcell activities | #1 |
| rats pristaneinduced arthritis | #1 |
| inflammatory arthritis assessment | #1 |
| physiological doses development | #1 |
| cii immunodominant | #1 |
| mcii707 | #1 |
| oxa backcrosses | #1 |
| cb11 sequence cii | #1 |
| m1s1a | #1 |
| genes antibodies | #1 |
| ox8 antibodies | #1 |
| psich2nh2 | #1 |
| mice cii immunization | #1 |
| cd68‐expressing cells | #1 |
| anticcp2negative patients | #1 |
| strains b10q | #1 |
| effects ciif4 | #1 |
| spontaneous tissue inflammation | #1 |
| expressions cyp7a1 | #1 |
| arthritis ides | #1 |
| genetic variants ncf1 | #1 |
| tlr3 upregulation flss | #1 |
| tolerance arthritis susceptibility | #1 |
| hladrbound peptides | #1 |
| glycopeptide stimulation | #1 |
| severity pia | #1 |
| cii vivo | #1 |
| suppressive development | #1 |
| cii olive oil | #1 |
| ncf4 | #1 |
| abetachains | #1 |
| beta haplotype | #1 |
| cia | #1 |
| cells cb11 | #1 |
| estrogenmediated suppression | #1 |
| cii antibodies | #1 |
| experimental collagen | #1 |
| ciif4 cartilage damage | #1 |
| joint proteins | #1 |
| cia ifa | #1 |
| congenic polymorphism illness | #1 |
| glycosylation cell recognition | #1 |
| new loci controlling | #1 |
| cia pathogenesis | #1 |
| collagen cii | #1 |
| collagen hybridomas | #1 |
| rats congenic arthritis | #1 |
| myeloid effector functions | #1 |
| genes arthritis | #1 |
| homologous type | #1 |
| biodegradation cryogels | #1 |
| mannaninduced | #1 |
| arthritis severity rats | #1 |
| collagen type cii | #1 |
| presentation cii | #1 |
| alpha type collagen | #1 |
| dominant hypersensitivity | #1 |
| estrogen physiological doses | #1 |
| ciispecific cells | #1 |
| b10q dba 1f1 | #1 |
| lymphocytes cartilage | #1 |
| rheumatoid arthritis eae | #1 |
| ros adaptive immunity | #1 |
| cartilage cii | #1 |
| cii human | #1 |
| congenic polymorphism | #1 |
| illness cia | #1 |
| h2q h2r | #1 |
| oestrogen‐induced suppression | #1 |
| collagen dendritic cells | #1 |
| da1f | #1 |
| cia chromosome | #1 |
| development oia | #1 |
| mmc transgene | #1 |
| mrl mice estrogen | #1 |
| cia experimental autoantibodies | #1 |
| rats pia9 alleles | #1 |
| autologous type collagen | #1 |
| cia cells | #1 |
| f1 hybrids disease | #1 |
| polymorphism mitochondrial genome | #1 |
| ciispecific cells day | #1 |
| da1u rats expression | #1 |
| igg2a vivo | #1 |
| autoantibodies collagen | #1 |
| nucleotide reactive | #1 |
| rheumatoid arthritis immunization | #1 |
| pc117 extracellular structures | #1 |
| cii259273 peptide | #1 |
| collagen arthritis iii | #1 |
| cia melatonin | #1 |
| pathway arthritis | #1 |
| chemiluminescent probe l012 | #1 |
| cia homologous cii | #1 |
| eae b10riii mice | #1 |
| act389949 fpr | #1 |
| arthritis antibody | #1 |
| phemagelatin | #1 |
| cia tsc transgenic | #1 |
| immunodominant cii | #1 |
| arthritis experimental | #1 |
| mhc mbp | #1 |
| preformed cartilage | #1 |
| qa2 gene clusters | #1 |
| cia2 arthritis | #1 |
| pia experimental chromosomes | #1 |
| arthritis traits | #1 |
| cii cross reactivity | #1 |
| arthritis estrus cycle | #1 |
| cia ros | #1 |
| arthritis‐susceptibility loci | #1 |
| interacting subloci | #1 |
| cxi collagen fibers | #1 |
| non‐mhc genes | #1 |
| cxi rats | #1 |
| major epitopes patients | #1 |
| animal immunosuppressive agents | #1 |
| collagen ii‐induced | #1 |
| pia cii | #1 |
| mice developed | #1 |
| synovial cells macrophages | #1 |
| myelomonocytic arthritis interleukin2 | #1 |
| caia mutant mice | #1 |
| animals arthritis | #1 |
| rat type collagen | #1 |
| cia rheumatoid autoantibodies | #1 |
| cii cartilage explants | #1 |
| ltabncr3 | #1 |
| antibodies consensus motif | #1 |
| rats clec4b | #1 |
| severe polyarthritis | #1 |
| rats cxi | #1 |
| arthritis promoting | #1 |
| genome b10riii | #1 |
| kgf cia | #1 |
| immunization heterologous cii | #1 |
| idd5 loci | #1 |
| glycosylated cii259 | #1 |
| arthritis mutant strains | #1 |
| protein ncf1m1j mice | #1 |
| protective alleles eae2 | #1 |
| therapeutic c4bp | #1 |
| specific antibody protection | #1 |
| g6pi chronic arthritis | #1 |
| pathogenesis cia | #1 |
| emission tomography mannan | #1 |
| complex aq molecules | #1 |
| type cii | #1 |
| cii256 | #1 |
| rabeximod arthritis | #1 |
| immunization cii | #1 |
| flss tlr3 expression | #1 |
| swr mice immunization | #1 |
| new therapy arthritis | #1 |
| tcell experimental cartilage | #1 |
| lew ztm ncf1 | #1 |
| siliac | #1 |
| cii lewis rats | #1 |
| mhc cii | #1 |
| pc8 pc117 | #1 |
| cartilagespecific protein | #1 |
| macrophage ros | #1 |
| transgenic nadph oxidase | #1 |
| isolated fragment chromosome | #1 |
| rheumatoid arthritis autoimmunity | #1 |
| cii mabs | #1 |
| cb268 | #1 |
| cuiiidaligands | #1 |
| human gpi protein | #1 |
| immunization lathyritic cii | #1 |
| ctbcii | #1 |
| bal cells work | #1 |
| macrophages cii | #1 |
| b10qbalb | #1 |
| collagen reactive | #1 |
| fcbinding | #1 |
| lps caia | #1 |
| arthritis adjuvants | #1 |
| cartilage specific | #1 |
| cia oestrogen | #1 |
| transgenic tolerance tlymphocytes | #1 |
| strains polychondritis | #1 |
| hla–dr1 | #1 |
| mhc‐congenic mouse strains | #1 |
| mouse cii | #1 |
| induced arthritis rats | #1 |
| arthritis development immunisation | #1 |
| cells dba mouse | #1 |
| arthritogenic antibodies | #1 |
| epitopes cb10 fragment | #1 |
| disease dba 1jpfp | #1 |
| inclusion negative predictive | #1 |
| fcγr3 | #1 |
| ul1 ciif4 | #1 |
| drb10401positive | #1 |
| arthritis immunisation | #1 |
| compsufficient mice | #1 |
| fecq4 locus | #1 |
| functional nox2 complex | #1 |
| cii pepsin | #1 |
| re04001activatedfpr1 | #1 |
| dba 1j | #1 |
| nox2 complex–derived ros | #1 |
| chemical collagen | #1 |
| mir144 tlr2 | #1 |
| naive experimental chromosomes | #1 |
| disease glycoproteins | #1 |
| polychondritis autoimmune disease | #1 |
| cii matrix protein | #1 |
| nonglycosylated peptide | #1 |
| murine psoriasis model | #1 |
| active arthritis complex | #1 |
| cii dendritic cells | #1 |
| kgf treatment onset | #1 |
| loci eae39 | #1 |
| sod3 peritonitis | #1 |
| h2q c3hnb | #1 |
| anticii response | #1 |
| cartilage‐specific | #1 |
| leukosialin rats | #1 |
| arthritis pristane | #1 |
| b10b | #1 |
| ciic1 mab ciif4 | #1 |
| periodontitis rats pia | #1 |
| therapeutic cleavage igg | #1 |
| rats rt1f mhc | #1 |
| cartilage collagen type | #1 |
| predominant selection | #1 |
| developed arthritis | #1 |
| dba 1 background | #1 |
| realtime pcr flss | #1 |
| cii induced arthritis | #1 |
| reactivity cii | #1 |
| pristane macrophages | #1 |
| administration antibodies hyaluronanreceptor | #1 |
| cii severe arthritis | #1 |
| pristane tlr3 expression | #1 |
| ll37 rcramp | #1 |
| cii pia | #1 |
| position cii256270 | #1 |
| collagen citrullination | #1 |
| arthritis mcaia | #1 |
| diabetes sialadenitis | #1 |
| position mouse cii | #1 |
| human α‐enolase | #1 |
| denatured cii | #1 |
| genes ncf1 | #1 |
| nzw parental strain | #1 |
| cia olive oil | #1 |
| ncf1 gene | #1 |
| ciic1 ciif4 | #1 |
| peptide characterisation | #1 |
| citrullinated variants | #1 |
| p47phox mutant | #1 |
| onset animals arthritis | #1 |
| thymectomy transgenes | #1 |
| arthritis congenic | #1 |
| p47phoxv232 | #1 |
| cii experimental arthritis | #1 |
| ncf1da | #1 |
| cia32 | #1 |
| immunisation cells | #1 |
| developed severe | #1 |
| vridine‐induced arthritis | #1 |
| sialadenitis incidence | #1 |
| adjuvant oils | #1 |
| patients china cohort | #1 |
| promoter regions antigens | #1 |
| 22 variant r620w | #1 |
| immunization heterologous | #1 |
| nox2derived ros | #1 |
| vivo experimental arthritis | #1 |
| qa2 ncf1 | #1 |
| tlr3 expression tnfα | #1 |
| col2259 | #1 |
| ncf1 ros | #1 |
| immunization rat | #1 |
| ifa cii ifa | #1 |
| cells arthritis progression | #1 |
| chromosome arthritis severity | #1 |
| strong response epitopes | #1 |
| periodontitis pristaneinduced arthritis | #1 |
| cryogel column antibodies | #1 |
| epitope type | #1 |
| oestradiol exacerbation | #1 |
| expression ncf1 | #1 |
| oxa nzb mice | #1 |
| eae39 locus cia | #1 |
| ncf1 ncf1 mice | #1 |
| type collagen cxi | #1 |
| arthritis animal | #1 |
| spread psoriasis | #1 |
| estrogen immune responses | #1 |
| selfcii | #1 |
| phytol rna | #1 |
| tumors immunosuppressive leukocytes | #1 |
| cia rat | #1 |
| ros autoimmune diseases | #1 |
| development cia | #1 |
| environments mice | #1 |
| concentrations rat cii | #1 |
| topoisomerase antagonist | #1 |
| arthritis ncf1 allele | #1 |
| toxin‐1‐producing staphylococci | #1 |
| pia4 | #1 |
| arthritis cia | #1 |
| fibroblasts ifnbetadeficient mice | #1 |
| joint inflammatory phase | #1 |
| chemical cartilage | #1 |
| mice ncf1m1j mutation | #1 |
| cia induced | #1 |
| ncf1m1j mice function | #1 |
| satellite encephalomyelitis autoimmune | #1 |
| cxi comp | #1 |
| ciiderived | #1 |
| dba 1jpfp cia | #1 |
| j1 epitope | #1 |
| nox2 functionality | #1 |
| liver contributes hfdmets | #1 |
| cii antibody | #1 |
| salivary glands antigen | #1 |
| mice salt concentrations | #1 |
| collagen epitope expression | #1 |
| comp cii | #1 |
| position ros production | #1 |
| rat pia | #1 |
| ciispecific cell responses | #1 |
| day ciispecific cells | #1 |
| ciic1 mabs | #1 |
| dr4 glycopeptides | #1 |
| cells ncf1 | #1 |
| new arthritis | #1 |
| controlling onset | #1 |
| development collageninduced arthritis | #1 |
| aplec locus | #1 |
| arthritis intraperitoneal injection | #1 |
| placental mhc class | #1 |
| collagen arthritis progesterone | #1 |
| rat cb11 immunization | #1 |
| galactosylated peptide | #1 |
| ethylene isostere | #1 |
| development pristaneinduced arthritis | #1 |
| antiidiotypic antibodies cd4 | #1 |
| role ncf1 | #1 |
| pristane induced | #1 |
| stages arthritis | #1 |
| citrullination cii | #1 |
| 371115tetramethyl2hexadecene1ol | #1 |
| autoantibody responses cii | #1 |
| vivo imaging l012 | #1 |
| inconsistent susceptibility | #1 |
| hdac3 pparγ | #1 |
| cell tolerance cii | #1 |
| ciic1 m2139 | #1 |
| cxi pia | #1 |
| healthy nzw | #1 |
| rats comp | #1 |
| sialadenitis congenic mice | #1 |
| ncf1 ptpn22 | #1 |
| functional ncf1 macrophages | #1 |
| tlr3 flss | #1 |
| upregulation tlr3 | #1 |
| arthritis aim | #1 |
| cii ncf1 | #1 |
| rats chronic disease | #1 |
| chronic arthritis mice | #1 |
| tlr2 tlr2 regulation | #1 |
| chondrocytes kgf | #1 |
| eae39 study | #1 |
| rabeximod inflammatory cells | #1 |
| lewis oia | #1 |
| concentrations cii | #1 |
| ncf1 association | #1 |
| increased salt exposure | #1 |
| satellite encephalomyelitis | #1 |
| cells cia | #1 |
| ncf1 allele | #1 |
| congenic fragments | #1 |
| arthritismodulating | #1 |
| fls ppt medium | #1 |
| caia riiis segment | #1 |
| b10q b10riii | #1 |
| hexadecane induce arthritis | #1 |
| macrophages autoimmune priming | #1 |
| reactivity cb268 | #1 |
| pristaneinduced arthritis rats | #1 |
| cii responsiveness | #1 |
| congenic mice genes | #1 |
| spleen pristane injection | #1 |
| dth antibody response | #1 |
| loci controlling diabetes | #1 |
| recombinant vaccine inflammation | #1 |
| phagocytic nox2 complex | #1 |
| cii cix | #1 |
| experimental autoimmunity cells | #1 |
| ii‐induced arthritis | #1 |
| cd4 treatment | #1 |
| arthritis b6n mice | #1 |
| ciispecific monoclonal | #1 |
| antibody induced | #1 |
| arthritogenicity cells | #1 |
| phase cia | #1 |
| rats established pia | #1 |
| immune priming events | #1 |
| adjuvanticity autoimmunity | #1 |
| rabeximod treatment | #1 |
| congenic arthritis rats | #1 |
| mice darkness | #1 |
| wt ncf1 | #1 |
| cia mip | #1 |
| eae2 | #1 |
| ecm mab | #1 |
| cii monoclonal arthritis | #1 |
| cii mouse | #1 |
| cnbr‐fragment | #1 |
| cii cb fragments | #1 |
| cartilage stability cartilage | #1 |
| dba1 mice | #1 |
| snat proteins | #1 |
| molecule aq | #1 |
| contrast nodq | #1 |
| methodspurified | #1 |
| caia experimental arthritis | #1 |
| arthritis amino | #1 |
| cia animal epitopes | #1 |
| mice h2q | #1 |
| identification genetic regions | #1 |
| tlr3 tlr3 expression | #1 |
| lpr mice granulocytes | #1 |
| cii h2q | #1 |
| epitopes arthritis | #1 |
| cii256 270 | #1 |
| ciif4 mab | #1 |
| major epitopes | #1 |
| genetic control pia | #1 |
| ncf1 mice | #1 |
| arthritis qtl pia7 | #1 |
| disease suggestive locus | #1 |
| hiit nox2 activity | #1 |
| pc117 | #1 |
| cii peptide molecules | #1 |
| tregs ros | #1 |
| cii259 273 | #1 |
| pv cd4 cells | #1 |
| fecq3 | #1 |
| lack arthritis | #1 |
| arthritis onset severity | #1 |
| cells synthetic glycopeptides | #1 |
| phagocyte oxidative burst | #1 |
| dependent autoimmune | #1 |
| anti cii acpa | #1 |
| function acpas | #1 |
| mhv runting neonates | #1 |
| chlorophyll component | #1 |
| cia caia | #1 |
| oestrogen‐induced | #1 |
| severity ides | #1 |
| immunization rat cii | #1 |
| ftirm cii | #1 |
| genetic encephalomyelitis autoimmune | #1 |
| idiotype‐specific binding | #1 |
| cell‐deficient mice | #1 |
| act389949 | #1 |
| nod nss1 loci | #1 |
| arthritis susceptibility mice | #1 |
| 17βestradiolregulation | #1 |
| adaptive immunity fcγrs | #1 |
| induction oia | #1 |
| ciiinduced | #1 |
| ciilysdnp mice | #1 |
| rat placenta uterus | #1 |
| inflammation caia | #1 |
| β1helix | #1 |
| cii h2p | #1 |
| epitopes cii | #1 |
| pepsin cii | #1 |
| chromosomes eae loci | #1 |
| cia opportunities | #1 |
| position ciilysdnp | #1 |
| arthritis rabeximod | #1 |
| mouse cii reactivity | #1 |
| pia experimental arthritis | #1 |
| arthritis induced | #1 |
| b10dr4ncf1 mice | #1 |
| argltgrpgda | #1 |
| susceptible strain cross | #1 |
| acpa discriminate | #1 |
| oestrogen induced | #1 |
| mice deficient ncf1 | #1 |
| nrc ova | #1 |
| disease lew | #1 |
| immunization autologous peptide | #1 |
| drb10401 col2259 | #1 |
| cia cii | #1 |
| b10dr4ncf1 | #1 |
| rats synthetic peptide | #1 |
| mab mab ciic1 | #1 |
| greater osteoclasts | #1 |
| autoantibodies cii | #1 |
| established pia disease | #1 |
| type collagen cii256−270 | #1 |
| saline arthritis | #1 |
| tlr3 rna interference | #1 |
| locus arthritis | #1 |
| arthritis pepsin | #1 |
| arthritis castration | #1 |
| collagen cxi | #1 |
| 6 cii | #1 |
| transgenic mice mhcii | #1 |
| innate‐associated disease | #1 |
| glycosylated epitope | #1 |
| cii articular cartilage | #1 |
| cia rat cii | #1 |
| genetic association ncf1 | #1 |
| kgf thymus | #1 |
| development humanized models | #1 |
| development aureus arthritis | #1 |
| chromosome 17 mhc | #1 |
| chronic pristane | #1 |
| serum interferon activity | #1 |
| c3hnb | #1 |
| mcaia ncf1 | #1 |
| anticii abs | #1 |
| m2139 ciic1 | #1 |
| prevents arthritis | #1 |
| antibody cartilage blymphocyte | #1 |
| arthritis control mice | #1 |
| m1j | #1 |
| ciid3 | #1 |
| cix cartilage | #1 |
| macrophages mannans | #1 |
| cii citrullinated | #1 |
| genes animal models | #1 |
| relapsing arthritis | #1 |
| cartilage explants ciic1 | #1 |
| nzw parental | #1 |
| nox2 complex | #1 |
| minor cartilage proteins | #1 |
| collagen 256 | #1 |
| arthritis ncf1 | #1 |
| ul1 vivo | #1 |
| heterologous collagen | #1 |
| collagen chains antibody | #1 |
| mannan mice | #1 |
| collagen antibodies | #1 |
| h2p h2q | #1 |
| cd200 btla | #1 |
| vivo monoclonal mouse | #1 |
| arthritis b10q mice | #1 |
| mir144 tlr2 expression | #1 |
| tumor models ncf1 | #1 |
| mouse chromosome eae39 | #1 |
| tolerance arthritis | #1 |
| cii mab | #1 |
| oestrogen cia | #1 |
| estrogeninduced suppression | #1 |
| cia5 qtl | #1 |
| ciif4 adverse effects | #1 |
| rat recombinants | #1 |
| cii major epitope | #1 |
| cii ciif4 | #1 |
| restricted role fcγr | #1 |
| nod loci genes | #1 |
| mab ciif4 ciic1 | #1 |
| cia9 | #1 |
| comp experimental autoantibodies | #1 |
| cii treatment | #1 |
| cii 256 | #1 |
| rat cii | #1 |
| citrullinated cii | #1 |
| peritonitis transgenic | #1 |
| arthritis estrogen treatment | #1 |
| ym1 pneumonitis | #1 |
| established sialadenitis | #1 |
| effector phase arthritis | #1 |
| insulitis strains | #1 |
| inbred dba pepsin | #1 |
| downregulating oestradiol | #1 |
| recognition lysine | #1 |
| cryogel matrix cells | #1 |
| maintained pregnancy levels | #1 |
| collagen autoantibody | #1 |
| comp arthritis models | #1 |
| ros rns inflammation | #1 |
| mbq mouse macrophages | #1 |
| psoriasis single locus | #1 |
| tumor colonization | #1 |
| pia disease | #1 |
| cells chronic arthritis | #1 |
| ciic1 antibody | #1 |
| caia model | #1 |
| response cii | #1 |
| pia model | #1 |
| single bout hiit | #1 |
| cia vivo priming | #1 |
| maintenance arthritis | #1 |
| cia experimental arthritis | #1 |
| sialadenitis cell phenotypes | #1 |
| cii mhc | #1 |
| strains developed | #1 |
| ros antigens | #1 |
| igg1 igg2b isotypes | #1 |
| sialadenitis strains | #1 |
| collagen induced | #1 |
| cia h2p | #1 |
| polymorphism ncf1 | #1 |
| cia antigens haplotypes | #1 |
| cii261 | #1 |
| role nox2derived ros | #1 |
| polymorphic fragment | #1 |
| arthritis incidence | #1 |
| innate immunity mip | #1 |
| cartilage damage vivo | #1 |
| arthritis development severity | #1 |
| inflammatory tissue attack | #1 |
| pristane hexadecane | #1 |
| c1iii type collagen | #1 |
| induction postpartum flare | #1 |
| arthritis collagen arthritis | #1 |
| e3xda | #1 |
| m1j mice | #1 |
| lathyritic cii | #1 |
| transient joint inflammation | #1 |
| ciif4 ciic1 | #1 |
| pepsin lewis | #1 |
| estrogen differential outcome | #1 |
| cii cia | #1 |
| activation cii | #1 |
| presence arthritogenic mabs | #1 |
| h‐2q mice | #1 |
| b10q h2q | #1 |
| collagens antibody | #1 |
| g6pi acute arthritis | #1 |
| arthritis anticii abs | #1 |
| arthritis autoantibody | #1 |
| susceptible cia | #1 |
| autoimmune priming | #1 |
| c4bp alternative pathway | #1 |
| arthritis | #1 |
| cia mhc | #1 |
| pia5 | #1 |
| confers arthritis susceptibility | #1 |
| ncf1339 allele | #1 |
| cia rheumatoid arthritis | #1 |
| phosphatase 22 | #1 |
| oestradiol dth | #1 |
| compdeficient mice | #1 |
| cii molecule | #1 |
| chronic intervention | #1 |
| autoantibody formation cia | #1 |
| mice interferon gamma | #1 |
| ciic1 fab | #1 |
| ros immunohistochemistry implants | #1 |
| histology vaccination | #1 |
| elimination carbohydrates | #1 |
| eae chromosomes | #1 |
| model rheumatoid | #1 |
| ciilysdnp | #1 |
| proteolipoprotein peptide | #1 |
| nox2 function | #1 |
| nodp nod | #1 |
| c3hq | #1 |
| mice arthritis | #1 |
| comp lack | #1 |
| chronic relapsing arthritis | #1 |
| arthritis pnipaam | #1 |
| ifa rats | #1 |
| proteins gay | #1 |
| rt1ba | #1 |
| rats ncf1 gene | #1 |
| ciipeptide | #1 |
| c57bl strains loci | #1 |
| polymer adjuvant activity | #1 |
| cii development | #1 |
| rat comp | #1 |
| mhc cia | #1 |
| cells mgps | #1 |
| methods | #1 |
| cii immunisation | #1 |
| hfdmets | #1 |
| collagen immunization | #1 |
| disease susceptibility castration | #1 |
| cii carbohydrates | #1 |
| lew mol strain | #1 |
| hg6pi | #1 |
| pia rats tlr3 | #1 |
| cia collagen | #1 |
| pia9 | #1 |
| caia mab | #1 |
| u1 antibodies patients | #1 |
| mice ncf4 | #1 |
| autoimmune accelerating | #1 |
| arthritis animal mice | #1 |
| cii ros | #1 |
| ifnbeta experimental arthritis | #1 |
| rat pristaneinduced arthritis | #1 |
| 15a11 | #1 |
| rfig lambda | #1 |
| cii specific | #1 |
| type epitopes | #1 |
| cii arthritis | #1 |
| b10riii riiis | #1 |
| wo2012127214 | #1 |
| animal epitopes | #1 |
| paamcryogel | #1 |
| urokinase enzyme | #1 |
| streptococcal endo | #1 |
| specificity arthritis | #1 |
| impact topoisomerase antagonist | #1 |
| anti type | #1 |
| modified glycopeptides | #1 |
| rats adjuvant oil | #1 |
| oxidases polymers | #1 |
| complex cia | #1 |
| nodq locus | #1 |
| bb2bb3 | #1 |
| nzb mice trait | #1 |
| potent disease accelerator | #1 |
| ros glucose transporter | #1 |
| headache paradigm | #1 |
| h2r h2q | #1 |
| b10q mice | #1 |
| mab cb268 | #1 |
| psiechch | #1 |
| lower capacity ros | #1 |
| arthritis pia | #1 |
| single monoclonal | #1 |
| clonal expansion arthritis | #1 |
| arthritis synovial tlr3 | #1 |
| suppression collagen | #1 |
| cells cii | #1 |
| major antigenic epitope | #1 |
| il10 cia | #1 |
| m2139 arthritogenic mab | #1 |
| h‐2b | #1 |
| heterologous peptide response | #1 |
| receptor γ pparγ | #1 |
| chronicity arthritis | #1 |
| arthritis independent | #1 |
| cia dominant epitope | #1 |
| severity arthritis | #1 |
| ros experimental arthritis | #1 |
| pepsin immunization | #1 |
| cii experimental autoantigens | #1 |
| heterologous cii | #1 |
| arthritogenic antibody | #1 |
| oxoethyl6h | #1 |
| ncf4 mice | #1 |
| polychondritis mice | #1 |
| minimal glycopeptide core | #1 |
| rats arthritis | #1 |
| congenic fragment | #1 |
| beta 10b beta | #1 |
| cartilage‐specific antibodiesis | #1 |
| rns type collagen | #1 |
| daxlewf1 | #1 |
| anticd4 treatment immunization | #1 |
| spread induced psoriasis | #1 |
| caia cii | #1 |
| b10q strain | #1 |
| plasminogen deficiency cia | #1 |
| gergaagiagpk | #1 |
| milk titers | #1 |
| humanized models disease | #1 |
| pia blocking arthritis | #1 |
| functional nox2 | #1 |
| chromosome pia | #1 |
| dba 1 | #1 |
| comp cxi | #1 |
| c3hq mice | #1 |
| cia swr mouse | #1 |
| tolerance cia | #1 |
| congenic strains rats | #1 |
| cii sera | #1 |
| ncf4 mip | #1 |
| treatment pia | #1 |
| chronic development | #1 |
| innate rats | #1 |
| mice c3h background | #1 |
| cia f1 males | #1 |
| cii recognition | #1 |
| mbpc5a | #1 |
| cia ul1 mab | #1 |
| type disease | #1 |
| dba 1 mouse | #1 |
| macrophages cii degradation | #1 |
| inbred strains severity | #1 |
| cd2 human cells | #1 |
| phase arthritis | #1 |
| cii rat cii | #1 |
| arthritis tlr3 upregulation | #1 |
| clec4b | #1 |
| induced arthritis cia | #1 |
| phytol molecular pathways | #1 |
| region eae3 | #1 |
| native cii | #1 |
| driven psoriatic arthritis | #1 |
| pia2–8 | #1 |
| rats rheumatoid | #1 |
| h2p susceptibility | #1 |
| cia antibody response | #1 |
| pia3 pia4 | #1 |
| protective role cia | #1 |
| cia pia | #1 |
| hydrolyzed igg | #1 |
| ides treatment severity | #1 |
| cii induce | #1 |
| carcinoma tumors ros | #1 |
| obs electrophoresis | #1 |
| olive oil cii | #1 |
| immunologic animals arthritis | #1 |
| aq glycopeptide | #1 |
| cia reduction | #1 |
| arthritis toe stiffness | #1 |
| rats ncf1 allele | #1 |
| suppression collagen arthritis | #1 |
| mabs cii | #1 |
| specific cii | #1 |
| ym1deficient mice | #1 |
| marginal ankylosis | #1 |
| major locus cia | #1 |
| ciiinduced arthritis | #1 |
| representative swedish | #1 |
| oestrogen lupus disease | #1 |
| arthritis rheumatoid arthritis | #1 |
| ncf1 mutation mice | #1 |
| autoimmune arthritis activation | #1 |
| antibody binding vivo | #1 |
| tissue attack | #1 |
| antitype collagen | #1 |
| early onset development | #1 |
| major role rp | #1 |
| development inflammatory attack | #1 |
| arthritis animals | #1 |
| cia cartilage | #1 |
| mbp c5a | #1 |
| multiple sclerosis rabeximod | #1 |
| genistein collagen | #1 |
| hyaluronanreceptor cd44 | #1 |
| immunospecific reactions | #1 |
| arthritis incidence severity | #1 |
| 1 ncf1 | #1 |
| glycosylated cii | #1 |
| disease transgenic models | #1 |
| tnfα tlr3 expression | #1 |
| genetic background rats | #1 |
| functional ncf1 | #1 |
| ncf1 mutant | #1 |
| arthritis development cross | #1 |
| experimental autoantigens | #1 |
| treatment cii immunization | #1 |
| arthritis male | #1 |
| mhc aq | #1 |
| signaling characterization | #1 |
| function targeted deletion | #1 |
| flss polyi | #1 |
| arthritis immunization | #1 |
| ncf1 deficient | #1 |
| caia monoclonal | #1 |
| anti collagen | #1 |
| oils induce | #1 |
| cxi cii | #1 |
| position 264 | #1 |
| mcia1 | #1 |
| arthritis genetics | #1 |
| severe arthritis immunization | #1 |
| inbred dba cii | #1 |
| cii rheumatoid autoantibodies | #1 |
| established arthritis | #1 |
| rats pristane | #1 |
| cii triple | #1 |
| targeted deletion ncf1 | #1 |
| cii immunization treatment | #1 |
| ccp2 negative | #1 |
| genetically segregating crosses | #1 |
| ncf1 mutated | #1 |
| c1iii | #1 |
| cii saline | #1 |
| wild type ncf1 | #1 |
| δ228 | #1 |
| ncf1 polymorphism | #1 |
| experimental chromosomes | #1 |
| model rheumatoid arthritis | #1 |
| severe arthritis | #1 |
| oestrogen treated | #1 |
| tracheolaryngeal cartilage | #1 |
| experimental autoantibodies | #1 |
| plasminogendeficient mice arthritis | #1 |
| ul1 ciif4 mab | #1 |
| fumia | #1 |
| publication animals arthritis | #1 |
| autoimmune arthritis apcs | #1 |
| hyaluronanreceptor | #1 |
| disease collagen | #1 |
| cxi chronic arthritis | #1 |
| cia recognition | #1 |
| presence sex hormones | #1 |
| cartilaginous joints | #1 |
| immunization mouse | #1 |
| mice salt intake | #1 |
| cxi 6 | #1 |
| anticardiolipin antibodies p005 | #1 |
| arthritis locus | #1 |
| new arthritis therapy | #1 |
| ncf1 339 | #1 |
| mutated ncf1 | #1 |
| eae39 | #1 |
| resistance collageninduced arthritis | #1 |
| rat cii cii | #1 |
| dba mouse epitopes | #1 |
| pia8 | #1 |
| c3bireceptors | #1 |
| homologous type collagen | #1 |
| dth response mrl | #1 |
| daf2cross | #1 |
| nephritis nodq | #1 |
| ncf1 nos2 | #1 |
| recombinants rt1u | #1 |
| pia3 | #1 |
| tlr3 expression fls | #1 |
| cii epitope | #1 |
| humans animals arthritis | #1 |
| ncf1m1j | #1 |
| intracellular processing cii | #1 |
| ox8 monoclonal | #1 |
| collagen type‐ii epitope | #1 |
| incidence arthritis | #1 |
| mip ncf4 | #1 |
| congenic | #1 |
| valphachain | #1 |
| avridine arthritis | #1 |
| thps cii | #1 |
| ncf1m1j m1j mice | #1 |
| frequency igaproducing cells | #1 |
| ccp positive patients | #1 |
| native comp | #1 |
| comp mabs | #1 |
| pregq2 fragment | #1 |
| pia7 | #1 |
| cia caia model | #1 |
| cia development | #1 |
| collagen arthritis hyaluronanreceptor | #1 |
| tlr3 synovium | #1 |
| cageeffects | #1 |
| mip cia | #1 |
| nox2derived ros mice | #1 |
| ncf1 lyme arthritis | #1 |
| mbq mouse | #1 |
| rats terpenes | #1 |
| injection mannan | #1 |
| arthritis males | #1 |
| incidence nod | #1 |
| act389949 fpr2 | #1 |
| p47phox ncf1 | #1 |
| genetic control sialadenitis | #1 |
| cia5 cia21 | #1 |
| kgf chondrocytes | #1 |
| dominant hypersensitivity dth | #1 |
| mice susceptible | #2 |
| psoriatic disease models | #2 |
| salt intake vivo | #2 |
| mph ros | #2 |
| mrl mice stages | #2 |
| igke | #2 |
| human animal models | #2 |
| cia anti | #2 |
| rats da1u | #2 |
| shared epitope cxi | #2 |
| nodq | #2 |
| c57bl 10 background | #2 |
| micro dams transgenic | #2 |
| mab cii | #2 |
| binding cartilage | #2 |
| ciif4 | #2 |
| epitope glycosylation | #2 |
| maintenance induced resistance | #2 |
| autoimmune congenic arthritis | #2 |
| biologicals 24 months | #2 |
| antibodies cep1 | #2 |
| smash recommendations | #2 |
| das28 acpa reactivities | #2 |
| increased severity development | #2 |
| sera rheumatoid arthritis | #2 |
| antileukoproteinase modulation | #2 |
| cartilage respiratory tract | #2 |
| mice genistein treatment | #2 |
| celldependent phase | #2 |
| b10g | #2 |
| mitochondria polymorphism | #2 |
| arthritis scoring | #2 |
| anticii antibody | #2 |
| mbp peptides immunization | #2 |
| fpr1 signaling | #2 |
| mph induction | #2 |
| neutrophil fpr2 | #2 |
| percentage peripheral cells | #2 |
| collagen antibody | #2 |
| mhc iii | #2 |
| nox2 macrophages | #2 |
| arthritogenic capacity | #2 |
| granulomas macrophages | #2 |
| induction p47phoxmutated mph | #2 |
| arthritis ethanol | #2 |
| c5ay35 | #2 |
| fibβ36 | #2 |
| eae caia | #2 |
| h2q response | #2 |
| wtc5a | #2 |
| macrophagespecific nox2 | #2 |
| rats utility | #2 |
| apc naïve cells | #2 |
| citrullinated peptides development | #2 |
| neutrophil functions modulation | #2 |
| rp animal ear | #2 |
| putative vulnerability locus | #2 |
| disease humanized mice | #2 |
| cii citrullination | #2 |
| cia mechanisms | #2 |
| m2139 | #2 |
| anti cii | #2 |
| induction cia | #2 |
| cxi l10d9 antibody | #2 |
| vaccination strategy c5a | #2 |
| flow cytometry ovx | #2 |
| lack functional nox2 | #2 |
| eae dxea strain | #2 |
| nadph oxidase elevations | #2 |
| disease promoting | #2 |
| matrilin 1 | #2 |
| cii311 | #2 |
| prophylactic treatment linomide | #2 |
| arthritis treatment | #2 |
| tracheolaryngeal cartilage rp | #2 |
| cia mice mice | #2 |
| linomide homologous cia | #2 |
| ifngamma spinal cord | #2 |
| mycobacteria granulomas | #2 |
| sialadenitis mice | #2 |
| pathogenic igg antibodies | #2 |
| ere activation treatment | #2 |
| arthritis progression | #2 |
| arthritis gender | #2 |
| immunosuppressive leukocytes | #2 |
| antitoxin immunoglobulin | #2 |
| kinloch | #2 |
| clever1 tumor | #2 |
| immunocap isac performance | #2 |
| arthritis oia | #2 |
| c2ta genetic polymorphisms | #2 |
| diseases collagen | #2 |
| fil307 | #2 |
| arthritogenic mab cii | #2 |
| dxeb strain immunization | #2 |
| immunization sch | #2 |
| toe stiffness | #2 |
| 111 vivo treatment | #2 |
| lew mol | #2 |
| new immunomodulatory drug | #2 |
| anticd4 treatment | #2 |
| epitope‐specific recognition | #2 |
| dominant suppressive | #2 |
| igkeegfp lentivirus expression | #2 |
| monodeoxygenation | #2 |
| pristane rats | #2 |
| intrinsic tolerance | #2 |
| fpr1 agonist | #2 |
| egfp cd19 cells | #2 |
| citcii311 | #2 |
| hiit skeletal muscle | #2 |
| igke promoter expression | #2 |
| experimental cloning | #2 |
| antibody response development | #2 |
| etoposide serum concentrations | #2 |
| arthritis models rats | #2 |
| conditions igke promoter | #2 |
| b10qncf1 mice cia | #2 |
| bmd caia | #2 |
| arthritis heterologous cia | #2 |
| igke promoter | #2 |
| cartilage‐specific autoimmunity | #2 |
| binding sites autoimmune | #2 |
| granulocytes alp | #2 |
| cartilage respiratory | #2 |
| ros source | #2 |
| mice collagen | #2 |
| glycopeptide complexes | #2 |
| alp monoclonal arthritis | #2 |
| mabs comp | #2 |
| ability arthritis | #2 |
| nox2 complex sle | #2 |
| endoglycosidase treatment | #2 |
| raloxifene oestradiol | #2 |
| galactosyl moiety | #2 |
| das28 values p001 | #2 |
| rats arthritogenic challenge | #2 |
| comp cia | #2 |
| agonist fpr2 | #2 |
| acpa reactivities | #2 |
| cii injection | #2 |
| ros peroxide | #2 |
| enhanced arthritis | #2 |
| cpg2088 | #2 |
| 18ffluoromannan | #2 |
| autoimmunity autoantibodies | #2 |
| disease 111 | #2 |
| nadph oxidase 2 | #2 |
| cartilage proteins sera | #2 |
| transgenic protein processing | #2 |
| circulating medium | #2 |
| w3 13 | #2 |
| immunization mbp89 | #2 |
| transgenic osteoporosis oestradiol | #2 |
| alterations neuroendocrine profile | #2 |
| 034positive | #2 |
| ncf1 mutants | #2 |
| cia monkeys | #2 |
| ncf1 ean6 | #2 |
| mice bacterial infections | #2 |
| l10d9 antibody | #2 |
| symptoms antibodies | #2 |
| tlymphocyte arthritis arthritis | #2 |
| snecs neutrophils | #2 |
| hiit skeletal | #2 |
| antibodies disease onset | #2 |
| iaexpressing cells | #2 |
| elastaseinduced emphysema nox2 | #2 |
| congenic polychondritis | #2 |
| epitopes rat | #2 |
| citcii | #2 |
| antipan | #2 |
| myelin ppd | #2 |
| cd8 cells incidence | #2 |
| oxidation increased severity | #2 |
| models autoimmune | #2 |
| c129s mutant disulfide | #2 |
| rno12 | #2 |
| higher levels anas | #2 |
| caia oestradiol | #2 |
| arthritis g6pi | #2 |
| chromosome rats | #2 |
| dancf1da | #2 |
| allelic variant type | #2 |
| oestrogen ean | #2 |
| arthritis fb | #2 |
| ncf1 oxidation | #2 |
| heterologous collagens arthritis | #2 |
| raloxifene estradiol treatment | #2 |
| l10d9 antibody cartilage | #2 |
| b10qf1 | #2 |
| re04 | #2 |
| peptides chronic eae | #2 |
| g6pi arthritis | #2 |
| rats heterologous cii | #2 |
| oestrogen suppressive | #2 |
| rats da1u rats | #2 |
| oxidation c129s | #2 |
| mhc congenic | #2 |
| ros granulomas | #2 |
| class immunoenzyme | #2 |
| tregs mph | #2 |
| lymphocytelike | #2 |
| da1u rats | #2 |
| homologous cia | #2 |
| dxea strain tgfbeta | #2 |
| ala261 | #2 |
| immunological requirements | #2 |
| wildtype mice macrophages | #2 |
| das28 24 months | #2 |
| severity collagen | #2 |
| skg model | #2 |
| arthritis antibody response | #2 |
| mog79 | #2 |
| positive anticcp2 test | #2 |
| integrin‐binding‐domain | #2 |
| oestradiol cia | #2 |
| disease development presence | #2 |
| oestrogen myelin | #2 |
| animal model arthritis | #2 |
| antibody cartilage | #2 |
| cia day | #2 |
| gender rats | #2 |
| rats lymphocytes | #2 |
| single nucleotide rats | #2 |
| ccp2 diagnostic accuracy | #2 |
| genetic regions psoriasis | #2 |
| vivo cii | #2 |
| snp position | #2 |
| fibroblast induced | #2 |
| antibodies cartilage | #2 |
| glut4dependent | #2 |
| mannan induced | #2 |
| igkeegfp lentivirus | #2 |
| mbp peptide eae | #2 |
| mbp89 peptides | #2 |
| fibß62 | #2 |
| p47phoxmutated | #2 |
| hkatpasecontaining vesicles | #2 |
| tolerance cii | #2 |
| genetic encephalomyelitis | #2 |
| animal haplotypes | #2 |
| development combination | #2 |
| ides treatment | #2 |
| mrl joints stages | #2 |
| 18fbicyclo610nonyne | #2 |
| rats polymorphism | #2 |
| fibα563 | #2 |
| nox2 neuropathological alterations | #2 |
| multiple antibody reactivities | #2 |
| disease cyclosporin treatment | #2 |
| caia effector phase | #2 |
| derived ros | #2 |
| sequences mbp89 | #2 |
| sle nadph oxidase | #2 |
| sle cgd | #2 |
| h12919 | #2 |
| cgd mice kynurenine | #2 |
| cii ciic1 | #2 |
| l10d9 antibody cxi | #2 |
| analyses comp | #2 |
| rats ifngamma | #2 |
| arthritogenic | #2 |
| caia eae | #2 |
| chronic autoimmune polyarthritis | #2 |
| c2ta genetic | #2 |
| mbp89 | #2 |
| eae protein rna | #2 |
| antibody fine | #2 |
| glycopeptides histocompatibility | #2 |
| mabs collagen | #2 |
| type collagen cii | #2 |
| selective fpr1 | #2 |
| cep1 fibß62 | #2 |
| ptpn22 protein disulfide | #2 |
| granulomas cgd mice | #2 |
| species susceptible haplotypes | #2 |
| utility comp | #2 |
| osteoclastogenesis endogenous dna | #2 |
| microscopic scoring arthritis | #2 |
| symptoms anti ccp2 | #2 |
| sialadenitis animals | #2 |
| ovx ncf1 mice | #2 |
| functional ncf1 variants | #2 |
| suppressive oestrogen | #2 |
| lymphoproliferative gene | #2 |
| c2ta mhcii expression | #2 |
| antileukoproteinase alp | #2 |
| rt1bb | #2 |
| influence chromosome | #2 |
| immunization mouse collagen | #2 |
| arthritis mice | #2 |
| ean6 | #2 |
| igg glycosylation arthritis | #2 |
| liver mice rna | #2 |
| liver histone | #2 |
| knockout illness | #2 |
| ptpn22 ncf1 | #2 |
| hladr2dq6 | #2 |
| neuroendocrine profile | #2 |
| titres ccp2 | #2 |
| mbp 87110 peptide | #2 |
| chronic relapsing disease | #2 |
| oestrogen pregnancy | #2 |
| dxea strain | #2 |
| hydroxyethylene | #2 |
| anticcp2negative | #2 |
| collagen ii‐induced arthritis | #2 |
| murine locus eae2 | #2 |
| synovial immune reactions | #2 |
| granulomas ros | #2 |
| c1epitope | #2 |
| autoimmune membrane proteins | #2 |
| pia rats | #2 |
| adjuvant rats | #2 |
| tgfbeta spinal cord | #2 |
| cia disease | #2 |
| implanted melanoma | #2 |
| eae cia | #2 |
| control subjects samples | #2 |
| lymphocytes animals | #2 |
| glycan activation | #2 |
| eosinophilia arthritis | #2 |
| chronic arthritis treatment | #2 |
| tcells recognition | #2 |
| cia arthritis | #2 |
| m2139 ciif4 | #2 |
| aetiology2–4 | #2 |
| autoimmune recognition | #2 |
| cells arthritis | #2 |
| mhciii | #2 |
| macrophagespecific nox2 development | #2 |
| severity collagen arthritis | #2 |
| l10d9 | #2 |
| fibα580 | #2 |
| tregs mph ros | #2 |
| pnipaam vpba | #2 |
| lack ifngamma | #2 |
| mog rats | #2 |
| pristane injection | #2 |
| cms eae | #2 |
| fpr1 neutrophils | #2 |
| early onset severity | #2 |
| congenic mice autoimmune | #2 |
| antibodies fibß62 | #2 |
| altered formation | #2 |
| ros tregs | #2 |
| macrophages enhances | #2 |
| pia rat | #2 |
| agonist study | #2 |
| 12 590 | #2 |
| dxeb | #2 |
| rheumatoid binding | #2 |
| ß62 | #2 |
| caia | #2 |
| staphylococcal infections mice | #2 |
| multiple sclerosis maps | #2 |
| i‐a molecule | #2 |
| suggestive locus | #2 |
| ncf1gene | #2 |
| collagen arthritis cii | #2 |
| terpenes animals | #2 |
| chitosanagarosegelatin | #2 |
| beta 10b | #2 |
| osteoclasts flow cytometry | #2 |
| cia animals | #2 |
| arthritis development rats | #2 |
| h2q mice mice | #2 |
| animal granulomatous disease | #2 |
| ciic1 | #2 |
| eno5 | #2 |
| cell tolerance c5a | #2 |
| ptpn22 disulfide | #2 |
| disease genotype hybridization | #2 |
| antibodies development | #2 |
| ptpn22 c129s | #2 |
| genotypes ovx | #2 |
| chain l10d9 antibody | #2 |
| collagen citrullination adhesion | #2 |
| b10qncf1 mice | #2 |
| transgenic oxidases zymosan | #2 |
| antibody‐mediated arthritis | #2 |
| human lung nox2 | #2 |
| matrilin cartilage proteins | #2 |
| arthritis female | #2 |
| psychosocial stress hpaaxis | #2 |
| design glycopeptides | #2 |
| cell dependent | #2 |
| paws mice | #2 |
| citc1359 | #2 |
| anticcp2negative presence | #2 |
| collageninduced arthritis mice | #2 |
| sequence analysis indel | #2 |
| arthritis raloxifene | #2 |
| igsecretors | #2 |
| rats disease onset | #2 |
| mhcii experimental arthritis | #2 |
| receptor‐specific manner | #2 |
| exclusive reactivity | #2 |
| cii depletion | #2 |
| comp titers | #2 |
| arthritogenic challenge | #2 |
| matrilin vivo | #2 |
| collagen arthritis immunization | #2 |
| injection w3 13 | #2 |
| incidence nephritis | #2 |
| da1u | #2 |
| cytosolic ros production | #2 |
| α3xi | #2 |
| adjuvant oils arthritis | #2 |
| comp cartilage | #2 |
| dr4 cii259 | #2 |
| nadph oxidase deficiency | #2 |
| redox regulation ptpn22 | #2 |
| cd19 cells egfp | #2 |
| incidence insulitis | #2 |
| castrated mice day | #2 |
| h2q | #2 |
| oestradiol induction phase | #2 |
| rheumatoid crosses | #3 |
| patients monoclonal chimeric | #3 |
| clever1 macrophages | #3 |
| cd8 cells ean | #3 |
| dxea | #3 |
| arthritis susceptible | #3 |
| incidence antinuclear antibodies | #3 |
| day disease duration | #3 |
| vim60 | #3 |
| lupus nets | #3 |
| db1 treatment day | #3 |
| rt11 rats | #3 |
| rats mog | #3 |
| disease immunization | #3 |
| major cell epitope | #3 |
| ctla4 deletion | #3 |
| rheumatoid cloning | #3 |
| sialadenitis | #3 |
| ifnbetadeficient mice | #3 |
| hladrb104 cochranmantelhaenszel test | #3 |
| ifngammali neurons | #3 |
| arthritis susceptibility | #3 |
| ean mca | #3 |
| ros deficiency | #3 |
| eae17 genetic heterogeneity | #3 |
| acpa titers | #3 |
| genotype knowledge | #3 |
| multiple sclerosis hladr2 | #3 |
| ifngammali | #3 |
| antibodies vim60 | #3 |
| cvrelated death adjustment | #3 |
| aureus arthritis mice | #3 |
| h2p mice | #3 |
| species lymphocytes | #3 |
| height disease | #3 |
| acpa combination | #3 |
| fibα573 fibβ74 | #3 |
| 95 cvrelated death | #3 |
| arthritis resistance | #3 |
| autoimmune models | #3 |
| lew ztm | #3 |
| acpas genetic factors | #3 |
| genetic influence susceptibility | #3 |
| subspecificities associations | #3 |
| glycosylated type | #3 |
| antigen monoclonal arthritis | #3 |
| neutrophil cytosolic factor | #3 |
| levels fibα591 | #3 |
| ifngamma neurons | #3 |
| isotypes acpas | #3 |
| early phase disease | #3 |
| antibodies citrullinated | #3 |
| h2qbearing | #3 |
| disease disease development | #3 |
| bcg ros | #3 |
| autoimmunity pia | #3 |
| induced immunospecific tolerance | #3 |
| arthritogenic mab | #3 |
| cbrh7919 cells | #3 |
| disease risk subsets | #3 |
| hladrb104 mann whitney | #3 |
| arthritis animal model | #3 |
| anticollagen antibody | #3 |
| arthritogenicity | #3 |
| restricted role | #3 |
| presence drb104 | #3 |
| disease development contribution | #3 |
| cartilage proteins | #3 |
| rtlu | #3 |
| immunization addition | #3 |
| acpas human serum | #3 |
| mice environments | #3 |
| rs729749 | #3 |
| cii species | #3 |
| ciic1 cii | #3 |
| arthritis effects | #3 |
| cd4∶cd8 lineage | #3 |
| disease genotype immunity | #3 |
| anti‐type | #3 |
| subspecificities occurrence | #3 |
| eae16 | #3 |
| eae5 ncf1 | #3 |
| class antigens keratinocytes | #3 |
| macroporous gel particles | #3 |
| transgenic osteoporosis | #3 |
| pia6 | #3 |
| cd4∶cd8 lineage commitment | #3 |
| common mouse model | #3 |
| cyp7a1 abca1 | #3 |
| occurrence subspecificities | #3 |
| mice copolymers | #3 |
| macrophages involvement | #3 |
| citrulline inflammation | #3 |
| fibβ74 | #3 |
| inflamed synovial tissues | #3 |
| mice constant light | #3 |
| cells naïve mice | #3 |
| fibβ62 81b | #3 |
| mmc mice | #3 |
| keratinocytes langerhans cells | #3 |
| disease anti lymphocyte | #3 |
| reactive idiotope | #3 |
| wildtype mice granulomas | #3 |
| hfdmets rats | #3 |
| rats disease | #3 |
| immuniozation | #3 |
| chromosome eae17 | #3 |
| eae17 chromosome | #3 |
| rt1a tap2 | #3 |
| acpas twins | #3 |
| cytotoxic t‐lymphocyte | #3 |
| pia | #3 |
| rheumatoid arthritis complement | #3 |
| role ros | #3 |
| advanced intercross eae5 | #3 |
| db1 treatment | #3 |
| cia animals arthritis | #3 |
| citc1iii fibα573 | #3 |
| citc1iii | #3 |
| citc1iii filaggrin | #3 |
| mnc salivary glands | #3 |
| combination acpa | #3 |
| rats rheumatoid arthritis | #3 |
| development collagen arthritis | #3 |
| allogeneic pregnancy | #3 |
| cryogel bioreactor | #3 |
| arthritis review | #3 |
| mice development | #3 |
| acpa subspecificities | #3 |
| anticollagen antibodies | #3 |
| genes disease development | #3 |
| eae5r1 | #3 |
| lew1f | #3 |
| cii elisa | #3 |
| cdk6 padi4 | #3 |
| antigen presentation mhcii | #3 |
| acpas plasma | #3 |
| low production | #3 |
| female immunoenzyme | #3 |
| acpa multiplex | #3 |
| ncf4 rs729749 | #3 |
| allopregnancy | #3 |
| response immune response | #3 |
| ctla4 adult mice | #3 |
| cia strains | #3 |
| activated cells mice | #3 |
| nox2 pathogenesis | #3 |
| onset combination | #3 |
| pnippam | #3 |
| cia hdac1 | #3 |
| loci antibodies | #3 |
| treatment arthritis | #3 |
| origin suggestive linkage | #3 |
| fibα591 | #3 |
| acpas fine specificities | #3 |
| arthritis autoimmunity | #3 |
| recombination rt1a | #3 |
| cystatin cdeficient mice | #3 |
| acpapositive twins | #3 |
| swedish patients antibodies | #3 |
| dnfb ears | #3 |
| arthritis levels | #3 |
| complex genetic control | #3 |
| crossreactive idiotope | #3 |
| fibα573 | #3 |
| citrullinated cyclic | #3 |
| fibα573 fibα591 | #3 |
| 81b | #3 |
| carriers hladrb104 | #3 |
| pfp mice | #3 |
| total abrogation | #3 |
| type c2ta | #3 |
| points acs | #3 |
| mca ean | #3 |
| citcii355 | #3 |
| citrullinated peptides time | #3 |
| ncf1 cldn4 | #3 |
| human cii | #3 |
| nadph oxidase complex | #3 |
| models arthritis | #3 |
| eae17 | #3 |
| binding aq | #3 |
| dce spe | #3 |
| rheumatoid autoimmune | #3 |
| cep1 filaggrin | #3 |
| fibβ74 onset | #3 |
| arthritis model | #3 |
| development arthritis | #3 |
| processing cii | #3 |
| natural alleles genes | #3 |
| endogenous ifnbeta | #3 |
| rs729749 ncf4 | #3 |
| antigens collagen | #3 |
| rodents6 | #3 |
| mice rheumatoid | #3 |
| h2aalpha | #3 |
| spe dce | #3 |
| oxidases reactive | #3 |
| animal glycosylation humans | #3 |
| chronic collagen | #3 |
| fibα591 vim60 | #3 |
| monoclonal cartilage sections | #3 |
| eae5 pia4 | #3 |
| female preponderance | #3 |
| complex autoimmune diseases | #3 |
| osteoclasts release | #3 |
| hdac1 pathogenesis | #3 |
| minimal adjuvant requirement | #3 |
| antibodies induce | #3 |
| nerve terminallike profiles | #3 |
| pristane‐induced arthritis | #3 |
| experimental arthritis | #3 |
| dual manner | #3 |
| targeting toll | #3 |
| twins acpas | #3 |
| model arthritis | #3 |
| disease w3 13 | #3 |
| twins acpapositive | #3 |
| pathogenesis pia | #3 |
| antibodies citc1iii | #3 |
| c2ta | #3 |
| c57bl mice illness | #3 |
| dthreaction | #3 |
| stroke cvrelated death | #3 |
| hdac1 rheumatoid arthritis | #3 |
| dancf1e3 | #3 |
| antibodies specific sets | #3 |
| mhc class betachain | #3 |
| differences citrullinated peptides | #3 |
| antigens keratinocytes | #3 |
| autoimmunity cartilage | #3 |
| cii reactive | #3 |
| cvrelated death | #3 |
| neutrophils eae | #3 |
| citrullinated peptides multiplex | #3 |
| igl genes | #3 |
| eae31 | #3 |
| apc cia | #3 |
| experimental cell | #3 |
| hydrocarbon oils | #3 |
| type collagen vivo | #3 |
| nox2 cgd | #3 |
| vivo control mice | #3 |
| acpa specificities presence | #3 |
| development acpas | #3 |
| eae1 | #3 |
| cvrelated death association | #3 |
| disease height | #3 |
| oxidase 2 | #3 |
| glands sialadenitis | #4 |
| smoking antibodies | #4 |
| strains arthritis | #4 |
| shared autoimmunity | #4 |
| glend2 | #4 |
| genistein addition | #4 |
| cii ifa | #4 |
| stages disease development | #4 |
| multispecific antibodies | #4 |
| antibodies citrullinated peptides | #4 |
| cytosolic ros | #4 |
| potent immunomodulator | #4 |
| mp‐lpr | #4 |
| cia b10q mice | #4 |
| cd4 cells stage | #4 |
| estrogen levels levels | #4 |
| adjuvant oil | #4 |
| cia lia | #4 |
| diseases rheumatoid | #4 |
| arthritis collageninduced arthritis | #4 |
| cia mouse | #4 |
| tcell activation development | #4 |
| variance animals arthritis | #4 |
| pathogenic antibody | #4 |
| collagen type | #4 |
| type collagen autoimmunity | #4 |
| mice etoposide | #4 |
| catabolism kynurenine | #4 |
| cryogel matrix | #4 |
| cellular transfer | #4 |
| type collagen rat | #4 |
| pathogenesis histone | #4 |
| mrl b6 | #4 |
| cia suppression | #4 |
| bxsb chromosome | #4 |
| cell response immunization | #4 |
| sh3gl1 | #4 |
| antitype collagen antibodies | #4 |
| positional cloning genes | #4 |
| autoimmune experimental phenotype | #4 |
| immunoglobulin deficient | #4 |
| rs12979659 | #4 |
| dth reaction | #4 |
| mhc eae | #4 |
| dead cell remnants | #4 |
| antigen sequence deletion | #4 |
| onset clinical arthritis | #4 |
| congenic c57bl | #4 |
| collagen immune | #4 |
| ox8 | #4 |
| c129s | #4 |
| vav1 rheumatoid arthritis | #4 |
| lnchc | #4 |
| collagen rheumatoid | #4 |
| fpr2 recognition | #4 |
| affinity case | #4 |
| genetic association vav1 | #4 |
| peptide mbp | #4 |
| synovial endothelium | #4 |
| cyclic software | #4 |
| experimental arthritis cii | #4 |
| antibody response mog | #4 |
| tsc mice | #4 |
| citrullinated peptides autoantibodies | #4 |
| type‐ii collagen | #4 |
| k8 k8 mice | #4 |
| endos igg | #4 |
| locus mouse chromosome | #4 |
| arthritis defined | #4 |
| arthritis severity | #4 |
| normal mouse igg | #4 |
| rs682626 | #4 |
| subsets presence | #4 |
| immunodominant cell | #4 |
| mrl dth | #4 |
| autoantibodies type collagen | #4 |
| cia6 | #4 |
| dae3 | #4 |
| cells maternal origin | #4 |
| development sialadenitis | #4 |
| fibβ62 | #4 |
| α1ii chain | #4 |
| type collagen arthritis | #4 |
| citrullinated protein antibodies | #4 |
| autoimmune mrl | #4 |
| krönke | #4 |
| elevated th1 | #4 |
| ethylene isosteres | #4 |
| tnfα p38 mapk | #4 |
| macrophages mycobacteria | #4 |
| anti‐t‐cell | #4 |
| mip mice | #4 |
| cb10 fragment | #4 |
| congenic rats rats | #4 |
| inbred dba peptides | #4 |
| response arthritis | #4 |
| candidate genes rats | #4 |
| rp sle | #4 |
| arthritis mouse | #4 |
| pristane‐induced | #4 |
| acpas serum | #4 |
| fcγr regulation | #4 |
| cii peptide | #4 |
| species regulate | #4 |
| cells cryogel column | #4 |
| parathyroid antibodies | #4 |
| cells cryogel | #4 |
| strain eae | #4 |
| dth mrl | #4 |
| elimination cd8 cells | #4 |
| il‐4‐deficient mice | #4 |
| collagen glycopeptides | #4 |
| rheumatoid arthritis rats | #4 |
| immune response cii | #4 |
| knowledge genetic association | #4 |
| treg cells ctla4 | #4 |
| experimental arthritis humans | #4 |
| placental mhc | #4 |
| autoimmunity rats | #4 |
| inpp4b474r 548p | #4 |
| lxrα pparγ | #4 |
| cii animal epitopes | #4 |
| interaction monoclonal antibody | #4 |
| estrogen cia | #4 |
| cathelicidins ll37 | #4 |
| mutation ncf1 | #4 |
| epitope collagen | #4 |
| experimental cattle cells | #4 |
| experimental genetic | #4 |
| arthritis comp | #4 |
| estrus cycling | #4 |
| asparaginelinked glycan | #5 |
| ros macrophages | #5 |
| rats developed | #5 |
| symptoms development | #5 |
| symptom onset frequency | #5 |
| igg endos | #5 |
| streptococcus pyogenes ides | #5 |
| c‐glycoside analogue | #5 |
| tubule cells kidney | #5 |
| biomarkers 2 polyradiculoneuropathy | #5 |
| wellknown role | #5 |
| position type collagen | #5 |
| glycopeptide | #5 |
| immunization type collagen | #5 |
| pineal gland development | #5 |
| nox animal models | #5 |
| chromosome cia7 | #5 |
| severe arthritis mice | #5 |
| cartilage type | #5 |
| swr mouse | #5 |
| α10i | #5 |
| cd8 deficiency | #5 |
| dba mouse | #5 |
| chick cii | #5 |
| regulating rat | #5 |
| development acpa | #5 |
| tlr3 expression | #5 |
| absence c5 | #5 |
| ovalbumin pepsin | #5 |
| collagen anti | #5 |
| symptoms rheumatoid arthritis | #5 |
| multiplex analyses | #5 |
| monoclonal antibody alpha | #5 |
| ros mca | #5 |
| lew1n | #5 |
| dba 1 mice | #5 |
| smoking prior | #5 |
| immunological involvement | #5 |
| severe sialadenitis | #5 |
| tlr3 macrophages | #5 |
| tbb infection | #5 |
| arthritis onset | #5 |
| oia | #5 |
| resistance cia | #5 |
| mice acpa | #5 |
| tsst1producing | #5 |
| subsets rheumatoid arthritis | #5 |
| cbrh7919 | #5 |
| epitope cii | #5 |
| classical adjuvant | #5 |
| oestradiol vehicle | #5 |
| multiplex array | #5 |
| higher levels melatonin | #5 |
| patients acpa levels | #5 |
| field nox | #5 |
| cgd hyperinflammation | #5 |
| aureus arthritis | #5 |
| immunization male | #5 |
| painlike behavior | #5 |
| hydroxynorvaline | #5 |
| mrvalues | #5 |
| cgd mice | #5 |
| experimental breeding | #5 |
| puccetti | #5 |
| apc cii | #5 |
| low dose tolerance | #5 |
| uterus cells | #5 |
| beta 11 cells | #5 |
| glycopeptidomimetics | #5 |
| citrullinated peptides ccp | #5 |
| eae5 | #5 |
| rt1eu | #5 |
| b‐cell epitope | #5 |
| overexpression hdac3 | #5 |
| tcell mrl | #5 |
| lethal inflammatory disorder | #5 |
| il4deficient mice | #5 |
| immunized animals controls | #5 |
| antibodies filaggrin | #5 |
| arthritis rats | #5 |
| oxidative radicals | #5 |
| congenic nod | #5 |
| recovery ean | #5 |
| ii‐induced | #5 |
| autoimmune disease models | #5 |
| tcell hybridomas | #5 |
| measurement nox activity | #5 |
| interaction cartilage | #5 |
| egfp flow cytometry | #5 |
| antileukoproteinase | #5 |
| glycopeptide fragment | #5 |
| cia model | #5 |
| multiparous mice | #5 |
| delayed immunization rats | #5 |
| pathogenesis autoimmune arthritis | #5 |
| autologous type | #5 |
| citrullinated peptides | #5 |
| lipidomic remodeling | #5 |
| exercise hiit | #5 |
| nox o2• h2o2 | #5 |
| raloxifene disease activity | #5 |
| avridineinduced arthritis | #5 |
| commonly model | #5 |
| type collagen cix | #5 |
| collageninduced arthritis cia | #5 |
| nox complex | #5 |
| o2• h2o2 nox | #5 |
| backcrossed | #5 |
| osteoclasts stromal cells | #5 |
| ly female | #5 |
| arthritogenic cells | #5 |
| cia type collagen | #5 |
| c57bl 6 background | #6 |
| acpa specificities | #6 |
| b10 mouse | #6 |
| activity neuroinflammation | #6 |
| complex mhc | #6 |
| glycoproteins nadph | #6 |
| arthritis antibodies | #6 |
| heterogeneous stock mice | #6 |
| cell recognition | #6 |
| mice congenic | #6 |
| rheumatoid arthritis collagen | #6 |
| murine loci | #6 |
| cia cd4 cells | #6 |
| animal genetic | #6 |
| immunization peptides | #6 |
| eae mhc | #6 |
| collagen cia | #6 |
| metabolic nuclear receptors | #6 |
| staphylococcus aureus arthritis | #6 |
| joints rats | #6 |
| pyramidal neurons loss | #6 |
| acpa anti | #6 |
| ltab | #6 |
| develop arthritis | #6 |
| cd4∶cd8 | #6 |
| controls arthritis | #6 |
| mhcii alleles | #6 |
| pathogenic events | #6 |
| contrasting roles | #6 |
| loci controlling | #6 |
| peptides arthritis | #6 |
| recombinant rat interferongamma | #6 |
| transgenic mice arthritis | #6 |
| cia26 | #6 |
| ccp2 positive | #6 |
| cartilage collagens | #6 |
| arthritis autoantibodies | #6 |
| monoclonal encephalomyelitis autoimmune | #6 |
| arthritis models | #6 |
| autoimmune experimental genes | #6 |
| anti ccp2 | #6 |
| knockout receptors igg | #6 |
| l3t4positive cells | #6 |
| pristane squalene | #6 |
| data ros | #6 |
| dominant suppression | #6 |
| isotypes patients | #6 |
| erosive polyarthritis | #6 |
| treatment oestradiol | #6 |
| macrophages mph | #6 |
| induced psoriasis | #6 |
| rheumatoid arthritis model | #6 |
| glycopeptide specificity | #6 |
| cells affinity surface | #6 |
| nox2 mediates | #6 |
| lys270 | #6 |
| rcramp | #6 |
| relapsing polychondritis rp | #6 |
| female lymphocyte | #6 |
| rheumatoid arthritis comp | #6 |
| betaoestradiol | #6 |
| hdac1 class | #6 |
| mrna tgfbeta | #6 |
| igg autoantibodies sera | #6 |
| tsst1 mice | #6 |
| functional selective | #6 |
| pv loss | #6 |
| mice sialadenitis | #6 |
| disease protective | #6 |
| mice investigated | #6 |
| collagen cells | #6 |
| collagen arthritis | #6 |
| affinity ligand protein | #6 |
| active arthritis | #6 |
| experimental postmenopausal | #6 |
| k8 mice | #6 |
| autoimmunity arthritis | #6 |
| cryogel column | #7 |
| citrullinated peptide antigens | #7 |
| murine psoriasis | #7 |
| nonarthritogenic | #7 |
| rheumatoid arthritis role | #7 |
| glycosylated collagen | #7 |
| congenic strains | #7 |
| g6pi | #7 |
| congenic mouse | #7 |
| strains disease | #7 |
| acpa titres | #7 |
| impaired induction | #7 |
| antigens differentiation arthritis | #7 |
| polychondritis relapsing | #7 |
| 3xi | #7 |
| induction arthritis | #7 |
| chronic experimental | #7 |
| psoriasiform skin disease | #7 |
| periodontitis arthritis | #7 |
| chronic phase arthritis | #7 |
| aplec | #7 |
| autoimmunity collagen | #7 |
| ciireactive cells | #7 |
| collagen arthritis rats | #7 |
| cia mice | #7 |
| antibodyinduced arthritis | #7 |
| autoantibodies lymphocytes | #7 |
| collagen arthritis cia | #7 |
| cii anti | #7 |
| animal immunization injections | #7 |
| cab3 | #7 |
| response immunization | #7 |
| collagen epitope | #7 |
| cii apc | #7 |
| isomerase peptide | #7 |
| ean animals | #7 |
| rats phases | #7 |
| mbp peptide | #7 |
| autoantibodies citrullinated peptides | #7 |
| transgenic class | #7 |
| snecs | #7 |
| arthritis strains | #7 |
| castrated females | #7 |
| region syntenic | #7 |
| cia5 | #7 |
| mediated vasculitis | #7 |
| arthritis genes | #7 |
| cognate activation | #7 |
| raassociated molecules | #7 |
| protective influences | #7 |
| impact cia | #7 |
| type collagen | #7 |
| hydrolases polymorphism | #7 |
| symptoms disease onset | #7 |
| arthritis type collagen | #7 |
| responses cii | #7 |
| macrophages alternative activation | #7 |
| conventional environment | #7 |
| regulatory cells macrophages | #7 |
| effector phase | #7 |
| mice constant darkness | #7 |
| analysis crosses | #7 |
| locus chromosome | #7 |
| oestrogen rats | #7 |
| role raloxifene | #7 |
| antibodies citrullinated antigens | #7 |
| yaa gene | #7 |
| mouse collagen | #7 |
| autoimmune human | #7 |
| haematogenously | #8 |
| expression hdac3 | #8 |
| t‐cell priming | #8 |
| eae genetic encephalomyelitis | #8 |
| murinised | #8 |
| parathyroid glands receptors | #8 |
| rats mhc | #8 |
| non‐mhc | #8 |
| hybridomas antibodies | #8 |
| antibody vivo | #8 |
| neutrophil cytosolic | #8 |
| diseases loci | #8 |
| supermacroporous cryogel | #8 |
| eae3 | #8 |
| chronic autoimmune arthritis | #8 |
| fcγr2b | #8 |
| dominant cell epitope | #8 |
| heterologous peptide | #8 |
| b10 background | #8 |
| inflamed synovia | #8 |
| sialadenitis mrl | #8 |
| cia animal model | #8 |
| onset incidence | #8 |
| autoantibodies collagen type | #8 |
| experimental binding | #8 |
| ifa cii | #8 |
| induced neuropathology | #8 |
| autoantibodies subset | #8 |
| experimental autoimmune disease | #8 |
| polymeric cryogels | #8 |
| persistent joint pain | #8 |
| destructive effects | #8 |
| hladrb11001 | #8 |
| mice techniques | #8 |
| arthritis lymphocytes | #8 |
| autologous peptide | #8 |
| antibodies acpas | #8 |
| clinical signs ean | #8 |
| murine locus | #8 |
| 297 cases | #8 |
| underlying genes | #8 |
| incidence cia | #8 |
| chromosomes loci | #8 |
| onset day day | #8 |
| cia2 | #8 |
| lyme arthritis severity | #8 |
| autoimmune congenic mice | #8 |
| rheumatoid chromosome | #8 |
| patients type collagen | #8 |
| cosphox | #8 |
| ros interplay | #8 |
| rt1f | #8 |
| α1‐microglobulin | #8 |
| illness igg | #8 |
| 42 rats | #8 |
| hlase alleles | #8 |
| oxidized peptides | #8 |
| antigenspecific priming | #8 |
| mice ifnbeta | #8 |
| ptpn22620w | #8 |
| treatment monoclonal | #8 |
| rheumatoid autoimmunity | #8 |
| mbp mog | #8 |
| humans experimental arthritis | #8 |
| oia2 | #8 |
| medium mem | #8 |
| typeii collagen | #8 |
| hdac3 expression | #8 |
| mumt mice | #8 |
| collagen complement | #9 |
| reduced arthritis | #9 |
| mammalian disease models | #9 |
| rheumatoid autoantibodies | #9 |
| 2 nadph | #9 |
| adaptive inflammation | #9 |
| nodp | #9 |
| bound carbohydrates | #9 |
| inbred lew tlymphocytes | #9 |
| rt1u | #9 |
| specific nox2 | #9 |
| oil adjuvants | #9 |
| alpha1inhibitor3 | #9 |
| avridine | #9 |
| cia transgenic mice | #9 |
| induced metabolic syndrome | #9 |
| histone 1 hdac1 | #9 |
| eae immunization | #9 |
| variants acpa | #9 |
| intranasal animals arthritis | #9 |
| early joint erosions | #9 |
| murine collagen | #9 |
| idiotype‐specific | #9 |
| loci rats | #9 |
| autoimmunogenic | #9 |
| collagen female | #9 |
| illness receptor | #9 |
| experimental genes | #9 |
| posttranslational glycosylation | #9 |
| antibody alpha | #9 |
| serum interferon | #9 |
| acpas patients | #9 |
| hitr | #9 |
| experimental arthritis rats | #9 |
| oligomeric matrix | #9 |
| class allele | #9 |
| pristane | #9 |
| hgpi325 | #9 |
| animal models urgent | #9 |
| rats rat | #9 |
| disease strains | #9 |
| antibodies vivo | #9 |
| development autoimmune arthritis | #9 |
| response mouse | #9 |
| patients acpas | #9 |
| human immunopeptidome | #9 |
| mouse peptide | #9 |
| differentiation autoimmune | #9 |
| psychological tyrosine | #9 |
| bovine cii | #9 |
| rheumatoid joints | #9 |
| postmenopausal arthritis | #9 |
| b10riii mice | #9 |
| ean myelin | #9 |
| specific sets | #9 |
| arthritis skg mice | #9 |
| effects mabs | #9 |
| il10 role | #9 |
| acpas | #9 |
| arthritis cross | #9 |
| ox19 | #9 |
| inbred dba mice | #9 |
| severe erosive | #10 |
| cartilage arthritis | #10 |
| mice genistein | #10 |
| animal models | #10 |
| h2ap | #10 |
| monoclonal arthritis | #10 |
| rats lewis rats | #10 |
| native collagen type | #10 |
| prl effects | #10 |
| cartilage collagen fibrils | #10 |
| passive transfer experiments | #10 |
| monoclonal antigens rats | #10 |
| mice nadph | #10 |
| tertbutylacrylamide | #10 |
| antibodies specific | #10 |
| cartilage oligomeric | #10 |
| abp gene | #10 |
| mbp peptides | #10 |
| rheumatoid arthritis dr4 | #10 |
| cell‐deficient | #10 |
| nih heterogeneous stock | #10 |
| development severity | #10 |
| collagen autoimmunity | #10 |
| reactivity acpas | #10 |
| activation male | #10 |
| presence acpa | #10 |
| alpha collagen chains | #10 |
| acpa diagnosis | #10 |
| immunization rats | #10 |
| o2• h2o2 | #10 |
| cd4 cells spleen | #10 |
| acutephase response rats | #10 |
| oestrogen | #10 |
| axotomized motor neurons | #10 |
| cells development | #10 |
| extracellular cartilage | #10 |
| experimental cartilage | #10 |
| mutated mice | #10 |
| hlase smoking | #10 |
| genetic experiments | #10 |
| cii mice | #10 |
| endogenous collagen | #10 |
| citrullinated antigen | #10 |
| knockout nadph | #10 |
| mice cii | #10 |
| stock mice | #10 |
| ifnbeta mice | #10 |
| antibody collagen | #10 |
| inbred dba | #10 |
| autoimmune disease humans | #10 |
| dense fractions | #10 |
| beta 11 | #10 |
| pain animal models | #10 |
| onset chromosome | #10 |
| cells increased production | #10 |
| 2xi | #11 |
| development rheumatoid | #11 |
| stromal cells macrophages | #11 |
| loci regulating | #11 |
| rat arthritis | #11 |
| gad6 | #11 |
| 84–102 | #11 |
| isotypes | #11 |
| antibody type collagen | #11 |
| lentiviral vector expression | #11 |
| cia7 | #11 |
| tailbase | #11 |
| rat collagen | #11 |
| naïve cells cells | #11 |
| mhc control | #11 |
| mice cd1 | #11 |
| antibodies association | #11 |
| chondrocytes ecm | #11 |
| antigen variability | #11 |
| ptpn22 smoking | #11 |
| chronic arthritis | #11 |
| liver receptor lxrα | #11 |
| fragments anti | #11 |
| rat liver rats | #11 |
| cells pia | #11 |
| nodb10h2b mice | #11 |
| cia30 | #11 |
| potential autoantigens | #11 |
| dss wt | #11 |
| monoclonal rheumatoid factors | #11 |
| mice mhc | #11 |
| species respiratory | #11 |
| individuals onset | #11 |
| inflammatory arthritis role | #11 |
| arthritis absence | #11 |
| pia1 | #12 |
| serum concentrations comp | #12 |
| reduces severity | #12 |
| lung macrophages mice | #12 |
| natural loss | #12 |
| stages pathogenesis | #12 |
| α1ii | #12 |
| immunodominant | #12 |
| stage cia | #12 |
| associations antibodies | #12 |
| rats cia | #12 |
| bovine type collagen | #12 |
| myelin ean | #12 |
| structure antibodies | #12 |
| natural polymorphism | #12 |
| frequencies antibodies | #12 |
| qa2 | #12 |
| peptide study | #12 |
| mbp response | #12 |
| cii patients | #12 |
| mutated mouse | #12 |
| chronic erosive arthritis | #12 |
| major haplotype | #12 |
| lymphoid cells development | #12 |
| study arthritis | #12 |
| onset symptoms | #12 |
| fpr2 agonists | #12 |
| riiis | #12 |
| illness sex characteristics | #12 |
| icmediated | #12 |
| mutation nadph | #12 |
| treatment experimental arthritis | #12 |
| loci disease | #12 |
| autoimmune monoclonal antigens | #12 |
| psoriasis mouse model | #12 |
| animal immunohistochemistry | #12 |
| genetic contamination | #12 |
| backgroundantibodies | #12 |
| encephalomyelitis induced | #12 |
| type collagen immunization | #12 |
| increased litter size | #12 |
| psoriasis arthritis | #12 |
| hydroxylysines | #12 |
| nonselfdiscrimination | #12 |
| rats expression | #12 |
| cell responses cii | #12 |
| antibodies structures | #12 |
| matrilin | #12 |
| cross rats | #12 |
| role arthritis | #12 |
| mice comp | #12 |
| ccp2 antibodies | #13 |
| mouse strains | #13 |
| behavioral alterations rats | #13 |
| antibodies citrullinated proteins | #13 |
| major loci | #13 |
| mtec aire | #13 |
| l012 | #13 |
| genes mouse chromosome | #13 |
| complement complement activation | #13 |
| nos2derived | #13 |
| factor isotypes | #13 |
| development type collagen | #13 |
| strains incidence | #13 |
| doses ici | #13 |
| μ chain | #13 |
| idd5 | #13 |
| macroscopic scoring | #13 |
| native type collagen | #13 |
| rfigg | #13 |
| species deficiency | #13 |
| lew1w | #13 |
| mannan | #13 |
| cells salivary glands | #13 |
| 24dinitro1fluorobenzene | #13 |
| cell epitope | #13 |
| advanced intercross | #13 |
| joints blood | #13 |
| citrullinated | #13 |
| oxidase nox2 | #13 |
| hladrb1 ptpn22 | #13 |
| t‐cell epitope | #13 |
| expression egfp | #13 |
| levels nabs | #13 |
| anticii | #13 |
| immunohistochemistry interferon | #13 |
| dba molecular | #13 |
| cyclic citrullinated | #13 |
| b10p | #13 |
| arthritis knowledge | #13 |
| epitope immunization | #13 |
| nonobese diabetic mouse | #13 |
| bcelldeficient mice | #13 |
| ho4 | #13 |
| dr1 transgenic | #13 |
| sequence collagen | #13 |
| oxidative regulation | #13 |
| multispecific | #13 |
| sirt1 mmp9 | #14 |
| candidate autoantigens | #14 |
| gut protection | #14 |
| autoimmunity animals | #14 |
| loci interaction | #14 |
| cia expression | #14 |
| collagen disease | #14 |
| immune regulators | #14 |
| antifilaggrin antibodies | #14 |
| peptides anti | #14 |
| collagen comp | #14 |
| experimental interferon | #14 |
| loci rheumatoid | #14 |
| b6n mice | #14 |
| humans nadph | #14 |
| blymphocyte female humans | #14 |
| macrophages immune response | #14 |
| arlacel | #14 |
| murine collageninduced arthritis | #14 |
| nasal inhalation | #14 |
| involvement cells | #14 |
| molecular disease models | #14 |
| arthritic paws | #14 |
| specific inflammation | #14 |
| deficient production | #14 |
| aggregated nets | #14 |
| autoimmune arthritis | #14 |
| osteoclasts vivo | #14 |
| efficient promotion | #14 |
| smallmolecule compound | #14 |
| presence mcv | #14 |
| mhc class region | #14 |
| protein collagen | #14 |
| thr233 | #14 |
| immunized rat | #14 |
| translationally modified | #15 |
| amps development | #15 |
| regulation adaptive immunity | #15 |
| type collagen development | #15 |
| presence anticarp antibodies | #15 |
| nodb10h2b | #15 |
| cdr regions | #15 |
| aire mtec | #15 |
| arthritis development | #15 |
| apcs macrophages | #15 |
| integrated bioprocess | #15 |
| 2 weight | #15 |
| rt1a | #15 |
| anticollagen | #15 |
| citrullinated peptides patients | #15 |
| monoclonal arthritis rats | #15 |
| treatment cia | #15 |
| rat genetics | #15 |
| raloxifene estradiol | #15 |
| tflask | #15 |
| ros cii | #15 |
| rheumatoid arthritis presence | #15 |
| rats monoclonal antigens | #15 |
| involvement pathogenesis | #15 |
| lentiviral gene delivery | #15 |
| dcii | #15 |
| mice immunization | #15 |
| mhc class molecule | #15 |
| mice type collagen | #15 |
| experimental allergic neuritis | #15 |
| osteoporosis development | #15 |
| antibodies arthritis | #15 |
| congenic rats | #15 |
| arthritis role | #15 |
| immune complex formation | #15 |
| murine cia | #15 |
| neuritis rats | #15 |
| polychondritis | #15 |
| cultured human chondrocytes | #15 |
| exaggerates | #15 |
| monolithic cryogel | #15 |
| antigenic epitope | #15 |
| cep1 | #16 |
| mumt | #16 |
| n305 | #16 |
| antinuclear autoimmunity | #16 |
| rt1 | #16 |
| nonglycosylated form | #16 |
| pparγ lxrα | #16 |
| rno10 | #16 |
| staphylococcal arthritis | #16 |
| arthritis cii | #16 |
| class transplantation | #16 |
| disease mice mice | #16 |
| males onset | #16 |
| rheumatoid factor production | #16 |
| mhcii ciita | #16 |
| levels natural antibodies | #16 |
| anti‐t | #16 |
| oligomeric matrix protein | #16 |
| subspecificities | #16 |
| hla–drb1 shared epitope | #16 |
| fewer osteoclasts | #16 |
| autologous collagen | #16 |
| mhc genes | #16 |
| lew1 | #16 |
| rheumatoid arthritis genes | #16 |
| epitopes mice mice | #16 |
| arthritis severity mice | #16 |
| development rheumatoid arthritis | #16 |
| rats experimental arthritis | #16 |
| indirect genetic predisposition | #16 |
| acute inflammation mice | #16 |
| matrilin proteins | #16 |
| h2p | #16 |
| congenic mice mice | #16 |
| lethal inflammatory | #16 |
| genes animals | #16 |
| leuphe | #17 |
| collagen induced arthritis | #17 |
| cells collagen | #17 |
| human fcγriia | #17 |
| cartilage collagen | #17 |
| animals congenic | #17 |
| progesterone development | #17 |
| cab4 | #17 |
| rats lewis | #17 |
| polyphosphate4 | #17 |
| mice rheumatoid arthritis | #17 |
| skg | #17 |
| cells presenting cells | #17 |
| rheumatoid arthritis subsets | #17 |
| genistein mice | #17 |
| spleen peyers patches | #17 |
| allergic neuritis | #17 |
| native denatured | #17 |
| clever1 | #17 |
| inbred lew | #17 |
| strains lymphocytes | #17 |
| triplehelical conformation | #17 |
| nox2 derived | #17 |
| cells female mice | #17 |
| onset rheumatoid arthritis | #17 |
| ethanol development | #17 |
| rt1av1 | #17 |
| arthritis rheumatoid autoantibodies | #17 |
| periodontitis antibodies | #17 |
| collagen specific | #17 |
| genes spleen | #18 |
| expression lxrα | #18 |
| anti cd44 | #18 |
| purified anti | #18 |
| cartilage type collagen | #18 |
| autoimmune illness | #18 |
| h2z | #18 |
| humanized transgenic mice | #18 |
| day immunization | #18 |
| ealkene | #18 |
| ros data | #18 |
| disease duration onset | #18 |
| arthritis anti | #18 |
| short‐term administration | #18 |
| joint inflammatory | #18 |
| collagen autoantibodies | #18 |
| moginduced eae | #18 |
| hybridomas mice mice | #18 |
| cuiiida | #18 |
| addition ros | #18 |
| keratinocytes induction | #18 |
| day arthritis | #18 |
| salivary glands mice | #18 |
| defined epitope | #18 |
| phenotypic feature | #18 |
| langerhans cells cells | #18 |
| galactose moiety | #18 |
| dra0101 | #18 |
| adjuvant arthritis rats | #18 |
| citrullinated proteins acpa | #19 |
| supermacroporous | #19 |
| cd4 transgenic | #19 |
| mice congenic mice | #19 |
| blood monocytes neutrophils | #19 |
| vivo elimination | #19 |
| patients polychondritis | #19 |
| three‐dimensional culture | #19 |
| tbetarii gene | #19 |
| single intradermal injection | #19 |
| new avenues | #19 |
| future utility | #19 |
| mice develop | #19 |
| beta oestradiol | #19 |
| elisa cia | #19 |
| inflammatory attack | #19 |
| mrl mp mice | #19 |
| cia eae | #19 |
| collagen response | #19 |
| trimolecular complex | #19 |
| peyers patches spleen | #19 |
| suppression dth | #19 |
| castrated female rats | #19 |
| protective alleles | #19 |
| protein comp | #19 |
| gly262 | #19 |
| rats snp | #19 |
| ciita mhcii | #20 |
| 5p14 | #20 |
| enhanced tcr | #20 |
| mbp rats | #20 |
| 5r5 | #20 |
| mhc class alleles | #20 |
| progesterone oestrogen | #20 |
| monkeys rodents | #20 |
| serm raloxifene | #20 |
| underlying gene | #20 |
| role nox | #20 |
| imaging reactive | #20 |
| stress phospholipids | #20 |
| matrilin1 | #20 |
| ncr3 | #20 |
| fls tnfα | #20 |
| knockout mice transgenic | #20 |
| mice cia | #20 |
| response mbp | #20 |
| inflammation mice | #20 |
| human rheumatoid arthritis | #20 |
| glycosylated | #20 |
| experimental autoimmunity | #20 |
| littermate | #20 |
| development disease | #20 |
| pvg1av1 | #20 |
| rt1d | #20 |
| antibody treatment | #20 |
| highly susceptible | #20 |
| nox1deficient mice | #20 |
| loci chromosomes | #20 |
| prominent infiltration | #20 |
| granule mobilization | #21 |
| nitratenitriteno pathway | #21 |
| cells adaptive immune | #21 |
| supermacroporous cryogels | #21 |
| suppressor cytotoxic cells | #21 |
| olahsd | #21 |
| mice mutant strains | #21 |
| conserved haplotype | #21 |
| nox2 mice | #21 |
| triplehelical peptides | #21 |
| n286 | #21 |
| genes controlling | #21 |
| arthritis pregnancy | #21 |
| igg fcgammar | #21 |
| serum levels comp | #21 |
| ean rats | #21 |
| linomide treatment | #21 |
| muscle ros | #21 |
| experimental rheumatoid | #21 |
| α1acidglycoprotein | #21 |
| positional cloning | #21 |
| diseases lymphocytes | #21 |
| n141 | #21 |
| onset severity | #21 |
| pathogenesis rheumatoid | #21 |
| drb11001 | #21 |
| nox2 activity | #21 |
| rats development | #21 |
| individual acpa | #21 |
| cia treatment | #21 |
| chronic relapsing | #21 |
| illness autoimmune | #21 |
| semiallogenic | #22 |
| identification susceptibility genes | #22 |
| 270 | #22 |
| 81a | #22 |
| rats loss | #22 |
| response myelin | #22 |
| rats nonalcoholic steatohepatitis | #22 |
| samples onset | #22 |
| induced eae | #22 |
| antiidiotypic antibody | #22 |
| ccp negative | #22 |
| determinant selection | #22 |
| mice independent | #22 |
| vh j558 | #22 |
| ul1 | #22 |
| c57bl mice subfamily | #22 |
| association pv | #22 |
| animal epitopes humans | #22 |
| cultured hepatic cells | #22 |
| experimental phenotype | #22 |
| onset cia | #23 |
| 17 betaoestradiol | #23 |
| mbp eae | #23 |
| mace association | #23 |
| rats inbred lew | #23 |
| experimental autoimmune diseases | #23 |
| tgfbeta resistance | #23 |
| inflammation absence | #23 |
| complex influences | #23 |
| diseases autoimmunity | #23 |
| cells presentation | #23 |
| 4npa | #23 |
| citrullinated antigens | #23 |
| castration rats | #23 |
| arthritis type | #23 |
| citrullinated epitopes | #23 |
| lymphocytes amino | #23 |
| comp | #23 |
| anti‐cd5 | #23 |
| immunopeptides | #23 |
| cryogel beads | #23 |
| monoclonal antigens autoimmune | #23 |
| b10r | #23 |
| loss collagen | #23 |
| antibodies acpa | #23 |
| phage clones | #23 |
| citrullinated protein | #23 |
| cells b10 | #23 |
| experimental chromatography | #23 |
| animal genes | #23 |
| peptide activation | #23 |
| mice nox2 | #24 |
| subloci | #24 |
| ftirm | #24 |
| cells c3h | #24 |
| inflammation arthritis | #24 |
| animal epistasis | #24 |
| flss patients | #24 |
| loci chromosome | #24 |
| severity ali | #24 |
| postpartum flare | #24 |
| severity chronicity | #24 |
| mediated arthritis | #24 |
| y35 | #24 |
| autoantibodies rheumatoid | #24 |
| monoclonal anti | #24 |
| experimental cells | #24 |
| antinuclear apoptosis | #24 |
| rat induction | #24 |
| new mouse | #24 |
| mouse models development | #24 |
| 339 | #24 |
| secondary immune response | #24 |
| chronic autoimmune diseases | #24 |
| levels comp | #24 |
| controls anti | #24 |
| experimental lupus | #24 |
| c57bl 10 mice | #24 |
| cix | #25 |
| parasitemia survival | #25 |
| autoimmune diseases humans | #25 |
| proteinarginine deiminase type | #25 |
| monocytes nadph | #25 |
| massive infiltration | #25 |
| rat mhc | #25 |
| interleukin2 mice receptors | #25 |
| arginine arthritis | #25 |
| murine lyme arthritis | #25 |
| autoantibody response | #25 |
| relapsing polychondritis | #25 |
| ros | #25 |
| tolerized rats | #25 |
| arthritis experimental arthritis | #25 |
| bnda | #25 |
| complex male | #25 |
| cell hybridomas | #25 |
| immunization development | #25 |
| rno4 | #25 |
| production monoclonal | #25 |
| 8 antibodies | #25 |
| common autoimmune disease | #25 |
| collagen cartilage | #25 |
| inbred lew rats | #25 |
| congenic animals | #25 |
| autoimmune messenger | #25 |
| b6 balb | #25 |
| beta lymphocytes | #25 |
| specific epitopes | #25 |
| cells immunization | #25 |
| immunodominant epitope | #25 |
| nitrophenylalanine | #26 |
| post translationally | #26 |
| cells joints | #26 |
| local exposure | #26 |
| mice gammadelta cells | #26 |
| hydrocarbon oil | #26 |
| helperinducer animals antibodies | #26 |
| autoantibodies citrullinated proteins | #26 |
| glutamax | #26 |
| igg2a mice | #26 |
| eae development | #26 |
| anti citrullinated | #26 |
| gene regions | #26 |
| viable chondrocytes | #26 |
| polychondritis rp | #26 |
| cb11 | #26 |
| granulocytes cells | #26 |
| interleukin21 tlymphocytes | #27 |
| immunodominant response | #27 |
| hladrb1 shared epitope | #27 |
| physiological level | #27 |
| ccp2 | #27 |
| individuals antibodies | #27 |
| innate interleukin10 | #27 |
| rheumatoid factor isotypes | #27 |
| c1i | #27 |
| intercrossed | #27 |
| pointmutation | #27 |
| nonmhc genes | #27 |
| immunospecific | #27 |
| trypsination | #27 |
| disease immunoglobulin | #27 |
| pannus tissue | #27 |
| perforin deficiency | #27 |
| antibodies type | #27 |
| onset day | #28 |
| mrna ifngamma | #28 |
| severity day | #28 |
| autoimmune inflammatory | #28 |
| animal models neurodegeneration | #28 |
| w3 25 | #28 |
| chronicity | #28 |
| antibodies mab | #28 |
| anti rat | #28 |
| protein peptides | #28 |
| cartilage vivo | #28 |
| nr8383 | #28 |
| rat strain | #28 |
| ros induction | #28 |
| mediated effects | #28 |
| lysine position | #28 |
| upregulation cytokines | #28 |
| eae susceptibility | #28 |
| antigenspecific tolerance | #28 |
| antily6g | #28 |
| cia3 | #28 |
| ls2616 | #29 |
| absence inflammation | #29 |
| phenomes | #29 |
| glucose transport capacity | #29 |
| presence synovial fluid | #29 |
| antibody producing cells | #29 |
| 246trinitrophenyl | #29 |
| acpa | #29 |
| cfa cia | #29 |
| chronic dss | #29 |
| smoking presence | #29 |
| parotid secretory protein | #29 |
| rfigm | #29 |
| hiit exercise | #29 |
| ros production macrophages | #29 |
| peptide anti | #29 |
| membrane lymphocytes | #29 |
| suboptimal doses | #29 |
| mice mab | #29 |
| immunopathogenicity | #29 |
| vgenes | #30 |
| linkage disease | #30 |
| plasminogendeficient mice | #30 |
| translational rats | #30 |
| increased salt | #30 |
| hlase | #30 |
| synovial cells patients | #30 |
| treatment raloxifene | #30 |
| ctla4 mice | #30 |
| metabolic syndrome rats | #30 |
| alphabetat | #30 |
| dba mice | #30 |
| acpa fine | #30 |
| development experimental | #30 |
| vivo exercise | #30 |
| adult thymectomy | #30 |
| variable heavy chain | #30 |
| paws | #30 |
| cultivation cells | #30 |
| 11 cells | #30 |
| disease immunity | #30 |
| chain collagen | #30 |
| vpba | #30 |
| chronic autoimmune | #30 |
| disease development | #31 |
| littermate controls | #31 |
| hiit training | #31 |
| psoriasis model | #31 |
| common chain | #31 |
| selfprotein | #31 |
| expressing cells | #31 |
| human type collagen | #31 |
| trimolecular | #31 |
| ige cd23 | #31 |
| pristaneinduced lupus | #31 |
| perpetuated | #31 |
| apc development | #31 |
| nox2 nox1 | #31 |
| phytol | #31 |
| monoclonal antibody production | #31 |
| comparative genetic analysis | #31 |
| immunization | #31 |
| acute‐phase response | #31 |
| synovial fluid blood | #31 |
| drugs addition | #31 |
| rats autoimmune | #31 |
| h2aq | #32 |
| ros rns | #32 |
| steen | #32 |
| epitope antibodies | #32 |
| 11 cell | #32 |
| acpa rheumatoid arthritis | #32 |
| polymorphic genes | #32 |
| rt11 | #32 |
| genomewide genotyping | #32 |
| influence genes | #32 |
| differentiation arthritis | #32 |
| nonb cells | #32 |
| cell ratio | #32 |
| congenic mice | #32 |
| arthritis therapy | #32 |
| caia mice | #32 |
| receptor preference | #32 |
| role osteoclastogenesis | #32 |
| cells uterus | #32 |
| ra33 | #32 |
| presence acpas | #32 |
| beta mice | #32 |
| mucosal tolerance | #32 |
| hladrb104 | #32 |
| bound peptides | #32 |
| nadph oxidases nox | #32 |
| type antibody | #32 |
| specificity function | #32 |
| methods serum samples | #32 |
| nodes mice | #32 |
| delayed type | #33 |
| skews | #33 |
| tolerance immunization | #33 |
| induced immunization | #33 |
| rheumatoid joint | #33 |
| cytosolic factor | #33 |
| antigenpresenting cells cells | #33 |
| tcell receptor | #33 |
| modified collagen | #33 |
| role vav1 | #33 |
| multiplex analysis | #33 |
| arthritic mice | #33 |
| autoantibody activity | #33 |
| epitopes antibodies | #33 |
| type cross | #33 |
| autoimmune demyelinating disease | #33 |
| patients animal models | #34 |
| nox2 deficiency | #34 |
| joint pathology | #34 |
| promiscuous expression | #34 |
| c4bp | #34 |
| chronic polyarthritis | #34 |
| heterogeneous stock | #34 |
| cells dendritic cells | #34 |
| neurodegeneration role | #34 |
| interferon activity | #34 |
| fpr1 | #34 |
| natural antibodies nabs | #34 |
| antirat | #35 |
| nets neutrophils | #35 |
| psoriasiform skin | #35 |
| vdr cells | #35 |
| phagotope | #35 |
| acs stroke | #35 |
| major regulators | #35 |
| 1xi | #35 |
| destructive arthritis | #35 |
| hybridomas | #35 |
| complex arthritis | #35 |
| autoreactive | #35 |
| patients populations | #35 |
| accessible sites | #35 |
| development chronic | #35 |
| antiarthritis | #35 |
| plasminogen deficiency | #35 |
| monoclonal rheumatoid | #35 |
| triple helical | #35 |
| arthritis disease | #35 |
| infectious disease models | #35 |
| dinitro1 | #36 |
| animals antigen | #36 |
| cii cfa | #36 |
| comparative genetics | #36 |
| techniques mice | #36 |
| tolerance tlymphocytes | #36 |
| protein specific | #36 |
| phagocyte | #36 |
| induction tregs | #36 |
| dth | #36 |
| nk cells recognition | #36 |
| specificity sera | #36 |
| oxidases rna | #36 |
| arthritis cartilage | #36 |
| h2g7 | #36 |
| flow cytometry expression | #36 |
| cartilage joints | #36 |
| variance animals antibodies | #36 |
| h2r | #36 |
| female histocompatibility | #36 |
| rich lipid | #37 |
| acpa positive | #37 |
| synthetic glycopeptides | #37 |
| oxidases oxidation | #37 |
| spontaneous arthritis | #37 |
| recombinant vaccine | #37 |
| susceptibility autoimmune diseases | #37 |
| immunopathological features | #37 |
| cii protein | #37 |
| genetic control | #37 |
| lymphocytes disease | #37 |
| role gamma interferon | #37 |
| joint cartilage | #37 |
| c129 | #37 |
| peptides binding | #37 |
| dba1 | #37 |
| mif pathogenesis | #37 |
| encephalomyelitis | #37 |
| target autoantigens | #38 |
| antibodies animals | #38 |
| cldn4 | #38 |
| human blood neutrophils | #38 |
| innovative tools | #38 |
| nitrogen species | #38 |
| sialophorin | #38 |
| cochranmantelhaenszel test | #38 |
| animal models pain | #38 |
| snat | #38 |
| endoβnacetylglucosaminidase | #39 |
| resultsrats | #39 |
| data myelin | #39 |
| ccia | #39 |
| wasting syndrome | #39 |
| nzw | #39 |
| ym1 | #39 |
| benoist | #39 |
| autoreactive cells | #39 |
| nfr | #39 |
| acpa response | #39 |
| allogeneically | #39 |
| oestrogen treatment | #39 |
| cell tolerance | #39 |
| measurement activity | #39 |
| clonal expansion cells | #39 |
| b6n | #39 |
| peptide cell | #40 |
| antigens arthritis | #40 |
| polyclonal cell activation | #40 |
| adjuvant induced | #40 |
| genetic complexity | #40 |
| rt1c | #40 |
| positive rheumatoid | #40 |
| disease animal models | #40 |
| addition impact | #40 |
| isostere | #40 |
| aq | #41 |
| effects experiments | #41 |
| rats anti | #41 |
| immunocap isac | #41 |
| rat myelin | #41 |
| severity incidence | #41 |
| ncii | #41 |
| congenic mapping | #41 |
| autoimmune | #41 |
| genes loci | #41 |
| mhc haplotype | #41 |
| priming phase | #41 |
| autoimmune inflammatory diseases | #41 |
| articular collagen | #42 |
| species receptors | #42 |
| ptpn22 locus | #42 |
| th17 axis | #42 |
| pineal gland melatonin | #42 |
| cartilage bone destruction | #42 |
| drb1 shared | #42 |
| fibroblasts mice | #42 |
| antibody isotypes | #42 |
| mhc class class | #42 |
| spleen weight | #42 |
| expected onset | #42 |
| p38 mapk nfκb | #42 |
| anticitrullinated | #43 |
| lew rats | #43 |
| pc8 | #43 |
| collagen | #43 |
| treatment autoimmune diseases | #43 |
| type‐ii | #43 |
| anticyclic | #43 |
| crosses genetic | #43 |
| cd11bly6g | #43 |
| kgf treatment | #43 |
| mice autoimmune | #43 |
| congeneic | #43 |
| arthritis data | #43 |
| immunodominant epitopes | #43 |
| rats sex | #43 |
| autoreactive cell | #43 |
| spinal glia | #43 |
| lew lymphocytes | #43 |
| c4bbinding protein c4bp | #44 |
| neuritis ean | #44 |
| mice adulthood | #44 |
| homozygous form | #44 |
| defensins humans | #44 |
| genetic linkage analysis | #44 |
| provocations | #44 |
| addition order | #44 |
| peptide induced | #44 |
| epitopes lymphocyte | #44 |
| mathis | #44 |
| inflammation animals | #44 |
| chloro23 | #44 |
| mice mice autoimmune | #44 |
| susceptibility arthritis | #45 |
| chromosome development | #45 |
| potent suppression | #45 |
| genetic encoding | #45 |
| relapsing disease | #45 |
| nzb | #45 |
| phagotopes | #45 |
| outbred rats | #45 |
| disease histocompatibility | #45 |
| rat2 | #46 |
| alphachains | #46 |
| neuritis autoimmune | #46 |
| posttranslationally | #46 |
| cocrystallisation | #46 |
| carp antibodies | #46 |
| lower severity | #46 |
| locus controlling | #46 |
| affinity purified | #46 |
| eae mbp | #46 |
| isosteres | #46 |
| disease induction | #46 |
| c227 | #46 |
| specific tolerance | #46 |
| mhc class humans | #46 |
| protective allele | #47 |
| complex mediated | #47 |
| f1 hybrid mice | #47 |
| diagnostic accuracy diagnosis | #47 |
| antibody reactivities | #47 |
| idiotypic antibody | #47 |
| association hladrb1 alleles | #47 |
| posttranslational rats receptors | #47 |
| intercrosses | #47 |
| rheumatoid factors | #47 |
| f1 crosses | #48 |
| mice nzb | #48 |
| humanized model | #48 |
| antibody specificity | #48 |
| collagen glycosylation | #48 |
| tlr12 | #48 |
| collagen peptide | #48 |
| acetylchitobiose | #48 |
| γchains | #48 |
| peptide recognized | #48 |
| synovial lining layer | #48 |
| mice carrying | #48 |
| experimental arthritis mice | #48 |
| cia rats | #48 |
| lupus disease | #48 |
| sex genes | #49 |
| polyvinylcaprolactam | #49 |
| monoclonal autoimmune diseases | #49 |
| experimental crosses | #49 |
| tcell stimulation | #49 |
| class major | #49 |
| histone hdacs | #49 |
| bystander activation | #49 |
| mouse cartilage | #49 |
| comp levels | #49 |
| immune nervous | #49 |
| mice caia | #49 |
| antigenantibody | #50 |
| ciiia | #50 |
| disease rats | #50 |
| dependent chronic | #50 |
| cytometry analyses | #50 |
| glutamine uptake | #50 |
| glycosylated form | #50 |
| mice tolerance | #50 |
| alagly | #50 |
| parathyroid cells | #50 |
| inflammation kynurenine | #50 |
| complex region | #50 |
| animal cell culture | #50 |
| loci animals | #50 |
| anticarbamylated protein | #50 |
| monoclonal epitopes | #50 |
| autoantibodies rheumatoid arthritis | #51 |
| aire mice | #51 |
| rheumatoid factor activity | #51 |
| c57bl 6j background | #51 |
| evidence animal models | #51 |
| runting | #51 |
| lentiviral particles | #51 |
| cells ova | #51 |
| inbred c57bl autoimmune | #51 |
| tracheal cartilage | #51 |
| antibodies cells | #51 |
| derived type | #51 |
| tolerized | #51 |
| fewer cells | #51 |
| delayed immunization | #51 |
| xor activity | #52 |
| antigenpresenting cells | #52 |
| macrophages skin | #52 |
| model collagen | #52 |
| matrix protein | #52 |
| ptpn22 | #52 |
| production reactive | #53 |
| antibodies epitopes | #53 |
| patients rheumatic conditions | #53 |
| triple helical structure | #53 |
| protein antibodies | #53 |
| arthritis induction | #53 |
| cartilage erosion | #53 |
| induced autoimmunity | #53 |
| carbamylated proteins | #53 |
| lysosomal compartments | #53 |
| aged peptides | #53 |
| melatonin day | #53 |
| physiological doses | #53 |
| gastric parietal cell | #53 |
| crossbreeding | #54 |
| melatonin animals | #54 |
| strain rats | #54 |
| rats social isolation | #54 |
| antigens myelomonocytic arthritis | #54 |
| development individuals | #54 |
| carbamylated protein | #54 |
| predating | #54 |
| yaa | #54 |
| imitating | #54 |
| nodes lymphocyte | #54 |
| animals autoimmune | #54 |
| major epitope | #54 |
| inflammatory manifestations | #55 |
| autoimmune nzb | #55 |
| arthritis genetic | #55 |
| complex genetic disease | #55 |
| susceptibility autoimmune disease | #55 |
| macrophage mannose receptor | #55 |
| autoimmune reactions | #55 |
| cells salivary | #56 |
| animals antibody | #56 |
| new animal | #56 |
| labels superoxide | #56 |
| mhc | #56 |
| selfreactive cells | #56 |
| alpha1microglobulin | #56 |
| antibodies bind | #57 |
| animals antirheumatic | #57 |
| arthritis pathogenesis | #57 |
| development autoimmune | #57 |
| vivo depletion | #57 |
| igg abs | #57 |
| collagen sequence | #57 |
| antibodies | #57 |
| cd1 mice | #57 |
| rat type | #58 |
| urokinase activity | #58 |
| chronic eae | #58 |
| schafer | #58 |
| peptide response | #58 |
| oestrogen progesterone | #58 |
| anticarp antibodies | #59 |
| articular joints | #59 |
| hydroxylase diet | #59 |
| cartilage matrix protein | #59 |
| anti cd8 | #59 |
| anti cell | #59 |
| genes mhc | #59 |
| encephalitogenicity | #59 |
| resistance eae | #59 |
| oligoclonal igg bands | #59 |
| inflammatory cells macrophages | #60 |
| macrophage mannose | #60 |
| assay epitopes | #60 |
| joint erosions | #60 |
| hpaaxis | #60 |
| alternative activation macrophages | #60 |
| immunohistopathology | #60 |
| dichotomous effects | #60 |
| protein peptide | #60 |
| species reactive | #61 |
| cells innate immune | #61 |
| experimental evoked potentials | #61 |
| differentiation myelomonocytic arthritis | #61 |
| epitope spreading | #61 |
| major histocompatibility | #61 |
| experimental rats rats | #61 |
| alpha1m | #61 |
| incidence severity | #61 |
| serum comp | #61 |
| autoantibody formation | #62 |
| toxin1 | #62 |
| antigens class histocompatibility | #62 |
| reduced oxidative | #62 |
| fpr2 | #62 |
| cyclic sensitivity | #62 |
| interferon‐β | #62 |
| basic characterization | #62 |
| adaptive immune | #62 |
| mice susceptibility | #62 |
| placenta uterus | #62 |
| syngeneically | #62 |
| hypersensitivity dth | #63 |
| delayed interferon | #63 |
| igaproducing cells | #63 |
| constant darkness | #63 |
| glycoprotein myelin | #63 |
| collagen cell | #63 |
| transfer animals | #63 |
| rats strain | #63 |
| protein disease | #63 |
| duval | #63 |
| induced experimental | #63 |
| mice polyi | #63 |
| peptide specific | #63 |
| post‐partum | #63 |
| specificity tumor | #63 |
| specific stages | #63 |
| nadph oxidases | #63 |
| mog1 | #63 |
| tolerance model | #64 |
| secondary immune | #64 |
| lower capacity | #64 |
| maternal origin | #64 |
| role apc | #64 |
| freund adjuvant | #64 |
| model chronic | #65 |
| autoimmunity humans | #65 |
| hindpaws | #65 |
| induced suppression | #65 |
| histocompatibility complex | #65 |
| flss | #65 |
| major subset | #65 |
| weight variation | #65 |
| peripheral joints | #66 |
| resemblances | #66 |
| spontaneous disease | #66 |
| hladr2 | #66 |
| multispecificity | #66 |
| experimental lymphocytes | #66 |
| chromosomes mammalian | #66 |
| thy1 antigen | #66 |
| acute arthritis | #66 |
| negative rheumatoid | #66 |
| phagocytosis oxidative burst | #66 |
| rheumatoid synovial cells | #66 |
| key interactions | #67 |
| experimental encephalomyelitis | #67 |
| development cell | #67 |
| experimental allergic | #67 |
| dendritic cells epitopes | #67 |
| myelomonocytic arthritis | #67 |
| fibrinogen genotype | #67 |
| endos | #67 |
| rheumatoid arthritis susceptibility | #67 |
| mice cell | #67 |
| strains susceptible | #67 |
| mice induced | #67 |
| severity periodontitis | #68 |
| tolerized mice | #68 |
| female sex hormones | #68 |
| individuals positive | #68 |
| rheumatoid chromosomes | #68 |
| complex class | #68 |
| helper phenotype | #68 |
| anti carp | #68 |
| sodium diethyldithiocarbamate | #68 |
| cells mhc class | #68 |
| iggrf | #68 |
| class region | #68 |
| frequent infections | #68 |
| frequency antibodies | #69 |
| rheumatoid disease | #69 |
| cells mouse | #69 |
| relapsing | #69 |
| vertebrate immune | #69 |
| direct damage | #69 |
| lymphocytes chronic | #69 |
| zap‐70 | #69 |
| role cells | #70 |
| prolonged graft survival | #70 |
| translationally | #70 |
| response type | #70 |
| presence rheumatoid factor | #70 |
| immunoglobulin interferon | #70 |
| mrl mice | #70 |
| ztm | #71 |
| expression pparγ | #71 |
| susceptibility female | #71 |
| cartilage mice | #71 |
| swr | #71 |
| cb10 | #71 |
| human psoriasis | #71 |
| isolated rats | #71 |
| antibodies binding | #72 |
| autoimmunity lymphocytes | #72 |
| interphalangeal joints | #72 |
| delayedtype hypersensitivity dth | #72 |
| dark agouti rats | #72 |
| napdh | #72 |
| study antibodies | #72 |
| lathyritic | #72 |
| naïve mice | #72 |
| species ros | #73 |
| treatment stages | #73 |
| type ifn signature | #73 |
| bovine type | #73 |
| mrl lpr | #73 |
| environmental lighting | #73 |
| oxidase complex | #73 |
| membrane animals | #73 |
| knockout protein processing | #73 |
| antigens class | #74 |
| igarf | #74 |
| hypersensitivity delayed | #74 |
| peptides sequences | #74 |
| pregnancyinduced | #74 |
| cartilage explants | #74 |
| dth mice | #75 |
| diabetes arthritis | #75 |
| inbred dba receptors | #75 |
| effects development | #75 |
| oestradiol | #75 |
| acpapositive | #75 |
| genetic disease models | #75 |
| cell reactivity | #75 |
| disease rheumatoid arthritis | #76 |
| rat splenocytes | #76 |
| anti carbamylated | #76 |
| type collagens | #76 |
| peptide mhc | #76 |
| cell deficient | #77 |
| pain inflammation | #77 |
| inbred mouse strains | #77 |
| oligomeric | #77 |
| collagen chains | #77 |
| eae induced | #77 |
| development insulitis | #77 |
| cyp7a1 | #77 |
| rt1n | #77 |
| lpr mrl | #77 |
| regulatory vaccines | #77 |
| rats eae | #77 |
| nerve conduction velocity | #77 |
| new animal model | #77 |
| cartilage integrity | #78 |
| pathogenesis rheumatoid arthritis | #78 |
| mhc expression | #78 |
| pythons | #78 |
| autoantigenic | #78 |
| rats respiratory | #78 |
| clinical arthritis | #78 |
| mononuclear lung | #79 |
| autoimmune experimental epitopes | #79 |
| 1ii | #79 |
| inflammatory autoimmune | #79 |
| susceptibility disease | #79 |
| shared epitope | #79 |
| erosive arthritis | #80 |
| chromosome study | #80 |
| detection autoantibodies | #80 |
| oxidases | #80 |
| spleen study | #81 |
| aspartic acid position | #81 |
| sex linkage | #81 |
| class antigen expression | #81 |
| mhcii expression | #81 |
| dr1 antigen | #81 |
| inflammatory phase | #81 |
| type macrophages | #81 |
| hnrnpa2 | #81 |
| mog mbp | #81 |
| estrogen suppression | #81 |
| mrl mp | #81 |
| induced leukocyte | #81 |
| expression ll37 | #81 |
| arthritis cells | #81 |
| 14weeks | #82 |
| pannus formation | #82 |
| nadphoxidase | #82 |
| drug encephalomyelitis | #83 |
| expression mhc | #83 |
| tlymphocyte genes | #83 |
| mice igg | #83 |
| bcg infection | #83 |
| cell independent | #83 |
| strains animals | #84 |
| spontaneous development | #84 |
| rat cardiac allografts | #84 |
| reactive cells | #84 |
| epidermal cells | #84 |
| multiple sclerosis evidence | #84 |
| arthritis day | #84 |
| naïve cells | #84 |
| inflammation joints | #85 |
| class molecule | #85 |
| cells recognize | #85 |
| homopentamer | #85 |
| antiifngamma | #85 |
| inflammation joint | #85 |
| knockout receptors | #85 |
| contribution genes | #86 |
| animal humans | #86 |
| preclinical stage | #86 |
| phagocyte nadph | #86 |
| monoclonal antibodies mab | #86 |
| severe eae | #86 |
| classical humans | #86 |
| anti cd4 | #86 |
| gfoger | #86 |
| mutant strains | #86 |
| inbred rat strains | #87 |
| estrogen induced | #87 |
| mhc class gene | #87 |
| smash | #87 |
| alpha1acid glycoprotein | #87 |
| levels anti | #88 |
| inguinal lymph nodes | #88 |
| narac | #88 |
| fine specificities | #88 |
| thps | #88 |
| copy variation | #88 |
| depletion cd8 cells | #89 |
| genetic quantitative | #89 |
| mabs mab | #89 |
| experimental autoimmune | #89 |
| arthritic | #89 |
| peptide immunization | #89 |
| mice antibodies | #89 |
| genistein treatment | #90 |
| monkeys mice | #90 |
| autoimmune inbred c57bl | #90 |
| rheumatoid arthritis cells | #90 |
| pineal hormone melatonin | #90 |
| susceptible | #90 |
| arthritis compared | #90 |
| ilc2 activation | #90 |
| adjuvant arthritis | #90 |
| mediated mechanisms | #90 |
| backgroundan | #91 |
| synovial fluid serum | #91 |
| cells apc | #91 |
| activation cd4 cells | #91 |
| histological sections | #91 |
| cattle collagen | #91 |
| protein induced | #91 |
| anticitrullinated protein | #92 |
| difco | #92 |
| nod mhc | #92 |
| abdominal region | #92 |
| humans immunodominant | #92 |
| experimental mouse models | #92 |
| mice melatonin | #93 |
| 290 patients | #93 |
| knockout myelin | #93 |
| cellspecific | #93 |
| animals autoantibodies | #93 |
| xor | #93 |
| natural polymorphisms | #93 |
| galactosylated | #94 |
| activated cells cells | #94 |
| endosomal acidification | #94 |
| macrophages development | #94 |
| autosomal genes | #94 |
| fcγrs | #94 |
| binding integrins | #95 |
| moderateintensity exercise | #95 |
| induced sarcoma | #95 |
| chronic phase disease | #95 |
| romani | #96 |
| nonglycosylated | #96 |
| lung emphysema | #96 |
| cell alpha | #96 |
| pregnancy disease | #96 |
| fetal rejection | #96 |
| messenger tolllike receptor | #96 |
| data rats | #96 |
| macrophages stimulation | #96 |
| ifnbeta | #96 |
| genetic female genes | #97 |
| macrophages fibroblasts | #97 |
| il33r | #97 |
| complex mice | #97 |
| antiimmunoglobulin | #97 |
| hydroxylysine | #97 |
| rheumatoid lymphocytes | #97 |
| citrullinated fibrinogen | #97 |
| cathelicidins | #97 |
| acpa igg | #98 |
| autoimmune rats | #98 |
| swr mice | #98 |
| rheumatoid cartilage | #98 |
| ean | #98 |
| autoimmune experimental | #98 |
| interleukin‐4 | #99 |
| collagen cytokines | #99 |
| rat chromosomes | #99 |
| alternative pathways | #99 |
| peptides cells | #100 |
| rats monoclonal antibodies | #100 |
| thy1 antigens | #100 |
| tap2 | #100 |
| inducer animals | #100 |
| tlymphocyte immunity | #100 |
| invading pathogens | #100 |
| cultured crosses | #100 |
| ccp anti | #100 |
| protein antibody | #100 |
| fprs | #101 |
| eira | #101 |
| cell determinants | #101 |
| bone degradation | #101 |
| safety drugs | #101 |
| susceptible strain | #101 |
| diarthrodial | #101 |
| singlenucleotide polymorphism | #101 |
| brucei infection | #102 |
| findings treatment | #102 |
| mouse monoclonal antibodies | #102 |
| eae animal encephalomyelitis | #102 |
| candidate autoantigen | #102 |
| drb10401 | #103 |
| oxidative burst | #103 |
| agalactosyl | #103 |
| ros homeostasis | #103 |
| pathogenesis emphysema | #103 |
| hla dr1 | #103 |
| mhcii | #104 |
| skg mice | #104 |
| male mice mice | #104 |
| nonarthritic | #104 |
| arthritic disease | #104 |
| haplotypes histocompatibility | #104 |
| mutation mice | #104 |
| f1 males | #104 |
| synchrotron infrared | #104 |
| thelper cells | #104 |
| development antibodies | #105 |
| autoreactivity | #105 |
| type 22 | #105 |
| vivo macrophages | #105 |
| fcγr | #105 |
| hybridoma cell | #105 |
| dmaam | #105 |
| osteoclasts mice | #105 |
| limited cross | #106 |
| primed cells | #106 |
| tcell immunity | #106 |
| proteoglycan loss | #106 |
| arthritis hla | #106 |
| 273 | #106 |
| disease dose | #106 |
| c3h mice | #107 |
| cells synovial | #107 |
| nzb mice | #107 |
| fpr | #108 |
| study tolerance | #108 |
| development autoimmune disease | #108 |
| littermates | #108 |
| monoclonal igg | #109 |
| type hypersensitivity | #109 |
| delayedtype hypersensitivity | #109 |
| autoantibodies autoantigens | #109 |
| structural polymorphism | #109 |
| citrullinated proteins | #109 |
| presentation cells | #109 |
| enthesophytes | #109 |
| reactive cell | #109 |
| carcinoma tumors | #110 |
| autoimmune encephalomyelitis | #110 |
| experimental female | #111 |
| dba 1j mice | #111 |
| backcross | #111 |
| mog eae | #111 |
| female hypersensitivity | #111 |
| streptococcal cell wall | #111 |
| inbred dba microscopy | #111 |
| toxic shock syndrome | #111 |
| cartilage | #111 |
| humoral autoimmunity | #112 |
| amide bond | #112 |
| presymptomatic individuals | #112 |
| alphabeta receptors antigen | #112 |
| extensive literature search | #112 |
| anti idiotypic antibodies | #112 |
| trait loci | #113 |
| db1 | #113 |
| adjuvant properties | #113 |
| autoimmune c57bl mice | #113 |
| xid mice | #113 |
| restricted cell | #113 |
| oligoclonality | #113 |
| mice collageninduced arthritis | #113 |
| tcra | #113 |
| ifngammaproducing cells | #114 |
| adjuvantinduced arthritis | #114 |
| anti mcv | #115 |
| autoantigens autoimmunity | #115 |
| drb10402 | #115 |
| mice disease | #115 |
| rats collagen | #115 |
| proinflammatory cytokine | #115 |
| lymphocyte female | #116 |
| susceptibility eae | #116 |
| lutz | #116 |
| glyco | #116 |
| transgenic peptides receptors | #116 |
| immunosorbents | #116 |
| ccp patients | #116 |
| pathogenesis autoimmune diseases | #116 |
| glycopeptides | #116 |
| experimental epitopes | #116 |
| tolerance induced | #117 |
| fluorescence nf | #117 |
| antiarthritic | #117 |
| encephalomyelitis autoimmune | #117 |
| antibodies reactive | #117 |
| mice type | #117 |
| congenic lines | #117 |
| α enolase | #118 |
| samples individuals | #118 |
| pineal hormone | #118 |
| psoriasiform dermatitis | #118 |
| rats immunized | #118 |
| alpha1acid | #118 |
| class expression | #118 |
| myelin oligodendrocyte | #118 |
| 05m | #119 |
| rheumatoid arthritis review | #119 |
| response cells | #119 |
| psa rheumatoid arthritis | #119 |
| cd4 tcells | #119 |
| radiological damage | #119 |
| neutrophils nets | #120 |
| protein mbp | #120 |
| experimental animal models | #121 |
| vivo animal models | #121 |
| chondrocyte cultures | #121 |
| acpa negative | #122 |
| patients acpa | #122 |
| transfer arthritis | #122 |
| pharmacological potential | #122 |
| t‐lymphocyte | #122 |
| immune complex deposition | #122 |
| genes age | #122 |
| treatment progesterone | #122 |
| transgenic neurons receptors | #122 |
| type cytokines | #123 |
| alphabeta cells | #123 |
| c5b | #123 |
| cell monoclonal | #123 |
| symptoms associations | #123 |
| nox2 activation | #123 |
| cartilage surface | #124 |
| inbred mouse | #124 |
| tlr4 stimulation | #124 |
| qtl genes | #125 |
| preimmunized | #125 |
| genetic rats | #125 |
| oxidases neutrophils | #125 |
| disease mechanisms | #125 |
| cryogel | #125 |
| blocking antigens | #125 |
| general mechanisms | #125 |
| helperinducer | #125 |
| immunodominant peptide | #125 |
| allelic variations | #125 |
| nzb nzw | #126 |
| cyclic polymorphism | #126 |
| female immunization | #126 |
| nonobese diabetic | #126 |
| pnipaam | #126 |
| atp8 | #127 |
| absence cells | #127 |
| microarray detection | #127 |
| knockout murine | #127 |
| animal enzyme | #127 |
| deiminases | #128 |
| dominant epitope | #128 |
| anticitrullinated peptide | #128 |
| chronic inflammatory disease | #128 |
| lining layer | #128 |
| multiple epitopes | #129 |
| rats patients | #129 |
| spleen rats | #129 |
| bxsb | #129 |
| oestradiol testosterone | #130 |
| cells eae | #130 |
| nos2 | #130 |
| psd1 | #130 |
| vivo absence | #130 |
| disease induced | #130 |
| epitope specific | #131 |
| lipomannan | #131 |
| onset arthritis | #131 |
| induction regulatory cells | #132 |
| kgf | #132 |
| linomide | #132 |
| disease cgd | #132 |
| intercross | #132 |
| mineral oils | #132 |
| pronociceptive | #132 |
| reduced severity | #133 |
| ggaa | #133 |
| leukosialin | #133 |
| rat chromosome | #133 |
| interstitial collagens | #134 |
| accentuate | #134 |
| myocellular | #134 |
| knockout receptors antigen | #134 |
| plasma synovial fluid | #134 |
| patients cytokines | #134 |
| eae | #134 |
| mice estrogen | #134 |
| species animals | #134 |
| spinal glial | #135 |
| peptides cyclic | #135 |
| igg immune complexes | #135 |
| intracellular reactive | #136 |
| chronic autoimmune disease | #136 |
| immunizing | #136 |
| macrophages dendritic | #136 |
| immunopathological | #137 |
| receptor upregulation | #137 |
| stimulated muscle | #137 |
| innate lymphocytes | #137 |
| ditiocarb | #138 |
| mice deficient | #138 |
| immunomodulatory drug | #139 |
| control development | #139 |
| dmannitol | #139 |
| autoimmune mice | #139 |
| tcrdelta | #140 |
| oligoclonal expansion | #141 |
| producing cell | #141 |
| thermoresponsive polymer | #141 |
| genetic factors development | #142 |
| single subcutaneous injection | #142 |
| or113 | #142 |
| phadia | #142 |
| interferon‐γ | #142 |
| rejection tolerance | #142 |
| smfish | #142 |
| gamma lymphocyte | #142 |
| phosphate isomerase | #143 |
| mice beta | #143 |
| tcell alphabeta receptors | #143 |
| class haplotypes | #143 |
| cell hybridoma | #143 |
| rat strains | #144 |
| mhc haplotypes | #144 |
| rheumatoid arthritis | #144 |
| synovial hyperplasia | #144 |
| lyme arthritis | #145 |
| syngenic | #145 |
| inbred buf rats | #145 |
| tnf production | #145 |
| severe chronic | #145 |
| treatment ici | #145 |
| tcr gamma delta | #145 |
| neonatal growth | #146 |
| rats induced | #146 |
| function cells | #147 |
| ccp antibodies | #147 |
| pregnancy levels | #147 |
| gammainterferon | #147 |
| cellular heterogeneity | #147 |
| systemic challenge | #147 |
| redox regulation | #148 |
| cell surface antigen | #148 |
| autoimmune disease | #148 |
| interestingly | #148 |
| α2i | #148 |
| phagocyte nadph oxidase | #148 |
| human autoimmune diseases | #149 |
| complex diseases | #149 |
| drb104 | #150 |
| mhc binding | #150 |
| larsen score | #150 |
| epicutaneously | #151 |
| levels antibodies | #151 |
| differential gene expression | #151 |
| mice animals | #151 |
| receptor rats | #151 |
| humans hybridomas | #151 |
| alphabeta receptors | #152 |
| key player | #153 |
| arthritic animals | #153 |
| pepsin | #153 |
| mononuclear cells | #153 |
| levels pregnancy | #153 |
| selfpeptides | #154 |
| daf1 | #154 |
| expression class | #154 |
| critical event | #154 |
| fcgammar | #154 |
| male rats rats | #154 |
| immune priming | #154 |
| c4bbinding protein | #154 |
| joint inflammation | #154 |
| arthritis rheumatoid | #155 |
| f1 mice | #155 |
| padi4 | #155 |
| infiltrating cells | #155 |
| mace acs | #155 |
| serum synovial fluid | #155 |
| autoantibodies autoimmune | #155 |
| specificities | #156 |
| mhc region | #156 |
| stabilin1 | #156 |
| suppressive role | #156 |
| downstream signals | #157 |
| murine keratinocytes | #157 |
| adjuvanticity | #157 |
| hypersensitivity reaction | #158 |
| analysis structure | #158 |
| parentals | #158 |
| genetic diabetes mellitus | #158 |
| inbred c3h mice | #159 |
| meaib | #159 |
| animals autoimmunity | #159 |
| arthritis infectious | #159 |
| systemic mice mice | #159 |
| consensus motif | #159 |
| specific autoimmunity | #161 |
| nursed | #161 |
| day onset | #161 |
| gamma interferon | #161 |
| factors anti | #161 |
| knockout severity | #161 |
| benzylated | #161 |
| anti ccp | #162 |
| epitope | #162 |
| cd152 | #162 |
| binding collagen | #162 |
| βarrestin recruitment | #162 |
| rheumatoid autoantigens | #162 |
| psors1 | #162 |
| arthritis inflammation | #162 |
| onset disease | #163 |
| chains humans | #163 |
| mouse type | #163 |
| laboratory rats | #163 |
| autoantibody responses | #164 |
| genes qtl | #164 |
| progesterone effects | #164 |
| endobetanacetylglucosaminidase | #164 |
| agalactosyl igg | #164 |
| rats induction | #164 |
| mrl | #164 |
| striking similarities | #164 |
| animal humans immunity | #165 |
| cells macrophages | #165 |
| tolerance induction | #166 |
| nonimmunized | #166 |
| pathogenic pathways | #166 |
| epitope alleles | #166 |
| melatonin mice mice | #166 |
| class mice | #167 |
| nox2 | #167 |
| human autoimmunity | #167 |
| tlymphocyte humans | #167 |
| ag7 | #167 |
| seronegative | #167 |
| cd1 | #168 |
| genetic backgrounds | #168 |
| phase disease | #168 |
| mice cd4 cells | #168 |
| acpa levels | #169 |
| p12 | #169 |
| oxazole | #169 |
| denoted | #169 |
| cryogels | #170 |
| experimental animal | #170 |
| joints male | #170 |
| inherited disorder | #170 |
| mirp | #170 |
| lymph node cells | #170 |
| pathogenesis arthritis | #170 |
| encephalomyelitis eae | #171 |
| ros nitric oxide | #171 |
| oxazolone | #171 |
| lst1 | #172 |
| rheumatoid | #172 |
| single nucleotide polymorphism | #172 |
| peripheral lymphoid organs | #172 |
| rat placenta | #172 |
| autoimmune eae | #172 |
| autoimmunity cell | #172 |
| sod3 | #173 |
| inbred dba models | #173 |
| monoclonal autoantibodies | #173 |
| class gene | #174 |
| studies pain | #174 |
| resistant rats | #174 |
| presence autoantibodies | #174 |
| nasal cartilage | #174 |
| maternal decidua | #175 |
| mice mutation | #175 |
| understanding pathogenesis | #175 |
| ifn signature | #175 |
| mammalian crosses | #176 |
| tryptophan catabolism | #176 |
| secondary challenge | #176 |
| moab | #176 |
| skin disease | #176 |
| new mouse model | #176 |
| strains molecular | #176 |
| lymphotoxinα | #177 |
| histocompatibility | #178 |
| ctla‐4 | #178 |
| hladrb1 alleles | #178 |
| mice role | #179 |
| protein anti | #179 |
| dextran sulphate sodium | #179 |
| nod genes | #179 |
| alternative pathway complement | #179 |
| immunized | #179 |
| complex disease | #180 |
| arthritis methods | #180 |
| epitopes female | #180 |
| cgd patients | #180 |
| alleles arthritis | #181 |
| genetic influence | #181 |
| molecular adaptations | #181 |
| autoimmunity disease | #181 |
| hormone melatonin | #182 |
| arginine deiminases | #182 |
| immunoglobulin mice mice | #185 |
| cells lymph nodes | #186 |
| multistep process | #186 |
| antigen processing presentation | #186 |
| rats reactive | #186 |
| b10 | #187 |
| drb1 chains | #187 |
| tcell recognition | #187 |
| dba | #187 |
| molecular peptide | #188 |
| substrains | #188 |
| chondritis | #188 |
| cells disease | #189 |
| mtec | #189 |
| hnrnpa2b1 | #190 |
| inflamed joint | #190 |
| synovial membranes | #190 |
| positionally | #190 |
| oligodendrocyte glycoprotein | #191 |
| autoantibody profiles | #192 |
| cross‐reactivity | #192 |
| ly1 | #192 |
| fmlf | #193 |
| passive mice mice | #193 |
| glycoprotein peptide | #194 |
| proteins myelin | #194 |
| cyclic predictive | #194 |
| chapter 16 | #195 |
| mice mutant | #195 |
| mhv | #195 |
| perpetuate | #195 |
| mhc class expression | #196 |
| oophorectomized | #196 |
| myelin glycoprotein | #196 |
| tcell response | #196 |
| lewis rat | #196 |
| acutephase response | #197 |
| evidence development | #197 |
| pannus | #197 |
| multiplex assay | #197 |
| swedish patients | #198 |
| early appearance | #198 |
| genetic links | #198 |
| igmrf | #198 |
| interleukin17 | #199 |
| dr4 antigen | #199 |
| rat genome | #199 |
| cell collagen | #200 |
| hla association | #200 |
| citrullinated peptide | #200 |
| pathogenesis autoimmune | #201 |
| dendritic cells macrophages | #202 |
| myelin proteins myelin | #202 |
| myelin proteolipid protein | #202 |
| acpa status | #202 |
| instigation | #202 |
| complete elimination | #203 |
| mice cells | #203 |
| immunization immunoglobulin | #204 |
| spleen staining | #204 |
| 2 complex | #204 |
| class molecules | #204 |
| suppresses | #205 |
| macrophages mice | #205 |
| dth response | #205 |
| native collagen | #205 |
| nonparametric tlymphocytes | #205 |
| ides | #205 |
| defb4 | #206 |
| wild rats | #206 |
| betaestradiol | #206 |
| induced upregulation | #207 |
| intranasal challenge | #207 |
| desmoglein 3 | #207 |
| mice peptide | #207 |
| insulitis diabetes | #207 |
| parental strains | #207 |
| alternative complement pathway | #207 |
| interleukin4 mice mice | #207 |
| noxs | #207 |
| severity disease | #208 |
| antigen presenting | #208 |
| immunization mice | #208 |
| highest probability | #208 |
| naive mice | #208 |
| vivo patients | #208 |
| disease rheumatoid | #209 |
| cotwins | #209 |
| immunoglobulin vh | #209 |
| vav1 | #210 |
| susceptible strains | #210 |
| highfatdiet | #210 |
| specific antibodies | #210 |
| citrullinated vimentin | #210 |
| valuable tools | #210 |
| natural antibodies | #211 |
| purified protein derivative | #211 |
| hla dr4 | #211 |
| diseases genetic | #211 |
| glucose6 phosphate | #211 |
| association rheumatoid arthritis | #212 |
| large numbers | #212 |
| cells immobilized | #212 |
| antibody binding | #213 |
| mice injected | #213 |
| psoriasiform | #213 |
| tsst1 | #214 |
| cytofluorometric | #215 |
| inbred rat | #215 |
| mhc class antigens | #215 |
| central tolerance | #215 |
| triethylsilane | #215 |
| antigen induced | #215 |
| training hiit | #216 |
| lower level | #216 |
| dissect | #216 |
| inflammatory infiltrates | #217 |
| joints mice | #217 |
| lentiviral vector | #217 |
| cd23 | #217 |
| induced autoimmune | #217 |
| rats immunization | #217 |
| resistant strain | #217 |
| antigen tcell | #218 |
| treatment onset | #218 |
| k8 | #219 |
| fcrγ | #219 |
| granuloma formation | #219 |
| peptide antibodies | #219 |
| autoimmunity | #219 |
| bone erosions | #220 |
| cells autoimmune | #220 |
| peptidylarginine deiminases | #220 |
| hyl | #220 |
| targeted deletion | #221 |
| agouti rats | #221 |
| rheumatoid factor | #221 |
| cells dendritic | #221 |
| cyclosporin treatment | #221 |
| fine specificity | #221 |
| pinealectomy | #221 |
| redox signaling | #221 |
| monoclonal antigens differentiation | #222 |
| wkymvm | #222 |
| cartilage damage | #222 |
| cybb | #222 |
| thymectomized | #222 |
| multiplex | #223 |
| carbamylated | #223 |
| experimental autoimmune neuritis | #223 |
| igg2a | #223 |
| inflammation vivo | #224 |
| expressing | #224 |
| lew | #225 |
| established disease | #225 |
| cells antigen | #225 |
| clinical scoring | #225 |
| interleukin‐10 | #225 |
| pathogenic antibodies | #226 |
| disease locus | #226 |
| j1 | #227 |
| macrophagelike cells | #227 |
| delayed type hypersensitivity | #228 |
| presenting cells | #228 |
| arthritis objective | #228 |
| presence anti | #229 |
| cell selection | #229 |
| eae rats | #230 |
| site inflammation | #230 |
| human rheumatoid | #231 |
| ls1 | #231 |
| monoclonal immunohistochemistry | #232 |
| reactive oxygen | #232 |
| synovial joints | #233 |
| ameliorated | #233 |
| lack expression | #233 |
| role eosinophils | #233 |
| production ros | #233 |
| centimorgan | #234 |
| lower numbers | #234 |
| staphylococcal infection | #235 |
| chronic psychosocial stress | #235 |
| mhc gene | #235 |
| chromosome 14 | #235 |
| specificity animals | #236 |
| immune complex | #236 |
| control strain | #237 |
| pathological mechanisms | #237 |
| progression arthritis | #238 |
| autoimmune chronic | #238 |
| c5 | #239 |
| trait locus | #239 |
| inbred dba tlymphocytes | #240 |
| study plasma | #241 |
| joint pain | #242 |
| strong influence | #242 |
| positive anti | #243 |
| hla drb1 | #243 |
| class genetic | #243 |
| multicomponent | #243 |
| protected | #243 |
| monoclonal antigen | #243 |
| inflammation cartilage | #244 |
| common denominator | #244 |
| treatment autoimmune | #244 |
| crosses | #244 |
| cutaneous infection | #244 |
| estrus cycle | #244 |
| binding antibodies | #245 |
| rt1l | #246 |
| allelic differences | #246 |
| development emphysema | #246 |
| antibodies anti | #247 |
| antibody response | #247 |
| florescence | #247 |
| normal cartilage | #247 |
| new model | #247 |
| inbred strain | #247 |
| activity assays | #248 |
| efficient expression | #248 |
| oxygen species | #249 |
| induced chronic | #249 |
| fragments rats | #250 |
| node cells | #250 |
| picryl | #250 |
| mouse rat | #250 |
| inflammation score | #250 |
| arthritic joints | #250 |
| treatment rats | #251 |
| develops | #251 |
| hyperinflammation | #251 |
| nadph oxidase | #251 |
| conditional knockout mice | #251 |
| mice lack | #252 |
| mice lymphocytes | #252 |
| response disease | #252 |
| dark agouti | #252 |
| role model | #252 |
| class mhc | #254 |
| lpr mice | #254 |
| cartilage matrix | #254 |
| dinitrofluorobenzene | #254 |
| onset clinical | #254 |
| proteins glycoproteins | #254 |
| lacking | #254 |
| autoimmune response | #255 |
| inbred c3h | #255 |
| anti arthritic | #256 |
| postmenopausal bone | #256 |
| specific neutralizing | #256 |
| specific subgroups | #256 |
| inflammatory disorder | #256 |
| disease cell | #257 |
| additive interaction | #258 |
| class mhc molecules | #259 |
| mir144 | #260 |
| relationship immunologic | #260 |
| chronic granulomatous | #260 |
| lymphocytes helper | #261 |
| secondary osteoporosis | #261 |
| mice expressing | #261 |
| denatured | #261 |
| mediated suppression | #261 |
| autoimmune neuritis | #261 |
| immunologic animals | #262 |
| selfantigen | #263 |
| primary immunization | #265 |
| genetic techniques | #265 |
| mouse strain | #265 |
| tolerance mice | #265 |
| pregnancy mice | #265 |
| crossreactive | #265 |
| rats animals | #267 |
| vim2 | #267 |
| cysteine proteases | #267 |
| antigen specific | #267 |
| posttranslational modifications | #268 |
| lentiviral gene | #268 |
| xid | #268 |
| mann whitney | #269 |
| pathogenic roles | #269 |
| oxpl | #270 |
| complement c5 | #270 |
| melatonin effects | #271 |
| monosodium urate crystals | #271 |
| selfantigens | #271 |
| castrated | #271 |
| amino acid transporters | #273 |
| experimental model | #273 |
| lewis rats | #274 |
| synovial lining | #275 |
| tcells | #275 |
| nasally | #275 |
| hdac1 | #275 |
| inhibitory peptide | #275 |
| macrophages dendritic cells | #276 |
| fcgr3b | #276 |
| rheumatoid arthritis association | #277 |
| producing cells | #277 |
| deiminase type | #277 |
| viral female hepatitis | #277 |
| metabolic properties | #278 |
| recognize | #278 |
| colon length | #279 |
| gp70 | #279 |
| interferongamma | #279 |
| induced tolerance | #280 |
| dinucleotide phosphate | #280 |
| recipient mice | #281 |
| passive transfer | #281 |
| immunological receptors antigen | #281 |
| neonatal mice | #281 |
| inflammatory conditions | #281 |
| hemiacetal | #282 |
| igg2b | #283 |
| inbred nod | #283 |
| disease susceptibility | #283 |
| factor production | #283 |
| isoflavone genistein | #283 |
| aire | #284 |
| severe colitis | #284 |
| helper inducer | #284 |
| increased serum levels | #284 |
| publication animals antibodies | #285 |
| aureus strain | #285 |
| idiotope | #285 |
| complete protection | #285 |
| endophilin | #285 |
| maintained | #285 |
| theilovirus | #285 |
| emulsified | #286 |
| hla dr2 | #287 |
| melatonin mice | #288 |
| antibody production | #288 |
| tlr9 mice | #288 |
| myelin basic protein | #288 |
| melatonin release | #288 |
| mice immunized | #289 |
| cells autoimmunity | #289 |
| disease cells | #291 |
| ctla4 expression | #291 |
| synovial cells | #291 |
| autoimmune mechanisms | #292 |
| rheumatic conditions | #292 |
| collagen receptors | #293 |
| induced ros | #293 |
| increased copy | #293 |
| cytokines disease | #293 |
| unique model | #294 |
| mouse genes | #294 |
| c57bl 6 mice | #295 |
| c3h | #295 |
| gastric parietal | #295 |
| antigen processing | #295 |
| nerve conduction | #296 |
| tissue‐specific | #296 |
| 6week | #296 |
| immunological receptors | #296 |
| murine dendritic cells | #297 |
| helical peptides | #297 |
| dnfb | #297 |
| phosphopyruvate | #297 |
| vivo imaging | #298 |
| gene selection | #298 |
| cd19 cells | #298 |
| ppad | #298 |
| transplantation antigens | #299 |
| citrullination | #299 |
| solidphase synthesis | #299 |
| tcr beta | #300 |
| neutrophil extracellular traps | #301 |
| posttranslational rats | #301 |
| draining lymph | #302 |
| peptide antibody | #302 |
| alphabeta | #302 |
| extraembryonic tissues | #302 |
| epidemiological investigation | #303 |
| 1 interferon | #303 |
| pathogeneses | #303 |
| strains mice | #303 |
| animals antibodies | #303 |
| autoimmune diseases | #304 |
| cgd | #304 |
| igg glycosylation | #304 |
| conditioned disease models | #304 |
| cells tcr | #305 |
| mutant strains mice | #305 |
| cartilage development | #305 |
| immunological function | #305 |
| hcdr3 | #306 |
| immunological studies | #306 |
| αgalcer | #306 |
| murine colitis | #306 |
| gammaifn | #306 |
| immunisation | #307 |
| inpp4b | #307 |
| class histocompatibility | #307 |
| basal metabolic rate | #308 |
| basal metabolic | #309 |
| chromosome 10 | #309 |
| articular cattle cells | #310 |
| arthritis study | #310 |
| perpetuation | #311 |
| multiple sclerosis eae | #311 |
| disease symptoms | #312 |
| synthetic peptide | #312 |
| inflamed joints | #312 |
| alleles animals | #312 |
| exuberant | #313 |
| epitopes | #313 |
| c3bi | #313 |
| induced colitis | #314 |
| activatory | #314 |
| intradermally | #315 |
| r620w | #315 |
| mice genes | #315 |
| trypanosoma brucei brucei | #316 |
| classical risk factors | #318 |
| onset rheumatoid | #318 |
| tubule cells | #319 |
| genetic interactions | #319 |
| galactosyl | #319 |
| mice subjected | #320 |
| deiminase | #320 |
| genomewide linkage analysis | #320 |
| spleen bone marrow | #320 |
| cells specific | #323 |
| il21r | #323 |
| daf2 | #324 |
| expressing human | #324 |
| ccp1 | #324 |
| impact disease | #324 |
| specific cell | #325 |
| expression cells | #325 |
| rat gene | #325 |
| surprisingly | #326 |
| mgps | #327 |
| resembles | #327 |
| allelic variant | #328 |
| c57bl mice | #328 |
| constant light | #329 |
| publication adjuvants | #329 |
| immunoenzyme | #329 |
| complex genes | #330 |
| early arthritis | #331 |
| glycoprotein mog | #332 |
| nucleotide polymorphism | #332 |
| rheumatoid synovial | #332 |
| fcgammariia | #332 |
| anticcp | #333 |
| mouse hepatitis virus | #333 |
| 35ssulfate | #334 |
| mrl lpr mice | #335 |
| susceptibility genes | #335 |
| joint tissues | #335 |
| autoimmune inflammation | #336 |
| cell response | #338 |
| delayed onset | #340 |
| epitope specificity | #340 |
| cells spleen | #340 |
| adjuvants immunologic | #341 |
| erosive | #341 |
| activation macrophages | #341 |
| ros oxygen species | #341 |
| rat | #341 |
| 6weeks | #342 |
| animal enzyme inhibitors | #342 |
| specific autoimmune | #342 |
| incident cardiovascular events | #342 |
| rapid spread | #343 |
| drb1 alleles | #343 |
| diabetic mouse | #343 |
| rats injection | #343 |
| sequence animals | #343 |
| monoclonals | #344 |
| 182780 | #344 |
| favor | #345 |
| acpa positivity | #345 |
| energetic costs | #346 |
| intraperitoneal injection | #347 |
| pemphigus vulgaris pv | #348 |
| complement activity | #349 |
| reduced capacity | #349 |
| neuritis | #349 |
| igg autoantibodies | #350 |
| phenotype rats | #351 |
| methylcholanthrene | #352 |
| thymic selection | #352 |
| c3h hej | #353 |
| immunoregulation | #353 |
| anti cyclic | #353 |
| mice induction | #353 |
| mice cd4 | #354 |
| arthritis synovial | #354 |
| autoantigens autoimmune | #354 |
| splenic macrophages | #355 |
| dsg3 | #357 |
| adjuvant activity | #358 |
| tbetarii | #358 |
| cells autoantibodies | #358 |
| neuritogenic | #359 |
| enos | #359 |
| injected | #359 |
| tcrbeta | #360 |
| tlr3 | #361 |
| pvg | #361 |
| freund | #361 |
| hla transgenic | #362 |
| murine lupus | #362 |
| allergic encephalomyelitis | #363 |
| identification genes | #363 |
| generation ros | #363 |
| mouse chromosome | #363 |
| determines | #363 |
| cells anti | #364 |
| recognized | #364 |
| hladr4 | #364 |
| glycoproteins mice | #366 |
| sex chromosomes | #366 |
| immune deviation | #366 |
| european journal | #366 |
| psychosocial stress | #367 |
| antiidiotypic antibodies | #367 |
| loci | #368 |
| 100 micrograms | #368 |
| ncf2 | #368 |
| autoimmune responses | #368 |
| affinity ligand | #368 |
| toxic shock | #368 |
| pentameric | #369 |
| nasal administration | #369 |
| histocompatibility antigens | #369 |
| immune pathogenesis | #370 |
| increased production | #370 |
| regulate | #371 |
| serum transfer | #371 |
| clinical onset | #371 |
| role mif | #372 |
| newborn antibodies | #372 |
| alternative activation | #373 |
| autoantigens | #375 |
| rheumatoid cell | #375 |
| undifferentiated arthritis | #376 |
| acutephase proteins | #376 |
| glucose6 | #377 |
| gia | #379 |
| reparixin | #380 |
| oxidase deficiency | #381 |
| induced lupus | #381 |
| mouse monoclonal antibody | #381 |
| fia | #382 |
| fragments immunoglobulin | #382 |
| granulomatous | #383 |
| naive rats | #384 |
| granulomatous disease | #384 |
| c1a | #384 |
| specific loci | #384 |
| shock syndrome | #385 |
| postmenopausal bone loss | #385 |
| cell specificity | #386 |
| pc4 | #386 |
| backcrosses | #387 |
| ptpn22 gene | #387 |
| antioxid | #387 |
| filaggrin | #387 |
| inbred nod receptors | #388 |
| phase response | #388 |
| downregulating | #389 |
| ovulation rate | #390 |
| deficient | #390 |
| greater 50 | #390 |
| anaphylatoxin c5a | #391 |
| radiological progression | #391 |
| peptidylarginine | #391 |
| finetune | #392 |
| il4 il10 | #394 |
| rf1 | #394 |
| ameliorating | #395 |
| autoantibody levels | #397 |
| induced metabolic | #397 |
| draining | #397 |
| juvenile chronic arthritis | #398 |
| immunized mice | #399 |
| protein myelin | #399 |
| regulation animals | #399 |
| inflammatory reactions | #400 |
| reactive oxygen species | #400 |
| antibody formation | #401 |
| genes cells | #401 |
| inflammation demyelination | #403 |
| biacore | #403 |
| immunopeptidome | #403 |
| fcγriib | #404 |
| beta chain | #404 |
| experimental | #405 |
| basic protein | #405 |
| rheumatoid case | #407 |
| effects models | #407 |
| n31 | #407 |
| pam3csk4 | #408 |
| major locus | #409 |
| immunogenetics | #409 |
| diabetes loci | #410 |
| 3hproline | #410 |
| intracellular processing | #410 |
| cd43 | #412 |
| cell phenotypes | #412 |
| hladrb1 | #412 |
| titres | #413 |
| susceptibility loci | #413 |
| reproductive performance | #414 |
| characteristic feature | #414 |
| cultured collagen | #415 |
| igk | #415 |
| female mice | #416 |
| levels autoantibodies | #416 |
| spontaneous mutation | #417 |
| synovial inflammation | #417 |
| lupus mice | #417 |
| genetically modified mice | #418 |
| molecular interactions | #419 |
| class hdacs | #419 |
| induced pain | #419 |
| wtccc | #419 |
| hiit | #420 |
| ameliorate | #420 |
| tcell | #421 |
| dr4 | #422 |
| lower affinity | #422 |
| lipidomic | #423 |
| restricted | #424 |
| subsets animals | #424 |
| hyaline cartilage | #425 |
| regulatory animals | #426 |
| inflammatory cells | #426 |
| congenic strain | #426 |
| carbohydrate moiety | #429 |
| postimmunization | #430 |
| nonimmunogenic | #430 |
| nod mouse | #430 |
| epitopes humans | #430 |
| immunoregulatory | #431 |
| patients healthy individuals | #433 |
| il10 mice | #433 |
| cells antibodies | #434 |
| spontaneous autoimmune | #435 |
| factor 5 | #435 |
| cells beta | #436 |
| reactivities | #436 |
| decalcified | #437 |
| chromosomes chromosome | #437 |
| mass spectrometric analysis | #437 |
| crystallizable | #437 |
| specific antigens | #438 |
| mice effects | #438 |
| immunised | #438 |
| helperinducer tlymphocytes | #438 |
| cells | #439 |
| joint swelling | #439 |
| nod | #440 |
| wildtype mice | #440 |
| normal rats rats | #441 |
| effector functions | #441 |
| female immunoglobulin | #441 |
| vitro techniques leukocytes | #441 |
| mice activation | #442 |
| complete adjuvant | #442 |
| patients population | #442 |
| methylβcyclodextrin | #443 |
| mhc class molecules | #443 |
| tlr2 expression | #444 |
| myelin basic | #444 |
| genomewide scan | #445 |
| systemic mice | #445 |
| mouse models | #445 |
| mice humans | #445 |
| skeletal muscle function | #445 |
| ros production | #447 |
| inbred strains receptors | #448 |
| pain model | #448 |
| induced mice | #448 |
| control mice | #448 |
| synovial tissue | #449 |
| tcell responses | #449 |
| complement factor | #449 |
| innate adaptive | #450 |
| apcs | #451 |
| igg anti | #451 |
| heterologous | #452 |
| reduced production | #452 |
| hybridoma cells | #452 |
| differs | #454 |
| lglutamine | #456 |
| cells chronic | #456 |
| inbred c57bl tlymphocytes | #457 |
| raloxifene | #457 |
| lung macrophages | #459 |
| eae cns | #459 |
| rheumatoid cells | #459 |
| priming | #459 |
| resembling | #459 |
| antibodies monoclonal | #460 |
| neutrophil functions | #462 |
| autoantigen | #462 |
| 256 | #462 |
| gilt | #463 |
| fab fragments | #464 |
| autoantibody production | #465 |
| receptor tcr | #466 |
| salivary glands | #466 |
| cells lymph | #467 |
| titers | #469 |
| earlier onset | #469 |
| arthritic rats | #474 |
| anticyclic citrullinated peptide | #474 |
| disease mice | #474 |
| antibody mediated | #474 |
| cartilage cells | #475 |
| human autoimmune | #476 |
| cluster genes | #477 |
| mice exhibited | #477 |
| mediated inflammation | #478 |
| therapeutic vaccination | #478 |
| laboratory rat | #479 |
| female hla | #479 |
| apoptosis arthritis | #479 |
| quantitative trait loci | #480 |
| aggravated | #480 |
| deacetylase 1 | #480 |
| anti idiotypic | #482 |
| polymorphonuclear cells | #482 |
| immune reactions | #484 |
| immunologists | #485 |
| immunoglobulin male | #486 |
| controlling | #487 |
| jca | #487 |
| oxyntic | #487 |
| tcralpha | #487 |
| specific immune | #488 |
| invariant natural | #488 |
| insulitis | #488 |
| gland animals | #489 |
| normal mice | #490 |
| cytoplasmic calcium | #494 |
| nacetylglucosaminidase | #495 |
| early rheumatoid | #496 |
| reactive nitrogen | #496 |
| gammadelta cells | #496 |
| h2b | #496 |
| conclude | #496 |
| mbp | #498 |
| small effects | #498 |
| receptor 9 | #499 |
| biologicals | #500 |
| autoreactive cd4 | #503 |
| immunoenzyme techniques | #503 |
| nadph | #503 |
| pathogenic | #506 |
| immunofluorescence analysis | #507 |
| chondrocytes collagen | #507 |
| isopropyl | #508 |
| mineral oil | #508 |
| mab mabs | #508 |
| persistent pain | #508 |
| gingipain | #509 |
| orosomucoid | #509 |
| immunization passive | #509 |
| mhc class | #510 |
| mice knockout mice | #510 |
| c3h hej mice | #511 |
| 812 | #511 |
| systemic spread | #511 |
| differential gene | #511 |
| deficient mice | #511 |
| blymphocytes | #512 |
| mrp8 | #515 |
| behavioral alterations | #517 |
| hydroxyquinolines | #517 |
| antibody complex | #518 |
| u1 | #518 |
| suggestive linkage | #519 |
| chronic granulomatous disease | #519 |
| inflammation | #519 |
| tcr recognition | #520 |
| modified form | #521 |
| dextran sulfate sodium | #522 |
| pcorr | #522 |
| ttg | #522 |
| inflammation role | #523 |
| data peptide | #523 |
| encephalitogenic | #524 |
| p47phox | #524 |
| litter size | #524 |
| neutrophil granulocytes | #525 |
| tconv | #526 |
| mnc | #526 |
| mechanical hypersensitivity | #526 |
| spleen cells | #527 |
| disease acute | #527 |
| maternal antibodies | #527 |
| vaccinates | #528 |
| larsen | #528 |
| primed | #528 |
| tolonium | #528 |
| tolllike receptor tlr4 | #529 |
| ifa | #529 |
| displayed | #529 |
| rat rats | #529 |
| pathogenesis sle | #530 |
| cell antibodies | #530 |
| autoantibody | #530 |
| antigen presentation | #530 |
| isac | #530 |
| ratg | #531 |
| epistatic | #532 |
| bred | #532 |
| complex role | #533 |
| lyt2 | #533 |
| posttranslational receptors | #534 |
| resorptions | #536 |
| translational modification | #536 |
| spleen lymphocytes | #536 |
| synovial | #537 |
| urokinase | #537 |
| animals | #538 |
| experimental rats | #538 |
| cells inflammatory | #538 |
| fibroblast synoviocytes | #540 |
| joints | #540 |
| antigen recognition | #540 |
| suppressive | #540 |
| membrane attack complex | #541 |
| rheumatoid humans | #543 |
| specific autoantibodies | #544 |
| regulating | #545 |
| protein tyrosine phosphatase | #545 |
| hypomorphic | #546 |
| animal gene | #547 |
| tlymphocytes | #547 |
| shortcut | #547 |
| immunohistochemical methods | #548 |
| entheses | #548 |
| formyl peptide receptors | #548 |
| mog | #550 |
| immunoglobulin fab | #552 |
| mixed lymphocyte reaction | #553 |
| nox activity | #554 |
| breeder | #555 |
| cell epitopes | #557 |
| beta animals | #557 |
| stronger association | #557 |
| cells control | #558 |
| early onset | #559 |
| healthy mice | #560 |
| elispot assay | #561 |
| transgenic molecular | #562 |
| ptdins3p | #563 |
| inbred strains | #563 |
| negative selection | #563 |
| neutrophil depletion | #564 |
| deeper layers | #565 |
| therapeutic treatment | #565 |
| immunoglobulin heavy chains | #566 |
| earlier | #566 |
| target tissue | #566 |
| darkness | #566 |
| crucial | #567 |
| interferon signature | #568 |
| disease loci | #568 |
| outbred | #568 |
| cells pathogenesis | #569 |
| neutrophilia | #569 |
| mycobacteria | #569 |
| concomitantly | #570 |
| mice compared | #571 |
| transgenic mouse models | #572 |
| btla | #572 |
| keratin8 | #573 |
| col2 | #574 |
| pepstatins | #576 |
| presenting | #576 |
| estrogen treatment | #577 |
| terpenes | #577 |
| keratinocyte growth factor | #578 |
| prolactin prl | #578 |
| sera patients | #579 |
| ptm | #579 |
| triple helix | #580 |
| methotrexate mice | #581 |
| f1 hybrids | #581 |
| production ifngamma | #583 |
| hybridoma | #583 |
| inflammatory joint | #583 |
| lymphocyte antigens | #584 |
| time onset | #584 |
| exaggerated | #584 |
| antibody reactions | #585 |
| traps nets | #590 |
| antigen antibody | #591 |
| environmental triggers | #591 |
| oligoclonal | #592 |
| lxrα | #592 |
| immunological tolerance | #592 |
| noncollagenous | #593 |
| transgenic models | #593 |
| adaptive immunity | #594 |
| autoimmune disorders | #594 |
| macrophages | #594 |
| multiplexing | #595 |
| clonal expansion | #595 |
| th1 cytokines | #595 |
| xanthine oxidoreductase | #596 |
| cells study | #599 |
| tcell activation | #599 |
| develop | #600 |
| spite | #602 |
| n85 | #602 |
| th2 cytokines | #602 |
| augmented | #602 |
| pemphigus vulgaris | #603 |
| common diseases | #603 |
| mouse monoclonal | #603 |
| cells male | #604 |
| cells involved | #604 |
| phagosomal | #604 |
| mice inbred | #606 |
| animal rats | #606 |
| oxa | #606 |
| class humans | #607 |
| genotype hla | #608 |
| frozen sections | #608 |
| spleen animals | #609 |
| regulatory role | #610 |
| inefficiently | #610 |
| naive | #611 |
| production ifn | #611 |
| positive individuals | #612 |
| quantitative trait locus | #615 |
| class antigens | #616 |
| alpha chains | #616 |
| acetophenones | #616 |
| idiotypic | #616 |
| exponential phase | #616 |
| th1 type | #616 |
| mutant strains receptors | #616 |
| autoantibodies | #616 |
| oral immunization | #617 |
| nonobese | #617 |
| beta type | #618 |
| day mice | #619 |
| promiscuous | #620 |
| wistar restraint | #620 |
| inflammatory role | #621 |
| receptor 3 | #621 |
| consequent | #621 |
| nicotinamide adenine | #622 |
| receptors antigen | #624 |
| fluorine18 | #624 |
| chronic stage | #625 |
| loci identified | #625 |
| cytoplasmic ca2 | #628 |
| animal mice | #628 |
| local injection | #629 |
| cross reactions | #630 |
| inflammatory disease | #630 |
| reactive antibodies | #632 |
| healthy rats | #632 |
| development eae | #633 |
| highintensity interval training | #634 |
| fibromodulin | #634 |
| langerhans cells | #635 |
| vivo binding | #635 |
| nabs | #637 |
| ifn beta | #637 |
| class genes | #638 |
| cells inhibition | #638 |
| inflammation autoimmunity | #640 |
| estrogens female | #640 |
| biotinylated | #643 |
| mouse lung | #644 |
| cell binding | #645 |
| immune serum | #646 |
| haplotype | #649 |
| antigen specificity | #650 |
| patients sera | #650 |
| genetic disease | #652 |
| hexadecane | #654 |
| idiotypic antibodies | #654 |
| antibody titres | #655 |
| interphalangeal | #655 |
| new pathway | #658 |
| genetic linkage | #658 |
| axotomized | #659 |
| cyba | #660 |
| sialoprotein | #660 |
| acute inflammation | #661 |
| peptide binding | #661 |
| inbred cba mice | #661 |
| mutated | #662 |
| cartilage destruction | #663 |
| ifng | #664 |
| animal ear | #665 |
| delayed hypersensitivity | #665 |
| lymphoid organs | #666 |
| 264 | #666 |
| superantigens | #666 |
| receptors igg | #666 |
| reactive | #666 |
| activation mice | #669 |
| apeced | #670 |
| drb1 | #670 |
| disease autoimmune | #671 |
| purified proteins | #673 |
| cells induce | #674 |
| treatment protocol | #674 |
| desmoglein | #675 |
| pyramidal neurons | #675 |
| genetic epistasis | #675 |
| strikingly | #676 |
| adherent cells | #677 |
| germinal center | #677 |
| idiotypes | #677 |
| china cohort | #678 |
| il12p70 | #679 |
| major genes | #679 |
| igg response | #679 |
| thelper | #680 |
| lymphocytes mice | #682 |
| cells role | #682 |
| inbred c57bl mice | #683 |
| normal animals | #683 |
| puzzle | #683 |
| specific antibody | #684 |
| helper cell | #684 |
| intradermal injection | #686 |
| transgenic receptors | #687 |
| βarrestin | #688 |
| subsets | #689 |
| foot joints | #689 |
| delayed | #689 |
| rendered | #690 |
| early rheumatoid arthritis | #690 |
| production autoantibodies | #691 |
| disease genes | #692 |
| knockout polymorphism | #695 |
| muscle glucose | #695 |
| paam | #696 |
| igg antibodies | #696 |
| anas | #697 |
| luminex | #697 |
| disease hla | #698 |
| mice model | #698 |
| uterus | #700 |
| heavy chain genes | #701 |
| microspectroscopy | #703 |
| quantitative trait | #704 |
| inbred | #704 |
| complete freund | #706 |
| fibroblastlike synoviocytes | #707 |
| histopathological analysis | #707 |
| extracellular trap | #708 |
| estradiol female | #710 |
| specific cells | #710 |
| igl | #712 |
| posttranslational | #713 |
| predetermined | #716 |
| spleens | #716 |
| mice lacking | #717 |
| antibodies patients | #718 |
| acute bout | #718 |
| lymphocyte depletion | #719 |
| proliferative response | #720 |
| regulatory function | #720 |
| deficiency syndromes | #721 |
| buf | #721 |
| surrounding tissues | #722 |
| th1 th17 | #723 |
| macrophages mice mice | #725 |
| human hand | #725 |
| dmaema | #728 |
| cd1d | #728 |
| th2 cytokine | #729 |
| mhc molecules | #729 |
| ccps | #729 |
| cdk6 | #730 |
| cns inflammation | #732 |
| administrated | #732 |
| cholesterol metabolism | #732 |
| animals antigens antigens | #732 |
| excessive inflammation | #734 |
| finding | #735 |
| net formation | #736 |
| rats treatment | #736 |
| locus | #737 |
| cheeks | #739 |
| operates | #740 |
| c57bl | #740 |
| cd5 cells | #741 |
| species specificity | #741 |
| tissue destruction | #742 |
| nkt | #742 |
| immunologic deficiency | #743 |
| vivo mice | #743 |
| cell responses | #743 |
| treatment anti | #744 |
| role disease | #746 |
| mycobacterial infections | #747 |
| nonobese diabetic mice | #749 |
| autoantibodies autoimmunity | #749 |
| intensity interval | #749 |
| keratinocyte | #749 |
| transferred | #751 |
| preclinical phase | #751 |
| control disease | #753 |
| hapten | #755 |
| ere | #755 |
| tlr activation | #755 |
| metabolomic | #755 |
| mice anti | #757 |
| autoantibodies type | #758 |
| disease protection | #758 |
| phenotypic differences | #758 |
| hyperinflammatory | #759 |
| reacted | #759 |
| linkage region | #760 |
| knockout tlymphocytes | #760 |
| ccp | #761 |
| ifngamma production | #761 |
| polycytidylic | #762 |
| immunocap | #763 |
| gamma ifn | #765 |
| glut4 translocation | #767 |
| periarticular | #772 |
| redox signal | #773 |
| hkexchanging | #773 |
| cells apcs | #773 |
| peripheral tolerance | #774 |
| afflicted | #777 |
| fab fragment | #778 |
| diseases cell | #778 |
| interacted | #779 |
| inbred nzb | #780 |
| acid transporters | #781 |
| pathogenic role | #782 |
| arthritis osteoarthritis | #782 |
| development autoimmunity | #782 |
| nox1 | #782 |
| arthritis psa | #783 |
| chronic colitis | #784 |
| clinical scores | #786 |
| transgenic mutation | #789 |
| inflammatory lesions | #790 |
| transgenic receptors antigen | #790 |
| peptide fragments | #790 |
| reduced incidence | #790 |
| pineal gland | #791 |
| polyarthritis | #792 |
| cell gamma | #793 |
| cell humans | #794 |
| antibodies directed | #794 |
| neutrophil extracellular | #796 |
| interval training | #796 |
| neutrophil function | #796 |
| pathogen free | #797 |
| genes immunoglobulin | #798 |
| lymphocyte proliferation | #798 |
| carbohydrate moieties | #800 |
| polyi | #801 |
| matrix proteins | #801 |
| monoclonal binding | #802 |
| innate adaptive immunity | #802 |
| thy1 | #802 |
| blymphocyte chain genes | #802 |
| redox control | #805 |
| induces | #805 |
| count male | #805 |
| helper cells | #805 |
| multinucleated giant cells | #808 |
| backcrossing | #809 |
| bone erosion | #810 |
| catabolism | #811 |
| function mutation | #811 |
| resident cells | #812 |
| strains receptors | #812 |
| acc1 | #812 |
| febuxostat | #813 |
| nonreceptor type | #815 |
| arginines | #817 |
| ctb | #817 |
| leads | #820 |
| auricle | #820 |
| collagen cross | #821 |
| cd8 antigens | #821 |
| leukocyte infiltration | #822 |
| piece | #823 |
| colocalizes | #824 |
| humoral immune response | #824 |
| electroporated | #824 |
| genetic environmental | #825 |
| psoriasis psoriatic arthritis | #825 |
| prominently | #825 |
| response animals | #826 |
| muscle training | #826 |
| chondroid | #827 |
| class antigen | #829 |
| growth factor beta | #829 |
| producing | #830 |
| effects immune | #830 |
| cross reactivity | #834 |
| inbred c57bl | #841 |
| lpr | #841 |
| immunoglobulin mice | #842 |
| peyers patches | #842 |
| diabetic nod | #844 |
| therapeutic approaches | #844 |
| il25 | #845 |
| chronic active | #845 |
| mice transgenic | #846 |
| inflammatory arthritis | #846 |
| induce | #848 |
| intermingled | #850 |
| macroscopically | #851 |
| antigen cell | #852 |
| lymphocyte | #852 |
| new possibilities | #854 |
| leukocyte migration | #854 |
| ms275 | #855 |
| tcell receptors antigen | #855 |
| alveolar mice mice | #856 |
| strongest association | #856 |
| importantly | #856 |
| mcv | #858 |
| post translational | #861 |
| immune defence | #862 |
| treatment reduced | #865 |
| lyme | #866 |
| knockin mice | #867 |
| factor anti | #867 |
| mice reduced | #867 |
| mediated inflammatory | #867 |
| strongest | #868 |
| cross reactive | #868 |
| parietal cells | #869 |
| lentiviral | #869 |
| hinge region | #869 |
| lnc | #872 |
| immune tolerance | #873 |
| dextran sulfate | #873 |
| parasitemia | #874 |
| lower expression | #874 |
| elisas | #875 |
| cells expressing | #876 |
| granulomas | #877 |
| synovial fluid patients | #878 |
| fcγri | #878 |
| arthritis inflammatory | #879 |
| adoptive | #881 |
| antigen4 | #881 |
| systemic autoimmune diseases | #882 |
| pregnancy animal | #882 |
| testosterone treatment | #883 |
| fluid synovial | #884 |
| cartilaginous | #888 |
| standard therapies | #890 |
| genetic dissection | #891 |
| psoriasis vulgaris | #891 |
| basic | #893 |
| regulator | #895 |
| completely | #896 |
| intranasal administration | #897 |
| inflammation mediators | #897 |
| interleukin1alpha | #898 |
| ctla4 antigen | #898 |
| phosphatase receptor | #902 |
| granulocytes | #904 |
| partly | #904 |
| inception cohort | #905 |
| γδ cells | #906 |
| infiltrations | #906 |
| rats inbred | #907 |
| lipocalins | #908 |
| extracellular traps | #909 |
| immunohistochemical analyses | #910 |
| immunoglobulin levels | #911 |
| liu | #911 |
| single injection | #911 |
| chromosome 16 | #912 |
| mitochondrial ros | #913 |
| lectin pathway | #913 |
| ciita | #914 |
| pneumonitis | #914 |
| enolase | #915 |
| proliferate | #915 |
| allelic variation | #915 |
| immunemediated diseases | #916 |
| cytokine response | #923 |
| psoriatic arthritis psa | #924 |
| neutrophil chemotaxis | #924 |
| antibodies antibody | #924 |
| cd200 | #925 |
| chromosome mapping | #925 |
| fluorobenzene | #925 |
| nkt cells | #926 |
| phenotypic analysis | #926 |
| repertoires | #929 |
| burst | #930 |
| tissue transglutaminase | #931 |
| data role | #932 |
| hydratase | #933 |
| citrulline | #933 |
| alpha animals | #935 |
| macropinocytosis | #936 |
| alters | #937 |
| lymphocyte activation | #938 |
| arthritides | #938 |
| 1040 | #939 |
| synovia | #939 |
| analysed | #940 |
| immune reactivity | #940 |
| rns | #940 |
| vitro stimulation | #941 |
| collagen structure | #941 |
| genetic analysis | #941 |
| disease model | #941 |
| mediated autoimmune | #944 |
| sciatic nerves | #945 |
| association hla | #945 |
| mice mice | #947 |
| fluid patients | #948 |
| inflammatory pathways | #948 |
| clinical observations | #948 |
| humanized mice | #949 |
| vivo | #950 |
| riii | #950 |
| l3t4 | #954 |
| environmental determinants | #955 |
| nos1 | #957 |
| carrying | #958 |
| differentiation tlymphocyte antigens | #959 |
| mhc peptide | #962 |
| levels ros | #962 |
| chronic disease | #963 |
| cellular immunization | #965 |
| monoclonal antigens | #967 |
| cells lymphocytes | #967 |
| animals cytokines | #967 |
| cytotoxic tlymphocytes | #967 |
| cell transfer | #969 |
| lower frequency | #969 |
| chromosome 15 | #971 |
| draining lymph nodes | #972 |
| secreting cells | #973 |
| susceptibility locus | #978 |
| cartilage articular | #979 |
| synovial membrane | #981 |
| lymphocytes | #982 |
| genes chromosome | #982 |
| w5 | #982 |
| binding peptides | #983 |
| pain behavior | #984 |
| tbb | #987 |
| tallele | #988 |
| microspectrophotometry | #990 |
| knockout models | #991 |
| macrophages cells | #991 |
| allergic contact dermatitis | #992 |
| immunodominance | #992 |
| cells reactive | #993 |
| transgenic expression | #994 |
| 510 | #994 |
| patients rp | #994 |
| hej | #995 |
| cartilage bone | #995 |
| spontaneously | #997 |
| formyl peptide | #997 |
| knee joints | #997 |
| laminin fibronectin | #998 |
| antigen expression | #999 |
| immunoglobulin fragments | #1000 |
| lymphocyte subpopulations | #1002 |
| multiple loci | #1003 |
| processing presentation | #1004 |
| expands | #1004 |
| aggravate | #1004 |
| protective role | #1007 |
| igg subclasses | #1011 |
| nrc | #1012 |
| cyclic peptides | #1012 |
| interleukin21 | #1013 |
| 95 stroke | #1013 |
| igg | #1015 |
| model multiple | #1015 |
| direct comparison | #1015 |
| nerve roots | #1016 |
| cellular composition | #1016 |
| cells mast | #1016 |
| aged arthritis | #1017 |
| patients early | #1019 |
| melatonin levels | #1019 |
| cd4 antigens | #1020 |
| immunoglobulin variable | #1022 |
| cysteine protease | #1025 |
| diseases animals | #1026 |
| genetic humans | #1027 |
| innate killer cells | #1028 |
| il4 | #1029 |
| baseline 24 months | #1031 |
| dr1 | #1031 |
| mice treated | #1032 |
| oxidase | #1034 |
| major regulator | #1036 |
| species production | #1039 |
| tramp | #1040 |
| arthritis psoriatic | #1041 |
| expression mrna | #1042 |
| complementary genes | #1043 |
| das28 | #1045 |
| parental strain | #1050 |
| myelin proteins | #1050 |
| patients rheumatoid | #1051 |
| chromosome 5 | #1052 |
| gamma delta | #1055 |
| inflammatory macrophages | #1055 |
| immune defense | #1056 |
| antigens differentiation | #1056 |
| mannans | #1057 |
| rat cells | #1060 |
| morula | #1062 |
| sterile inflammation | #1062 |
| lymphocytes cells | #1062 |
| transgenic | #1063 |
| tarsus | #1066 |
| disease humans polymorphism | #1069 |
| oxazoles | #1069 |
| role immune | #1069 |
| decidua | #1069 |
| synovial fluids | #1071 |
| transgenic cells | #1075 |
| fcγ | #1076 |
| radiological | #1077 |
| peptidylarginine deiminase | #1078 |
| epistasis | #1079 |
| key steps | #1080 |
| adjuvant cfa | #1080 |
| lymphoid cells | #1082 |
| reestablishment | #1082 |
| irf1 | #1086 |
| dependent regulation | #1087 |
| al2 | #1088 |
| uppsala | #1089 |
| haplotypes | #1089 |
| enlarged | #1091 |
| inflamed | #1092 |
| osteoclast formation | #1093 |
| 7 weeks | #1096 |
| oligodendrocyte | #1098 |
| inkt cells | #1102 |
| igs | #1103 |
| effector mechanisms | #1104 |
| cells increased | #1105 |
| arginine deiminase | #1114 |
| subdominant | #1115 |
| molecular mimicry | #1115 |
| fibril | #1115 |
| clinical disease | #1116 |
| sclerosis myelin | #1116 |
| animal immunity | #1117 |
| antitoxin | #1117 |
| deamidation | #1117 |
| cd5 | #1117 |
| genetic factors | #1117 |
| disulfide | #1117 |
| antigenic peptides | #1118 |
| pil | #1121 |
| lymphocytes regulatory | #1123 |
| recognizing | #1126 |
| primary immunodeficiency | #1127 |
| cells ifn | #1128 |
| isomerase | #1128 |
| predisposing | #1128 |
| foreign antigens | #1128 |
| humans lymphocyte | #1128 |
| dissected | #1130 |
| treatment day | #1132 |
| skeletal muscle fibers | #1132 |
| superantigen | #1134 |
| immune response | #1135 |
| cryosections | #1135 |
| vivo administration | #1136 |
| overlapped | #1136 |
| glucosyl | #1136 |
| c57 | #1137 |
| peptide sequence | #1138 |
| underline | #1138 |
| anticardiolipin antibodies | #1139 |
| editorial | #1139 |
| cd4foxp3 | #1142 |
| mice rats | #1146 |
| syntenic | #1147 |
| helpers | #1149 |
| treatment animals | #1149 |
| agonist | #1150 |
| cd4 cells | #1151 |
| subcloned | #1155 |
| disease onset | #1157 |
| antibody affinity | #1160 |
| inactivating | #1161 |
| lxr | #1161 |
| respiratory burst | #1163 |
| prolactin rats | #1164 |
| demonstrating | #1168 |
| stainings | #1168 |
| increased severity | #1170 |
| activated cells | #1171 |
| transduction toll | #1174 |
| gp91phox | #1175 |
| nadph oxidoreductases | #1176 |
| inflamed tissues | #1178 |
| models disease | #1178 |
| 10b | #1179 |
| preponderance | #1180 |
| recombinant interferon | #1180 |
| genetic background | #1181 |
| destructive | #1182 |
| chemiluminescent | #1182 |
| arginine residues | #1184 |
| objective investigate | #1186 |
| disease haplotypes humans | #1186 |
| lymphocytes cell | #1188 |
| synovial fibroblasts | #1188 |
| human type | #1190 |
| ileitis | #1191 |
| rat human | #1192 |
| splenic cells | #1192 |
| antiphospholipid | #1193 |
| infiltrates | #1195 |
| primary sjögrens syndrome | #1195 |
| cells rheumatoid | #1199 |
| susceptibility | #1200 |
| basic mechanisms | #1200 |
| antibody | #1200 |
| antibodies mabs | #1200 |
| somatically | #1201 |
| lung mice mice | #1204 |
| protein arginine | #1208 |
| identified loci | #1210 |
| h2k | #1211 |
| predisposition disease | #1212 |
| onset progression | #1212 |
| c5a | #1213 |
| rationales | #1214 |
| singlecell | #1214 |
| hdacs | #1217 |
| chronic inflammation | #1218 |
| critical issues | #1218 |
| igg subclass | #1220 |
| ilc2 | #1221 |
| mononuclear | #1223 |
| adaptive immune response | #1223 |
| compared wt | #1223 |
| subcellular fractionation | #1224 |
| adaptive immune responses | #1225 |
| tlymphocyte antigens | #1226 |
| chromosome 4 | #1227 |
| linkage analysis | #1229 |
| antimicrobial peptides amps | #1229 |
| analyse | #1230 |
| experimental models | #1231 |
| therapeutically | #1232 |
| subsets lymphocytes | #1233 |
| aps | #1233 |
| host defense | #1238 |
| immunological mechanisms | #1240 |
| human cd4 | #1241 |
| cell lymphocytes | #1244 |
| indel | #1247 |
| mouse | #1250 |
| immune inflammatory | #1251 |
| lining | #1252 |
| animal | #1253 |
| ltb | #1253 |
| dead cells | #1254 |
| animal doseresponse relationship | #1259 |
| mesenteric lymph nodes | #1263 |
| differentiation lymphocyte | #1263 |
| antigen presenting cells | #1264 |
| synovium | #1265 |
| pathogenic mechanisms | #1266 |
| suppress | #1269 |
| adenine dinucleotide | #1269 |
| suppressive function | #1270 |
| rheumatoid arthritis patients | #1270 |
| molecular pathogenesis | #1270 |
| synovial fluid | #1271 |
| rat mouse | #1273 |
| eae model | #1274 |
| claudin4 | #1274 |
| chromosomal regions | #1275 |
| rats mice | #1275 |
| inducer | #1279 |
| rattus norvegicus | #1282 |
| becn1 | #1282 |
| c4a | #1283 |
| hla molecules | #1283 |
| staphylococcal | #1283 |
| rodent models | #1284 |
| spreading | #1286 |
| joint destruction | #1287 |
| attacked | #1288 |
| disease response | #1290 |
| pathological processes | #1294 |
| immunochip | #1295 |
| suppressor cells | #1296 |
| serm | #1297 |
| peripheral cells | #1297 |
| day pregnancy | #1297 |
| nadph oxidase activity | #1299 |
| production anti | #1299 |
| publication animals antigens | #1300 |
| data protein | #1300 |
| restimulation | #1305 |
| hdac3 | #1307 |
| model experimental | #1307 |
| peptide library | #1309 |
| ali | #1310 |
| social isolation | #1310 |
| fab2 | #1312 |
| generated | #1313 |
| phagocytic cells | #1313 |
| introgressed | #1314 |
| lymphoproliferation | #1315 |
| permissive | #1315 |
| immune | #1316 |
| detailed characterization | #1316 |
| increased susceptibility | #1316 |
| protects | #1319 |
| estradiol treatment | #1320 |
| immunoglobulin isotypes | #1321 |
| hydrolyzes | #1321 |
| phagocytes | #1322 |
| healthy human subjects | #1322 |
| intrathymic | #1322 |
| submandibular | #1323 |
| collagen types | #1323 |
| aureus infections | #1325 |
| valuable tool | #1327 |
| acute phase proteins | #1327 |
| therapeutic antibodies | #1328 |
| dietary nitrate | #1329 |
| human igg | #1330 |
| receptor 2 | #1330 |
| immunological memory | #1332 |
| pockets | #1333 |
| thymectomy | #1335 |
| identically | #1335 |
| new therapies | #1336 |
| rats rats | #1336 |
| acute phase response | #1338 |
| cells mice | #1341 |
| induction phase | #1341 |
| adjuvants | #1344 |
| increasing evidence | #1348 |
| knockout mutation | #1349 |
| promiscuity | #1350 |
| galactosylceramides | #1356 |
| allergic contact | #1359 |
| alp | #1361 |
| elimination | #1361 |
| position | #1361 |
| regulatory genes | #1362 |
| believed | #1364 |
| disease activity score | #1364 |
| n44 | #1366 |
| hypersensitivity | #1367 |
| 590 | #1368 |
| bacterial arthritis | #1372 |
| ameliorates | #1374 |
| trait | #1375 |
| shared | #1375 |
| membrane glycoproteins | #1375 |
| betad | #1375 |
| rat spinal cord | #1379 |
| il1r | #1381 |
| abrogates | #1383 |
| immunogen | #1383 |
| surface cells | #1384 |
| rats humans | #1388 |
| exacerbation | #1388 |
| suffer | #1389 |
| variable region | #1389 |
| cd2 | #1390 |
| clinical signs | #1390 |
| regulatory treg | #1390 |
| human patients | #1392 |
| squalene | #1392 |
| feto | #1393 |
| phage display | #1393 |
| cd4cd8 | #1394 |
| effects rats | #1396 |
| inbred mice | #1397 |
| disease outcomes | #1397 |
| positional | #1399 |
| submandibular glands | #1400 |
| early patients | #1403 |
| joint disease | #1403 |
| mononuclear phagocytes | #1406 |
| linkage genetic | #1409 |
| disease phenotypes | #1412 |
| animals disease | #1413 |
| antigens humans | #1415 |
| enzymelinked immunosorbent | #1416 |
| activation neutrophils | #1417 |
| humans immune | #1417 |
| cytokine profile | #1424 |
| class switching | #1425 |
| bacterial infections | #1431 |
| genetic heterogeneity | #1436 |
| gene usage | #1438 |
| stages disease | #1439 |
| cells type | #1440 |
| peptide | #1441 |
| guillainbarré syndrome | #1451 |
| arthritis systemic | #1453 |
| inbred strains mice | #1454 |
| alpha1 | #1458 |
| cell activation | #1458 |
| monoclonal | #1460 |
| knockout rats | #1461 |
| proinflammatory responses | #1461 |
| expression genetic | #1462 |
| lupus | #1464 |
| salt concentrations | #1465 |
| opens | #1467 |
| pfp | #1467 |
| ccr6 | #1467 |
| cell origin | #1468 |
| inflammatory properties | #1469 |
| cells pregnancy | #1472 |
| activation status | #1473 |
| immune deficiency | #1474 |
| cartilage cell | #1474 |
| muscle muscle | #1476 |
| cells activated | #1478 |
| allelic variants | #1479 |
| allotype | #1480 |
| specific gene | #1482 |
| responses animals | #1482 |
| blisters | #1483 |
| markers genetic | #1483 |
| initiate | #1486 |
| inflammatory diseases | #1486 |
| cells lung | #1486 |
| genetic regulation | #1486 |
| stroke 95 | #1487 |
| hormone release | #1489 |
| host defence | #1489 |
| donated | #1490 |
| mice day | #1491 |
| human cartilage | #1491 |
| inbred rats | #1491 |
| humoral immune | #1497 |
| emphysematous | #1499 |
| myelin | #1499 |
| regulatory effects | #1504 |
| treatment inflammatory | #1504 |
| monocytes neutrophils | #1504 |
| specific monoclonal | #1505 |
| vivo vitro | #1505 |
| joint arthritis | #1507 |
| mimicking | #1507 |
| eluate | #1507 |
| fls | #1508 |
| mapped | #1509 |
| inflammatory cell | #1510 |
| hindlimbs | #1511 |
| chromosome 6 | #1512 |
| stimulates | #1515 |
| egfp | #1516 |
| induced ali | #1520 |
| human leukocyte antigen | #1524 |
| earlier studies | #1525 |
| lia | #1525 |
| genes dominant | #1528 |
| knockout mitochondria | #1530 |
| sex steroids | #1531 |
| streptococcus pyogenes | #1533 |
| glutamic acid | #1535 |
| malaise | #1536 |
| lysines | #1537 |
| downregulate | #1540 |
| net release | #1545 |
| protein rna | #1546 |
| unexpectedly | #1547 |
| production macrophages | #1547 |
| increased numbers | #1548 |
| acetylglucosaminidase | #1549 |
| chronic phase | #1554 |
| higher level | #1555 |
| mediated diseases | #1559 |
| intraperitoneally | #1560 |
| neuroimmunomodulation | #1563 |
| 4 humans | #1563 |
| copy variations | #1563 |
| activate | #1564 |
| intradermal | #1565 |
| vsg | #1566 |
| guerin | #1567 |
| matrix components | #1567 |
| mammalian embryo | #1568 |
| immunoglobulin humans | #1568 |
| formyl | #1569 |
| sufficient | #1573 |
| pineal | #1574 |
| cytotoxic lymphocyte | #1574 |
| independent | #1577 |
| cochran | #1577 |
| cathelicidin | #1578 |
| glycolipid | #1580 |
| collagens | #1585 |
| fab | #1592 |
| mac1 | #1593 |
| factor beta | #1597 |
| directed | #1597 |
| conserved | #1597 |
| defines | #1598 |
| twins | #1600 |
| adoptive transfer | #1600 |
| cell mediated | #1600 |
| f1 | #1600 |
| reactive nitrogen species | #1603 |
| autoantibodies biomarkers | #1604 |
| cell receptor | #1605 |
| estriol | #1607 |
| cells th17 | #1607 |
| helical | #1611 |
| stromal cells | #1615 |
| chondrocyte | #1616 |
| immunity animals | #1617 |
| chronic inflammatory diseases | #1617 |
| isosteric | #1619 |
| autoimmune diabetes | #1621 |
| humans immunoglobulin | #1622 |
| c57bl 6 | #1622 |
| anaphylatoxin | #1622 |
| differently | #1625 |
| antigen | #1626 |
| unreactive | #1626 |
| rat spinal | #1629 |
| iggs | #1630 |
| complement component | #1632 |
| c3b | #1635 |
| immunohistology | #1635 |
| collagen fibers | #1639 |
| lund | #1639 |
| type interferon | #1641 |
| mice increased | #1642 |
| p6 | #1644 |
| abrogated | #1644 |
| c4b | #1645 |
| aspartic acid | #1647 |
| intracellular ros | #1651 |
| sjl | #1652 |
| opsonization | #1653 |
| complement activation | #1657 |
| linked | #1658 |
| defence | #1658 |
| commonly | #1660 |
| complement receptors | #1660 |
| staphylococcal enterotoxin | #1661 |
| immune complexes | #1661 |
| transporter type | #1661 |
| enterotoxins | #1662 |
| mice knockout | #1664 |
| tcell receptors | #1665 |
| salt intake | #1668 |
| tumor vasculature | #1669 |
| coincided | #1670 |
| primary sjögren | #1671 |
| isopropylacrylamide | #1672 |
| pathogenic cells | #1673 |
| immunologic epitopes | #1673 |
| gamma production | #1678 |
| single nucleotide | #1683 |
| cd206 | #1686 |
| complement c5a | #1686 |
| auto | #1689 |
| cocktail | #1689 |
| igm antibodies | #1691 |
| method analysis | #1693 |
| agouti | #1694 |
| ido1 | #1694 |
| classical pathway | #1696 |
| transgenic mice | #1696 |
| severity | #1701 |
| 5 months | #1704 |
| precede | #1704 |
| animals autoantigens | #1704 |
| triple | #1704 |
| suppressors | #1706 |
| encoded | #1707 |
| disulfiram | #1711 |
| treg cells | #1711 |
| beta chains | #1712 |
| erosions | #1712 |
| mice neutrophils | #1714 |
| ankylosis | #1719 |
| sjögrens syndrome | #1719 |
| evoke | #1720 |
| tolerance | #1721 |
| pulmonary aspergillosis | #1721 |
| skewing | #1725 |
| oophorectomy | #1727 |
| showing | #1728 |
| myelin proteolipid | #1729 |
| mutant mice | #1729 |
| drug targets | #1732 |
| 369 | #1734 |
| analysis protein | #1734 |
| immune responses | #1734 |
| staphylococcal infections | #1736 |
| phagocytic | #1737 |
| sicca | #1737 |
| fmoc | #1739 |
| intranasally | #1740 |
| arthritis patients | #1742 |
| affinity binding | #1743 |
| prophylactic treatment | #1744 |
| 626 | #1744 |
| cd11 | #1745 |
| osteoclasts | #1746 |
| zap70 | #1748 |
| strain mice | #1748 |
| alternative pathway | #1748 |
| new loci | #1749 |
| responded | #1750 |
| neoplastic disease models | #1753 |
| peroxide | #1758 |
| infiltrating | #1762 |
| endoglycosidase | #1764 |
| inhibitory receptors | #1766 |
| dr2 | #1766 |
| multiple genes | #1770 |
| triggering | #1770 |
| higher frequency | #1770 |
| glycosylation | #1774 |
| peptide antigens | #1775 |
| operate | #1776 |
| blocking | #1781 |
| adoptively | #1782 |
| cnbr | #1783 |
| ll37 | #1784 |
| articular cell | #1784 |
| local administration | #1788 |
| immunohistological | #1789 |
| compartmentalized | #1791 |
| carbohydrates | #1792 |
| pathogenesis | #1793 |
| dogma | #1794 |
| render | #1794 |
| competed | #1797 |
| immune recognition | #1800 |
| disease pathogenesis | #1801 |
| polymorphism genetic | #1801 |
| rat models | #1802 |
| rechallenge | #1803 |
| cd19 antigens | #1803 |
| peyer | #1804 |
| obese diabetic | #1805 |
| aureus infection | #1808 |
| predisposed | #1810 |
| immunogenic | #1810 |
| complement pathway | #1811 |
| activated lymphocytes | #1811 |
| elucidation | #1811 |
| psoriatic | #1813 |
| recovery phase | #1814 |
| pregnancy rats | #1817 |
| nonfunctional | #1817 |
| promoting | #1818 |
| il2r | #1818 |
| ossification | #1818 |
| blymphocyte | #1819 |
| intravenously | #1819 |
| crossed | #1823 |
| katpase | #1824 |
| myelin sheath | #1825 |
| hydroxylated | #1825 |
| neurodegenerative diseases | #1827 |
| deplete | #1830 |
| female sex | #1833 |
| genetic susceptibility | #1836 |
| new treatments | #1839 |
| pathogenesis disease | #1841 |
| trif | #1843 |
| resolution inflammation | #1844 |
| subsequently | #1846 |
| clinical score | #1846 |
| inflammation macrophages | #1847 |
| estrogen | #1848 |
| cultured disease | #1849 |
| pyogenes | #1852 |
| specific immunity | #1854 |
| genetic variance | #1854 |
| cd8 lymphocytes | #1856 |
| macrophages neutrophils | #1856 |
| humoral | #1857 |
| rac2 | #1858 |
| barre | #1858 |
| cocktails | #1860 |
| haenszel | #1862 |
| secreting | #1863 |
| structural basis | #1864 |
| aggravation | #1864 |
| lacrimal apparatus | #1865 |
| silastic | #1871 |
| rats groups | #1871 |
| immunoadsorption | #1873 |
| inkt | #1874 |
| carries | #1875 |
| major | #1876 |
| subsequent development | #1879 |
| cartilages | #1879 |
| candidate | #1883 |
| antigen humans | #1890 |
| inflammation lung | #1892 |
| polyclonal | #1893 |
| bacterial clearance | #1894 |
| ovalbumin | #1897 |
| cyanogen | #1900 |
| striking | #1902 |
| tcr repertoire | #1903 |
| lymphatics | #1903 |
| complexity | #1905 |
| indicating | #1905 |
| proteins rats | #1907 |
| model rats | #1908 |
| gammadelta | #1910 |
| mediated | #1910 |
| enzyme linked | #1911 |
| cells neutrophils | #1912 |
| cell maturation | #1912 |
| interferon gamma | #1914 |
| erythematosus sle | #1916 |
| chromosome | #1916 |
| totally | #1918 |
| 6 hours | #1920 |
| cartilage tissue | #1923 |
| anti | #1924 |
| 721 | #1924 |
| gαq | #1926 |
| pronounced | #1927 |
| ears | #1929 |
| isoantigens | #1931 |
| bcell receptors | #1933 |
| expression cytokines | #1934 |
| trypanosoma brucei | #1937 |
| animals lymphocytes | #1937 |
| sialyltransferases | #1939 |
| mice receptors | #1940 |
| antigen tcell receptors | #1944 |
| type plasminogen | #1945 |
| predisposition | #1949 |
| prevented | #1950 |
| subclasses | #1950 |
| constituting | #1955 |
| cardiac allografts | #1956 |
| snakes | #1957 |
| perforin | #1957 |
| agp | #1959 |
| mmc | #1962 |
| levels serum | #1967 |
| pinocytosis | #1967 |
| edition | #1967 |
| iga igg | #1967 |
| fcγ receptor | #1969 |
| possibilities | #1969 |
| strong | #1971 |
| intravenous injection | #1972 |
| react | #1975 |
| mip | #1977 |
| stimulations | #1978 |
| carp | #1979 |
| synovial tissues | #1979 |
| ova | #1980 |
| inbred cba | #1980 |
| cd154 | #1982 |
| pregnant rats | #1983 |
| cell clone | #1985 |
| disease pathology | #1985 |
| milder | #1988 |
| spans | #1997 |
| mast cell | #1999 |
| cd18 | #2000 |
| transgenic rats | #2001 |
| microglia activation | #2002 |
| presenting cell | #2006 |
| heteroplasmy | #2007 |
| rats effects | #2008 |
| contact dermatitis | #2008 |
| reverted | #2008 |
| prototypic | #2011 |
| response infection | #2016 |
| abca1 | #2016 |
| barré syndrome | #2018 |
| knockout | #2020 |
| tissue inflammation | #2021 |
| immunoglobulin | #2023 |
| genes | #2025 |
| cell | #2027 |
| cytokine secretion | #2028 |
| mabs | #2028 |
| demyelination | #2030 |
| chord | #2031 |
| tetramers | #2032 |
| c5ar | #2033 |
| conformational epitopes | #2035 |
| mesenteric lymph | #2035 |
| beta gene | #2035 |
| 4 tlr4 | #2041 |
| factor mif | #2041 |
| mab | #2042 |
| diethyldithiocarbamate | #2043 |
| immunomodulatory properties | #2044 |
| sex chromosome | #2045 |
| cell immunity | #2047 |
| oestrogens | #2050 |
| hypergammaglobulinemia | #2050 |
| species signal | #2053 |
| cell function | #2053 |
| castration | #2053 |
| coinciding | #2055 |
| emphysema | #2056 |
| glycosylation humans | #2057 |
| increased frequency | #2058 |
| innate inflammation | #2058 |
| dramatically | #2059 |
| vitro vivo | #2061 |
| activation complement | #2061 |
| accompanied | #2067 |
| genetic differences | #2068 |
| dominant | #2070 |
| contributors | #2071 |
| proteomics analysis | #2072 |
| hyaluronoglucosaminidase | #2072 |
| mdsc | #2076 |
| polyradiculoneuropathy | #2077 |
| mature cells | #2077 |
| respiratory tract | #2079 |
| lysine residues | #2080 |
| antiphospholipid syndrome | #2081 |
| cell depletion | #2082 |
| mice pregnancy | #2083 |
| methotrexate mtx | #2094 |
| complement | #2094 |
| conditional deletion | #2095 |
| lysine | #2096 |
| addressed | #2097 |
| bioreactor | #2100 |
| αβ | #2100 |
| suggested | #2102 |
| evokes | #2103 |
| led | #2103 |
| antigens hla | #2104 |
| patients rheumatoid arthritis | #2105 |
| human chondrocytes | #2110 |
| nose | #2117 |
| lentiviral vectors | #2120 |
| pulmonary inflammation | #2122 |
| glycan | #2122 |
| immune functions | #2126 |
| pad4 | #2127 |
| oxidants | #2129 |
| total igg | #2130 |
| secondary receptors | #2133 |
| inducing | #2136 |
| occurring | #2139 |
| histopathological | #2140 |
| selective estrogen | #2141 |
| target tissues | #2141 |
| dissection | #2142 |
| plasminogen | #2143 |
| transduction lymphocytes | #2145 |
| subphenotypes | #2146 |
| extracellular calcium | #2146 |
| bound | #2147 |
| h2d | #2147 |
| circulating monocytes | #2149 |
| 129 strain mice | #2151 |
| immunohistochemical analysis | #2151 |
| reality | #2153 |
| clinical aspects | #2157 |
| periphery | #2161 |
| major histocompatibility complex | #2162 |
| late stages | #2165 |
| moabs | #2165 |
| rheumatoid biomarkers | #2165 |
| prone | #2169 |
| entire | #2174 |
| syringes | #2176 |
| mimics | #2177 |
| animal model | #2179 |
| immune regulation | #2180 |
| human leukocytes | #2181 |
| dynorphins | #2184 |
| psoriatic arthritis | #2184 |
| dnp | #2185 |
| native | #2188 |
| injury ali | #2200 |
| dss | #2203 |
| lps stimulation | #2204 |
| structural requirements | #2211 |
| molecular pathways | #2213 |
| confirming | #2214 |
| 12th | #2215 |
| interleukin2 | #2216 |
| therapeutic effects | #2216 |
| activation cells | #2217 |
| animal mice mice | #2217 |
| naïve | #2219 |
| galactose | #2220 |
| regulates | #2220 |
| suggesting | #2221 |
| wt mice | #2224 |
| immunoreactivity | #2225 |
| mammalian | #2232 |
| shrna | #2232 |
| governs | #2233 |
| neutralized | #2233 |
| presentation | #2234 |
| accelerates | #2236 |
| autoimmune conditions | #2239 |
| reduced susceptibility | #2239 |
| ctla4 | #2239 |
| lacked | #2240 |
| graft rejection | #2244 |
| inflammatory phenotype | #2248 |
| cholera toxin | #2248 |
| cell priming | #2252 |
| exacerbated | #2253 |
| monoclonal antibodies | #2254 |
| cell receptors | #2256 |
| tcell proliferation | #2261 |
| sjögren | #2263 |
| regulation immune | #2265 |
| involved pathogenesis | #2267 |
| hla | #2269 |
| progeny | #2274 |
| mph | #2274 |
| immunospot | #2278 |
| murine | #2279 |
| antigenic | #2279 |
| mice treatment | #2280 |
| neutrophil apoptosis | #2280 |
| lymph nodes | #2281 |
| dependent | #2284 |
| inflammatory | #2288 |
| immunizations | #2289 |
| homologous | #2292 |
| plasmatic | #2293 |
| modified proteins | #2296 |
| determining | #2296 |
| histological evaluation | #2296 |
| cba mice | #2297 |
| regulatory mechanisms | #2299 |
| knockout mice | #2300 |
| apocynin | #2302 |
| segregating | #2308 |
| infiltrating macrophages | #2309 |
| presentation antigens | #2310 |
| wounding | #2312 |
| drastically | #2315 |
| genetic basis | #2315 |
| il10 | #2317 |
| healthy donors | #2318 |
| hydroxylation | #2320 |
| barré | #2320 |
| inflammatory mechanisms | #2321 |
| throughput nucleotide | #2325 |
| sera | #2325 |
| p00002 | #2326 |
| antigens histocompatibility | #2328 |
| wild | #2329 |
| cells induced | #2331 |
| demyelinating disease | #2336 |
| n24 | #2338 |
| lewis | #2345 |
| gk | #2347 |
| receptor α | #2353 |
| reciprocal | #2353 |
| specific igg | #2358 |
| ethylenes | #2358 |
| illness stress | #2361 |
| monosaccharide | #2363 |
| hyaline | #2364 |
| biological agents | #2365 |
| acrylamides | #2366 |
| sex hormone | #2366 |
| lectins type | #2366 |
| degradative | #2367 |
| phosphoproteins | #2369 |
| wf | #2374 |
| eliminated | #2374 |
| immunogens | #2375 |
| peptides derived | #2375 |
| lymphotoxin | #2375 |
| genetic selection | #2376 |
| treatment rheumatoid arthritis | #2376 |
| amps | #2382 |
| cxcl1 | #2382 |
| antinociceptive | #2383 |
| nonalcoholic steatohepatitis | #2384 |
| contaminating | #2386 |
| mouse model | #2386 |
| sidechain | #2391 |
| phenotypes | #2391 |
| receptor transforming | #2392 |
| knock | #2394 |
| syngeneic | #2394 |
| septic arthritis | #2396 |
| systemic lupus erythematosus | #2397 |
| hla genes | #2398 |
| p38 mapk | #2400 |
| inflammatory reaction | #2400 |
| serum autoantibodies | #2408 |
| increased incidence | #2409 |
| mice models | #2411 |
| equina | #2413 |
| intraperitoneal injections | #2418 |
| genetic receptors | #2420 |
| genetic studies | #2420 |
| structure analysis | #2423 |
| realtime pcr | #2424 |
| mice expression | #2426 |
| tlr2 tlr4 | #2429 |
| suggestive evidence | #2430 |
| lentivirus | #2430 |
| acute phase | #2430 |
| unmodified | #2431 |
| cytokines chemokines | #2432 |
| cko | #2432 |
| lymphocytes cd4 | #2432 |
| collagen fibrils | #2432 |
| cells antigens | #2434 |
| early phases | #2440 |
| agents arthritis | #2440 |
| inflammatory activity | #2442 |
| mice multiple | #2446 |
| genetic predisposition | #2449 |
| b6 | #2450 |
| receptors complement | #2450 |
| 551 | #2451 |
| lipoxin | #2458 |
| inflammatory demyelinating | #2459 |
| animal disease models | #2463 |
| exemplified | #2466 |
| idiotype | #2468 |
| antibody responses | #2469 |
| strains | #2471 |
| administration intranasal | #2473 |
| animals cd4 | #2473 |
| axotomy | #2477 |
| additively | #2477 |
| translational modifications | #2477 |
| class | #2480 |
| quantitative | #2480 |
| regulatory | #2487 |
| animal experiments | #2492 |
| specific | #2493 |
| organ specific | #2497 |
| transforming growth factor | #2498 |
| negative feedback | #2501 |
| alleviated | #2502 |
| albeit | #2502 |
| cystatin | #2504 |
| mhc class genes | #2505 |
| multiparous | #2511 |
| transgenic microscopy | #2512 |
| bystander | #2515 |
| il17a | #2516 |
| ppd | #2518 |
| chemokines cytokines | #2519 |
| dichotomous | #2519 |
| contribute | #2522 |
| naturally | #2523 |
| treatment rheumatoid | #2524 |
| hyperostosis | #2525 |
| amiloride | #2526 |
| nod mice | #2527 |
| microsatellite markers | #2534 |
| pathogenicity | #2534 |
| infiltration | #2541 |
| resemblance | #2542 |
| undertaken | #2545 |
| postmenopausal osteoporosis | #2546 |
| proteolipid | #2552 |
| dapsone | #2560 |
| similarities | #2561 |
| igm iga | #2562 |
| plp | #2563 |
| kynurenine | #2563 |
| deprotection | #2564 |
| nox | #2566 |
| succeeded | #2567 |
| transferring | #2573 |
| fine | #2573 |
| passive | #2574 |
| dying cells | #2575 |
| rp patients | #2575 |
| tumor models | #2576 |
| incomplete | #2577 |
| quantitative traits | #2577 |
| complementarity | #2580 |
| peptides | #2585 |
| chick | #2589 |
| calgranulin | #2590 |
| antibody levels | #2591 |
| peritoneal macrophages | #2591 |
| misinterpretation | #2593 |
| interferon type | #2595 |
| sex hormones | #2597 |
| fibrinolysin | #2598 |
| onset | #2603 |
| antiinflammatory properties | #2603 |
| unlinked | #2605 |
| zymosan | #2610 |
| induction | #2611 |
| postulated | #2614 |
| exert | #2615 |
| antimicrobial peptides | #2618 |
| surprising | #2621 |
| interferon beta | #2623 |
| proteolipid protein | #2632 |
| ifn α | #2634 |
| single chain | #2639 |
| sialoglycoproteins | #2643 |
| plasmin | #2647 |
| unable | #2649 |
| asparagine | #2651 |
| tlr9 | #2653 |
| antigens | #2656 |
| disease genotype | #2658 |
| hla antigens | #2659 |
| submandibular gland | #2663 |
| antinuclear | #2663 |
| functional impact | #2663 |
| eluted | #2666 |
| osteonectin | #2667 |
| invading | #2670 |
| brucei | #2670 |
| n22 | #2670 |
| microliters | #2671 |
| biological pathways | #2673 |
| bordetella | #2680 |
| new therapeutic strategies | #2683 |
| ease | #2683 |
| leukocyte antigen | #2688 |
| th1 | #2690 |
| acd | #2696 |
| day treatment | #2697 |
| allelic | #2697 |
| genetic variations | #2698 |
| igg3 | #2698 |
| animal encephalomyelitis | #2702 |
| neutrophils macrophages | #2703 |
| gamma mice | #2711 |
| peptides protein | #2714 |
| γδ | #2716 |
| treatment mice | #2717 |
| rat model | #2718 |
| human complement | #2725 |
| patients anti | #2727 |
| polymorphic | #2729 |
| ifngamma | #2730 |
| biased | #2730 |
| lymphocyte subsets | #2730 |
| post partum | #2731 |
| fumigatus | #2735 |
| lamina propria | #2735 |
| serum anti | #2738 |
| fragment | #2743 |
| vav | #2743 |
| mice exposed | #2750 |
| leucocyte | #2754 |
| resemble | #2762 |
| bromocriptine | #2768 |
| transgenic mouse | #2772 |
| depleting | #2773 |
| human leukocyte | #2774 |
| tyrosine phosphatase | #2774 |
| strong evidence | #2777 |
| cytolysis | #2777 |
| qtls | #2777 |
| enigmatic | #2780 |
| iga igm | #2780 |
| detectable | #2780 |
| genetically | #2782 |
| explanation | #2785 |
| finemapping | #2785 |
| alcoholic steatohepatitis | #2786 |
| treated rats | #2786 |
| intraperitoneal | #2787 |
| tolerogenic | #2789 |
| bone cartilage | #2790 |
| sjogren syndrome | #2791 |
| current review | #2798 |
| inbred mrl | #2798 |
| animal encephalomyelitis autoimmune | #2799 |
| hk | #2801 |
| callithrix | #2804 |
| spleen | #2812 |
| 261 | #2813 |
| neuropathology | #2817 |
| genistein | #2819 |
| alpha | #2821 |
| lack | #2822 |
| activated macrophages | #2825 |
| hyaluronidase | #2830 |
| conventionally | #2831 |
| narrowed | #2832 |
| prl | #2835 |
| olive oil | #2838 |
| demyelinating diseases | #2841 |
| resistant | #2842 |
| hallmark | #2843 |
| glucose uptake | #2846 |
| beta receptor | #2847 |
| beta tgf | #2848 |
| bind | #2848 |
| th1 response | #2852 |
| demyelinating | #2852 |
| polymorphonuclear leukocytes | #2856 |
| phases | #2858 |
| dependent cell | #2859 |
| treg cell | #2859 |
| interleukin receptors | #2864 |
| polymorphonuclear | #2864 |
| antibodies antinuclear | #2864 |
| characterising | #2865 |
| splenocytes | #2865 |
| interleukin33 | #2869 |
| rats inbred strains | #2869 |
| cyanogen bromide | #2874 |
| guillain | #2875 |
| disease characterized | #2875 |
| cells cd8 | #2881 |
| periodontitis | #2882 |
| parvalbumin | #2884 |
| reveals | #2885 |
| clone cells | #2885 |
| exacerbate | #2888 |
| igg iga | #2891 |
| migration inhibitory | #2892 |
| costimulatory molecules | #2895 |
| tgfbeta | #2895 |
| innate immune responses | #2896 |
| dce | #2896 |
| antigens class humans | #2898 |
| dq | #2905 |
| antigen hla | #2907 |
| atp synthase | #2909 |
| linked immunosorbent | #2911 |
| enhancement | #2911 |
| studying | #2918 |
| diseases disease | #2920 |
| shortly | #2920 |
| ergometry | #2921 |
| allogenic | #2921 |
| steadily | #2925 |
| vaccine development | #2925 |
| type lectin | #2926 |
| obvious | #2927 |
| ifn γ | #2931 |
| autoimmune disorder | #2935 |
| dextran | #2939 |
| female flow | #2943 |
| injections | #2944 |
| expression macrophages | #2944 |
| ifn gamma | #2945 |
| proteins peptides | #2946 |
| cd68 | #2947 |
| patients antibodies | #2949 |
| interleukin4 | #2950 |
| cells immune | #2955 |
| eventually | #2956 |
| toll receptor | #2961 |
| cell infiltration | #2962 |
| expressions | #2963 |
| calcium ions | #2964 |
| qtl | #2965 |
| histocytochemistry | #2967 |
| suppressed | #2967 |
| hnrnp | #2980 |
| genetics | #2982 |
| ifn response | #2985 |
| cepacia | #2988 |
| antirheumatic agents | #2993 |
| elusive | #2994 |
| hdac | #2995 |
| thymus gland | #2997 |
| swedish | #2998 |
| respective | #3000 |
| lineage commitment | #3003 |
| time points | #3009 |
| indoleamine | #3009 |
| cells female | #3010 |
| innate | #3014 |
| therapeutic strategies | #3014 |
| illustrating | #3017 |
| anthrax | #3019 |
| interferon ifn | #3020 |
| wild type mice | #3026 |
| defensins | #3027 |
| vdr | #3031 |
| accelerating | #3033 |
| lung inflammation | #3033 |
| macrophage migration | #3036 |
| endo | #3039 |
| t‐cell | #3039 |
| synthetic peptides | #3040 |
| appearance | #3045 |
| quinoxalines | #3047 |
| cd8 | #3048 |
| immunomodulator | #3050 |
| model mice | #3051 |
| longterm treatment | #3052 |
| twin studies | #3053 |
| complex traits | #3055 |
| ppt | #3058 |
| interleukin23 | #3061 |
| profound | #3067 |
| sjögren syndrome | #3069 |
| prevailing | #3073 |
| salivary | #3076 |
| mediated immune | #3077 |
| role cell | #3078 |
| beta | #3080 |
| destruction | #3082 |
| irrespective | #3083 |
| model human | #3083 |
| gene expression profiling | #3086 |
| impairing | #3087 |
| nodes | #3091 |
| inhibitory factors | #3092 |
| glutamic | #3092 |
| parvalbumins | #3093 |
| inbred balb mice | #3098 |
| receptor 4 | #3098 |
| genetic deletion | #3100 |
| detailed description | #3101 |
| postpartum period | #3107 |
| germinal | #3108 |
| antirheumatic | #3109 |
| staphylococcus | #3114 |
| type wt | #3120 |
| neuronal cell | #3123 |
| effects treatment | #3124 |
| suspect | #3127 |
| igm igg | #3130 |
| specificity | #3131 |
| glycans | #3136 |
| monoclonal antibody | #3137 |
| receptors tlrs | #3142 |
| psoriasis | #3142 |
| logarithm | #3146 |
| cd4 cd8 | #3147 |
| preformed | #3151 |
| immune systems | #3152 |
| possibility | #3153 |
| cell activity | #3154 |
| molecule | #3155 |
| propria | #3155 |
| cba | #3164 |
| posttranslational modification | #3167 |
| sjogren | #3171 |
| massively | #3172 |
| accumulated | #3180 |
| cell specific | #3185 |
| precedes | #3185 |
| blockage | #3187 |
| tissue specific | #3191 |
| dynorphin | #3191 |
| pertussis toxin | #3192 |
| adult mice | #3193 |
| cells rats | #3193 |
| keratinocytes | #3194 |
| unravel | #3199 |
| reactivity | #3202 |
| helper | #3204 |
| modified | #3205 |
| ovx | #3208 |
| serum levels | #3210 |
| antiinflammatory | #3211 |
| erbeta | #3211 |
| nitroarginine | #3212 |
| phagosomes | #3212 |
| abs | #3216 |
| publication arthritis | #3224 |
| cells animals | #3224 |
| gpi | #3226 |
| chromosome 1 | #3237 |
| class iii | #3239 |
| clarified | #3242 |
| permitting | #3246 |
| macrophage | #3247 |
| collagenous | #3247 |
| lod score | #3252 |
| bacterial antibodies | #3254 |
| backbone | #3257 |
| nonalcoholic steatohepatitis nash | #3260 |
| female gonadal | #3263 |
| treated animals | #3264 |
| acrylic | #3265 |
| chronic inflammatory | #3267 |
| meps | #3270 |
| immunosorbent assay | #3272 |
| implicate | #3274 |
| proteoglycans | #3278 |
| inflammation interferon | #3278 |
| sch | #3280 |
| arthralgia | #3283 |
| nephritis | #3283 |
| gonadal steroid | #3284 |
| normal rats | #3287 |
| abundantly | #3289 |
| igg1 | #3298 |
| models genetic | #3298 |
| immunoglobulin heavy | #3303 |
| erythematosus | #3305 |
| adaptations | #3309 |
| proteins mice | #3309 |
| elicits | #3314 |
| characterise | #3314 |
| blastocyst | #3315 |
| nociception | #3316 |
| absence | #3318 |
| diseases autoimmune | #3321 |
| publication animals | #3325 |
| beta receptors | #3325 |
| mice protein | #3327 |
| anticardiolipin | #3328 |
| confirmed | #3329 |
| gc cells | #3331 |
| serologically | #3332 |
| suppression | #3338 |
| regional lymph nodes | #3341 |
| macromolecular | #3343 |
| clinical phenotypes | #3345 |
| cd62l | #3353 |
| influenced | #3355 |
| trypanosoma | #3358 |
| akr | #3371 |
| vitamin d3 | #3373 |
| editor | #3377 |
| antinuclear antibodies | #3382 |
| sle | #3384 |
| genetic polymorphisms | #3385 |
| ovariectomy | #3386 |
| mechanistic studies | #3395 |
| macroporous | #3395 |
| levels inflammatory | #3395 |
| explains | #3396 |
| mount | #3397 |
| tubercle | #3402 |
| somatic mutations | #3406 |
| receptors transforming | #3410 |
| early phase | #3413 |
| haptens | #3413 |
| positions | #3418 |
| nk cells | #3419 |
| erythematosus systemic | #3419 |
| reacts | #3421 |
| neutrophil activation | #3421 |
| penetrant | #3425 |
| reply | #3432 |
| proving | #3434 |
| receptor type | #3434 |
| dendritic cells | #3436 |
| serum igg | #3437 |
| alleles | #3440 |
| permitted | #3441 |
| cauda | #3443 |
| 4 months | #3444 |
| injection | #3445 |
| superoxide production | #3446 |
| protein tyrosine | #3447 |
| obscure | #3448 |
| humans immunization | #3448 |
| increased sensitivity | #3449 |
| antimicrobial peptide | #3451 |
| diffusely | #3459 |
| characterised | #3469 |
| h5n1 | #3470 |
| patients sle | #3470 |
| flow cytometry | #3476 |
| modifying | #3477 |
| multimers | #3491 |
| inflammatory mediators | #3491 |
| proteoglycan | #3496 |
| successes | #3497 |
| il21 | #3500 |
| ly | #3501 |
| elucidate | #3503 |
| developed | #3505 |
| classical | #3505 |
| protein processing | #3506 |
| salivary gland | #3507 |
| publication animals animals | #3509 |
| neutrophilic | #3510 |
| pathobiology | #3511 |
| pathological features | #3517 |
| specific cd4 | #3519 |
| globulins | #3526 |
| deoxyguanosine | #3528 |
| 267 | #3528 |
| germline | #3529 |
| phenotypically | #3529 |
| predispose | #3532 |
| lacrimal | #3534 |
| micrometer | #3534 |
| transglutaminases | #3535 |
| radiolabelled | #3539 |
| cyclosporins | #3540 |
| regulatory cells tregs | #3540 |
| mbq | #3541 |
| dominantly | #3548 |
| histological examination | #3554 |
| investigate | #3559 |
| infections staphylococcus | #3561 |
| mast cells | #3563 |
| cultured disease models | #3568 |
| socs1 | #3570 |
| humans interferon | #3571 |
| histological | #3574 |
| homogenate | #3576 |
| interesting | #3580 |
| gamma | #3580 |
| negative patients | #3583 |
| artificially | #3584 |
| role development | #3585 |
| cytolytic | #3589 |
| hindlimb | #3590 |
| il33 | #3593 |
| compared wild | #3597 |
| triggered | #3597 |
| usage | #3601 |
| immunohistochemical staining | #3608 |
| upregulation | #3612 |
| previous findings | #3617 |
| intranasal | #3619 |
| tcr | #3622 |
| potential roles | #3624 |
| cleave | #3624 |
| genetic association | #3629 |
| rp | #3633 |
| attenuate | #3633 |
| mapping chromosomes | #3634 |
| valuable | #3637 |
| genetic | #3637 |
| adhere | #3638 |
| today | #3645 |
| cultured culture media | #3651 |
| allele | #3655 |
| enhances | #3657 |
| gene deletion | #3657 |
| cd4 positive | #3659 |
| exerts | #3663 |
| tolllike receptor | #3665 |
| clinical severity | #3665 |
| luminol | #3667 |
| 95 association | #3671 |
| cd44 | #3678 |
| il23 | #3690 |
| tgf beta | #3691 |
| female genes | #3694 |
| fibronectins | #3697 |
| toll receptors | #3700 |
| igg igm | #3702 |
| heavy chain | #3705 |
| publication animals humans | #3708 |
| synovitis | #3708 |
| cyclohexanecarboxylic | #3709 |
| aggregated | #3717 |
| inbred nod mice | #3730 |
| systemic male | #3735 |
| sequence deletion | #3740 |
| dh | #3742 |
| 378 | #3746 |
| cells produce | #3750 |
| therapeutic benefit | #3752 |
| macrophage cell | #3753 |
| contributing | #3754 |
| mediate | #3754 |
| complement c4 | #3758 |
| immunochemistry | #3759 |
| type 4 | #3763 |
| biomedicine | #3763 |
| lymphocytes tumor | #3766 |
| epitope mapping | #3767 |
| identification | #3771 |
| partum | #3772 |
| mtdna | #3773 |
| d3 | #3775 |
| th17 | #3786 |
| jakob | #3786 |
| reduced expression | #3787 |
| diphtheria | #3803 |
| immunohistochemical | #3805 |
| hind | #3808 |
| skewed | #3820 |
| superoxide | #3822 |
| integrins | #3822 |
| ribonucleoprotein | #3823 |
| new opportunities | #3831 |
| models immunological | #3834 |
| encompassing | #3838 |
| puerperal | #3839 |
| mmp9 expression | #3839 |
| noncoding rna | #3840 |
| unclear | #3847 |
| amelioration | #3854 |
| il17 | #3858 |
| postulate | #3858 |
| identical | #3859 |
| housed | #3861 |
| genetic dna | #3867 |
| cells treg | #3873 |
| genetic promoter regions | #3880 |
| kinase2 | #3887 |
| prominent | #3887 |
| glycoside | #3887 |
| reacting | #3888 |
| dinucleotide | #3894 |
| decreased levels | #3896 |
| synoviocytes | #3900 |
| microsatellite repeats | #3903 |
| superoxides | #3904 |
| dominate | #3907 |
| recognition | #3912 |
| endogenous | #3918 |
| established | #3919 |
| animal studies | #3926 |
| rats messenger | #3931 |
| hladr | #3934 |
| immunophenotyping | #3941 |
| manifestations | #3942 |
| nerves | #3944 |
| toes | #3946 |
| affect | #3947 |
| neutrophils | #3947 |
| polymorphism | #3949 |
| gingivalis | #3957 |
| nets | #3958 |
| mechanisms involved | #3961 |
| involvement | #3973 |
| disrupted | #3975 |
| associate | #3975 |
| 297 | #3982 |
| adult arthritis | #3988 |
| stimulate | #3992 |
| heavy chains | #3992 |
| ifn β | #3999 |
| question | #3999 |
| broader | #4001 |
| patients osteoarthritis | #4009 |
| elevated levels | #4012 |
| sinuses | #4016 |
| superoxide dismutase | #4018 |
| chondrocytes | #4018 |
| individual patients | #4028 |
| ags | #4029 |
| inflammatory processes | #4033 |
| higher expression | #4034 |
| influences | #4034 |
| efficiently | #4050 |
| glycoproteins | #4054 |
| hla alleles | #4059 |
| expression cell | #4063 |
| conferred | #4065 |
| c1q | #4069 |
| fragments | #4072 |
| produce | #4072 |
| hinge | #4074 |
| eliciting | #4075 |
| stat4 | #4076 |
| requirement | #4076 |
| glycoprotein | #4077 |
| plethora | #4077 |
| contrast | #4085 |
| llc | #4089 |
| upregulated | #4090 |
| systemic lupus | #4092 |
| expression type | #4098 |
| fine mapping | #4102 |
| atpases | #4103 |
| leukocyte | #4105 |
| glands | #4107 |
| conferring | #4108 |
| neutrophil | #4113 |
| creutzfeldt | #4115 |
| current concepts | #4116 |
| gelatin | #4120 |
| absent | #4121 |
| therapy genetic | #4122 |
| sclerosis animals | #4124 |
| regulatory cells | #4126 |
| drives | #4126 |
| protect | #4131 |
| mycobacterial | #4133 |
| promoter polymorphism | #4137 |
| stat1 | #4144 |
| functionally | #4147 |
| articular cartilage | #4161 |
| lupus erythematosus | #4162 |
| hla dq | #4165 |
| motor neurons | #4166 |
| polygenic | #4169 |
| placenta pregnancy | #4173 |
| tumour necrosis factor | #4177 |
| stimulatory | #4178 |
| early pregnancy | #4180 |
| immunology | #4183 |
| effector | #4184 |
| systemic disease | #4187 |
| superoxide anion | #4191 |
| infiltrating lymphocytes | #4192 |
| spe | #4193 |
| monocyte | #4201 |
| breeders | #4203 |
| enterotoxin | #4206 |
| porphyromonas gingivalis | #4207 |
| ici | #4207 |
| beads | #4213 |
| antigens cd8 | #4214 |
| animal drug | #4222 |
| depletion | #4223 |
| cytometric analysis | #4224 |
| parathyroid | #4225 |
| long noncoding | #4227 |
| mutant | #4232 |
| inbred balb | #4239 |
| treated mice | #4242 |
| kidneys | #4244 |
| macrophage infiltration | #4244 |
| granulocytic | #4249 |
| continuously | #4250 |
| chondrosarcoma | #4250 |
| witnessed | #4252 |
| conjunction | #4256 |
| immunological | #4257 |
| immunity innate | #4258 |
| bout | #4260 |
| igh | #4262 |
| lymphoid | #4264 |
| cell repertoire | #4268 |
| day1 | #4270 |
| denominator | #4270 |
| complex | #4272 |
| suggestive | #4276 |
| dermatitis | #4285 |
| experimental mice | #4285 |
| clues | #4286 |
| gene targeting | #4290 |
| cd4 | #4291 |
| balb | #4292 |
| disease genetic | #4294 |
| repertoire | #4302 |
| provocation | #4303 |
| molecular modeling | #4303 |
| sciatic | #4307 |
| shares | #4307 |
| tuberculin | #4308 |
| positive cells | #4309 |
| functional role | #4310 |
| receptors interleukin2 | #4317 |
| cell populations | #4317 |
| suppressive effects | #4320 |
| hydroxy2deoxyguanosine | #4331 |
| pparγ | #4350 |
| new insight | #4353 |
| trypanosomiasis | #4358 |
| fungal infection | #4364 |
| glutamine | #4364 |
| peritonitis | #4365 |
| wildtype | #4370 |
| immunoassays | #4373 |
| swelling | #4375 |
| caused | #4381 |
| penetrance | #4381 |
| cell clones | #4396 |
| mucous | #4402 |
| disease chronic | #4402 |
| prevents | #4414 |
| restored | #4417 |
| joint | #4420 |
| modulating | #4426 |
| closer | #4434 |
| receptor beta | #4434 |
| disturbed | #4434 |
| buprenorphine | #4435 |
| model systems | #4443 |
| early | #4453 |
| acute chronic | #4454 |
| aspartic | #4458 |
| parathyroid glands | #4470 |
| confers | #4473 |
| inflammatory pain | #4477 |
| disease duration | #4480 |
| thymocytes | #4481 |
| calmette | #4488 |
| strains rats | #4489 |
| synthase type | #4490 |
| treg | #4493 |
| neutralizing antibodies | #4503 |
| thickened | #4503 |
| human cell | #4505 |
| genetic loci | #4510 |
| extensively | #4516 |
| colitis | #4526 |
| derived cells | #4532 |
| therapeutic implications | #4534 |
| immunotoxins | #4535 |
| beta cells | #4539 |
| cells th2 | #4541 |
| challenged | #4542 |
| lymphocytes cd8 | #4545 |
| 101 | #4546 |
| cytotoxic lymphocytes | #4547 |
| articular chondrocytes | #4553 |
| interleukin5 | #4558 |
| messenger rats rats | #4564 |
| beta cell | #4566 |
| homing | #4576 |
| extracellular ca2 | #4576 |
| hydrolases | #4577 |
| fasl | #4578 |
| cell separation | #4580 |
| proliferative | #4581 |
| neurosecretory | #4585 |
| immunologic | #4592 |
| production inflammatory | #4593 |
| suggests | #4596 |
| inbred shr rats | #4607 |
| modulatory | #4608 |
| interact | #4613 |
| igg antibody | #4613 |
| ros levels | #4613 |
| confer | #4616 |
| depleted | #4639 |
| conditioned medium | #4642 |
| environmental factors | #4643 |
| fashion | #4658 |
| positive selection | #4658 |
| porphyromonas | #4666 |
| visualized | #4667 |
| endorphins | #4669 |
| implicated | #4670 |
| determinant | #4675 |
| causing | #4678 |
| langerhans | #4681 |
| chains | #4681 |
| monocytes macrophages | #4683 |
| animals antigens | #4693 |
| 259 | #4696 |
| female rats | #4699 |
| protecting | #4707 |
| lymph | #4707 |
| inherited | #4709 |
| defined | #4710 |
| destabilization | #4716 |
| facs | #4718 |
| human studies | #4720 |
| orthomyxoviridae infections | #4725 |
| humans inflammation | #4729 |
| cell population | #4734 |
| positive patients | #4736 |
| α1 | #4739 |
| clone | #4741 |
| mediating | #4744 |
| factor 88 | #4750 |
| panel | #4753 |
| gout | #4757 |
| new drugs | #4764 |
| histopathology | #4767 |
| orchiectomy | #4773 |
| cellular localization | #4775 |
| e4 | #4776 |
| alveolar macrophages | #4776 |
| purified | #4778 |
| differing | #4793 |
| eralpha | #4798 |
| male membrane | #4800 |
| rodents | #4801 |
| osteoclastogenesis | #4809 |
| displaying | #4809 |
| hydrolyzed | #4815 |
| tumor antigens | #4816 |
| effector cells | #4819 |
| paw | #4821 |
| cytokines | #4821 |
| cd4 cd8 cells | #4821 |
| cholera | #4822 |
| distinct | #4831 |
| coincides | #4833 |
| litters | #4843 |
| stress rats | #4846 |
| tissue injury | #4847 |
| rats receptors | #4850 |
| matrix ecm | #4852 |
| interferon γ | #4852 |
| stemness | #4860 |
| articular | #4861 |
| venules | #4863 |
| infiltrate | #4868 |
| th17 cells | #4872 |
| tlr2 | #4880 |
| hpa axis | #4882 |
| ifn | #4885 |
| exocrine | #4888 |
| multifactorial | #4889 |
| 116 | #4891 |
| lod | #4892 |
| specific binding | #4893 |
| ige | #4896 |
| humoral immunity | #4897 |
| induced lung | #4899 |
| preimplantation | #4905 |
| essential roles | #4915 |
| discuss | #4916 |
| immunosorbent | #4917 |
| correlating | #4923 |
| interleukins | #4927 |
| deacetylases | #4928 |
| closely | #4932 |
| timepoints | #4940 |
| humans multiple | #4945 |
| deficiency | #4946 |
| disease process | #4962 |
| naturally occurring | #4962 |
| monitored | #4964 |
| elicit | #4966 |
| forelimb | #4967 |
| contradictory | #4975 |
| point mutation | #4976 |
| cell antigen | #4990 |
| understand | #4995 |
| male rats | #4998 |
| kupffer cells | #5001 |
| thymic | #5003 |
| innate immune | #5004 |
| eosinophilia | #5004 |
| modulates | #5011 |
| isotype | #5012 |
| wt | #5012 |
| upa | #5014 |
| opened | #5018 |
| sh3 | #5019 |
| granuloma | #5021 |
| gland | #5024 |
| vimentin | #5026 |
| enhancing | #5026 |
| expand | #5026 |
| poliomyelitis | #5041 |
| explaining | #5042 |
| il5 | #5044 |
| diamines | #5048 |
| heterozygous | #5049 |
| coculture techniques | #5051 |
| cd8 cells | #5055 |
| caveolin | #5065 |
| linkage | #5067 |
| th1 cells | #5067 |
| phospholipid | #5071 |
| arthritis juvenile | #5072 |
| sitedirected mutagenesis | #5076 |
| molecular basis | #5084 |
| cells blood | #5085 |
| bcg | #5086 |
| autologous | #5087 |
| alum | #5087 |
| olive | #5088 |
| new treatment | #5089 |
| multiple sclerosis | #5098 |
| master regulator | #5100 |
| osteopontin | #5109 |
| aged anti | #5110 |
| occurs | #5112 |
| elispot | #5112 |
| sulfasalazine | #5115 |
| isoantibodies | #5120 |
| dq antigens | #5134 |
| contributes | #5139 |
| lesser | #5145 |
| traditionally | #5148 |
| cytosolic | #5152 |
| epidermis | #5158 |
| connection | #5165 |
| cytokines female | #5170 |
| titrated | #5171 |
| preceded | #5175 |
| antigen receptor | #5178 |
| lymphocytes cytotoxic | #5179 |
| binding | #5185 |
| sex characteristics | #5186 |
| transfer | #5187 |
| polymorphism single | #5188 |
| phenotypic | #5191 |
| complement proteins | #5192 |
| molecular level | #5196 |
| ovariectomized | #5210 |
| popliteal | #5224 |
| ers | #5235 |
| serves | #5238 |
| beta2 | #5238 |
| chimeric | #5241 |
| immunosuppressive | #5246 |
| epidermal | #5250 |
| cognate | #5258 |
| mucus | #5258 |
| cd86 | #5261 |
| tested | #5262 |
| deleterious effects | #5266 |
| progenitors | #5270 |
| costimulation | #5275 |
| detects | #5277 |
| osteoclast | #5277 |
| erosion | #5278 |
| therapeutic intervention | #5280 |
| prolactin | #5280 |
| maternally | #5289 |
| gels | #5292 |
| leu | #5294 |
| plasmapheresis | #5298 |
| clinical findings | #5299 |
| drug humans | #5301 |
| key component | #5301 |
| neutralization | #5301 |
| amino | #5310 |
| suggestion | #5312 |
| staphylococcus aureus | #5312 |
| anhydrases | #5315 |
| manner | #5320 |
| c57bl 6j | #5320 |
| spontaneous | #5321 |
| lipopolysaccharides macrophages | #5345 |
| genetic mapping | #5348 |
| ketoglutarate | #5350 |
| opposing | #5352 |
| proinflammatory | #5365 |
| clathrin | #5369 |
| multiplexed | #5371 |
| glomerulonephritis | #5377 |
| modifies | #5379 |
| cultured human | #5386 |
| expansion | #5387 |
| il1α | #5391 |
| tolllike receptors | #5397 |
| oxidation reduction | #5398 |
| new strategies | #5401 |
| mice molecular | #5402 |
| positive lymphocytes | #5402 |
| tnf α | #5411 |
| epigenetic mechanisms | #5417 |
| antiinflammatory agents | #5417 |
| adversely | #5418 |
| fulvestrant | #5420 |
| activation | #5420 |
| dendritic | #5428 |
| compartments | #5429 |
| antigens surface | #5429 |
| signaling molecules | #5432 |
| mif | #5457 |
| cell culture | #5458 |
| wide spectrum | #5473 |
| sideeffects | #5478 |
| multitude | #5482 |
| located | #5499 |
| immunoglobulins | #5500 |
| histological analysis | #5507 |
| reproduced | #5507 |
| lactating | #5515 |
| cytotoxic | #5519 |
| cytokines humans | #5525 |
| balb mice | #5542 |
| therapeutic | #5547 |
| thymus | #5551 |
| immunosuppressive agents | #5559 |
| sexual dimorphism | #5560 |
| pv | #5560 |
| nociceptive | #5565 |
| redox | #5572 |
| cell expansion | #5578 |
| acute lung | #5583 |
| t1d | #5585 |
| percentage | #5588 |
| allergic reactions | #5592 |
| typed | #5596 |
| lipopolysaccharide lps | #5598 |
| potently | #5600 |
| acute lung injury | #5603 |
| oxidase activity | #5613 |
| control animals | #5614 |
| structural homology | #5616 |
| sequence amino | #5621 |
| synthases | #5633 |
| biotinylation | #5642 |
| bead | #5645 |
| pemphigus | #5649 |
| urgent | #5650 |
| type ifn | #5655 |
| proliferative responses | #5658 |
| abolished | #5660 |
| explants | #5660 |
| regarded | #5663 |
| 198 | #5671 |
| directing | #5676 |
| lung mice | #5677 |
| heterotrimeric | #5684 |
| antioxidant defense | #5685 |
| numbers | #5685 |
| aetiology | #5687 |
| triggers | #5689 |
| keratins | #5695 |
| progression disease | #5697 |
| cytokine expression | #5697 |
| skeletal muscle | #5698 |
| experimental animals | #5700 |
| immune mediated | #5710 |
| avenues | #5715 |
| effective treatments | #5735 |
| altogether | #5737 |
| variable | #5759 |
| integrases | #5760 |
| hfd | #5762 |
| ecm | #5776 |
| mechanisms | #5794 |
| mast | #5802 |
| linking | #5808 |
| frozen | #5808 |
| b16 | #5808 |
| inflammatory disorders | #5809 |
| diabetes t1d | #5814 |
| allergic | #5820 |
| splenic | #5829 |
| bal | #5830 |
| hampered | #5832 |
| toxoid | #5835 |
| earliest | #5837 |
| key regulators | #5844 |
| gabapentin | #5847 |
| type receptors | #5850 |
| large proportion | #5851 |
| proteinases | #5862 |
| cfa | #5868 |
| stronger | #5871 |
| disease genotype humans | #5872 |
| hyaluronan receptors | #5875 |
| deleted | #5875 |
| vitro experiments | #5880 |
| microtomography | #5882 |
| single cells | #5896 |
| evidence role | #5898 |
| modulation | #5900 |
| ace2 | #5917 |
| standardization | #5918 |
| abp | #5919 |
| synthetic | #5920 |
| bronchoalveolar lavage fluid | #5925 |
| low doses | #5925 |
| ics | #5932 |
| subclass | #5941 |
| identifying | #5941 |
| depend | #5947 |
| genomic regions | #5947 |
| explain | #5951 |
| interfere | #5953 |
| biobank | #5960 |
| cytokine production | #5962 |
| expression humans | #5965 |
| nerve regeneration | #5966 |
| factor 1 | #5968 |
| avidin | #5970 |
| foxp3 | #5975 |
| costimulatory | #5977 |
| clarify | #5980 |
| symptom onset | #5983 |
| denaturation | #5986 |
| inability | #5988 |
| knee joint | #5990 |
| eosinophils | #5991 |
| cell subset | #6000 |
| glyburide | #6010 |
| immunity | #6010 |
| 88 | #6014 |
| tetanus | #6019 |
| stress induced | #6022 |
| consisting | #6023 |
| fluorescent dyes | #6044 |
| cnvs | #6045 |
| stimulated | #6056 |
| nih | #6065 |
| igm | #6073 |
| cleared | #6074 |
| tumor infiltrating | #6074 |
| laminin | #6075 |
| genetic therapy | #6077 |
| relapsing remitting | #6083 |
| sle patients | #6089 |
| responsible | #6091 |
| undertook | #6097 |
| messengers | #6100 |
| cages | #6103 |
| stat6 | #6105 |
| ligated | #6107 |
| uncoupling | #6115 |
| bone diseases | #6115 |
| telomeric | #6122 |
| infection mice | #6127 |
| unique | #6140 |
| replacing | #6149 |
| plasma cells | #6150 |
| lowers | #6156 |
| inguinal | #6166 |
| responses | #6171 |
| susceptibility gene | #6171 |
| prophylactic | #6183 |
| genomewide association studies | #6193 |
| instances | #6210 |
| cell functions | #6210 |
| models human | #6217 |
| interferon | #6220 |
| translation | #6222 |
| humans lupus | #6235 |
| characterized | #6236 |
| progesterone | #6253 |
| introduction | #6260 |
| cell type | #6265 |
| exclusively | #6269 |
| protective | #6270 |
| microarray | #6272 |
| serum concentration | #6278 |
| sexes | #6280 |
| immune cell | #6285 |
| myelomonocytic | #6286 |
| histone | #6287 |
| biological evaluation | #6290 |
| difficult | #6298 |
| dermis | #6313 |
| sheath | #6316 |
| monolithic | #6318 |
| allowed | #6320 |
| minor | #6320 |
| tracheal | #6322 |
| estrus | #6336 |
| immunomodulatory | #6337 |
| lymphocyte count | #6339 |
| localize | #6347 |
| tumor immune | #6348 |
| remitting | #6355 |
| cell biology | #6355 |
| borrelia burgdorferi | #6355 |
| microsatellite | #6356 |
| virgin | #6356 |
| signs | #6360 |
| tears | #6363 |
| tryptic | #6370 |
| pertussis | #6372 |
| unresolved | #6378 |
| ros generation | #6379 |
| cells cell | #6381 |
| metalloproteinase | #6392 |
| human subjects | #6394 |
| nicotinamide | #6408 |
| registers | #6410 |
| prodromal | #6450 |
| gonadal | #6451 |
| neuropathological | #6454 |
| models molecular | #6455 |
| peritoneum | #6460 |
| express | #6470 |
| biologic | #6473 |
| transgenes | #6474 |
| c4 | #6475 |
| immunity mucosal | #6476 |
| inoculation | #6477 |
| genetic variants | #6477 |
| severe | #6501 |
| gene function | #6502 |
| demonstrates | #6508 |
| organ specificity | #6511 |
| cell numbers | #6513 |
| stages | #6515 |
| chronic | #6523 |
| nitrite | #6523 |
| synergy | #6523 |
| share | #6539 |
| played | #6540 |
| proteins animals | #6559 |
| apc | #6559 |
| antibody titers | #6572 |
| cytotoxicity immunologic | #6575 |
| pace | #6583 |
| proteases | #6588 |
| rheumatic | #6588 |
| toll | #6603 |
| expression genes | #6603 |
| stain | #6604 |
| major source | #6614 |
| translocating | #6615 |
| parturition | #6635 |
| hpa | #6636 |
| whitney | #6639 |
| solid phase | #6644 |
| affinity | #6645 |
| parenchyma | #6650 |
| regulation | #6650 |
| presently | #6651 |
| sclerosis | #6655 |
| memory cell | #6657 |
| cystine | #6658 |
| cells cd4 | #6665 |
| subfamily | #6672 |
| melatonin | #6683 |
| animals antioxidants | #6683 |
| current understanding | #6687 |
| burgdorferi | #6696 |
| macrophages alveolar | #6701 |
| long noncoding rnas | #6715 |
| histone deacetylases | #6742 |
| pups | #6747 |
| normal levels | #6747 |
| estrogens | #6749 |
| demonstration | #6755 |
| relevant | #6761 |
| comparative genomics | #6768 |
| elastase | #6774 |
| cd8 positive | #6776 |
| helpful | #6782 |
| interleukin18 | #6782 |
| cytometric | #6804 |
| demonstrate | #6812 |
| study role | #6813 |
| glucose transport | #6814 |
| crystal structure | #6819 |
| intra articular | #6825 |
| induced acute | #6825 |
| cterminal | #6829 |
| cd19 | #6829 |
| eosinophil | #6829 |
| conflicting | #6830 |
| lname | #6833 |
| antilymphocyte | #6836 |
| molecules | #6840 |
| case control | #6852 |
| aspergillosis | #6852 |
| lymphoid tissues | #6854 |
| participates | #6855 |
| periodontal disease | #6855 |
| vascular endothelium | #6862 |
| sciatic nerve | #6863 |
| alter | #6865 |
| bioreactors | #6867 |
| activating | #6871 |
| facial nerve | #6873 |
| cell communication | #6882 |
| tool | #6883 |
| cytokine release | #6887 |
| lethality | #6889 |
| inflammatory responses | #6893 |
| lung injury | #6900 |
| ankle joint | #6907 |
| harboring | #6908 |
| gastritis | #6915 |
| tumour necrosis | #6921 |
| recessive | #6922 |
| acetaldehyde | #6925 |
| induced pulmonary | #6931 |
| alternative | #6934 |
| microarray analysis | #6937 |
| cyclic | #6951 |
| inflammatory response | #6953 |
| sulfones | #6960 |
| player | #6974 |
| likewise | #6976 |
| exacerbations | #6984 |
| cdr | #6993 |
| equally | #7001 |
| rac1 | #7013 |
| biological function | #7014 |
| mapping | #7016 |
| translational | #7020 |
| degrade | #7020 |
| mimic | #7025 |
| fewer | #7033 |
| assay elisa | #7033 |
| suppressing | #7047 |
| th1 th2 | #7048 |
| histology | #7056 |
| nucleotide | #7060 |
| target cells | #7063 |
| genome wide | #7063 |
| heterogeneous | #7071 |
| subjected | #7072 |
| aureus | #7072 |
| immune cells | #7075 |
| serine proteases | #7082 |
| proportion | #7083 |
| reduced | #7086 |
| glomeruli | #7088 |
| finally | #7092 |
| atherosclerotic lesions | #7094 |
| orthomyxoviridae | #7108 |
| lyme disease | #7115 |
| thp1 cells | #7121 |
| apoptotic cells | #7124 |
| dividing | #7134 |
| mounted | #7137 |
| autophagy | #7144 |
| extracellular | #7153 |
| immunity cellular | #7161 |
| genetic markers | #7162 |
| messenger rats | #7166 |
| cascades | #7175 |
| synteny | #7188 |
| moiety | #7194 |
| promoted | #7198 |
| higher incidence | #7202 |
| lymphoid tissue | #7205 |
| bovine serum albumin | #7219 |
| dependency | #7223 |
| amino acid | #7225 |
| relevance | #7233 |
| mtx | #7237 |
| recognised | #7238 |
| polysaccharides | #7242 |
| sirt1 | #7251 |
| participate | #7253 |
| prevalent | #7262 |
| immuno | #7265 |
| role pathogenesis | #7272 |
| breeding | #7286 |
| inheritance | #7292 |
| rolling | #7300 |
| prime | #7313 |
| dissecting | #7326 |
| avidity | #7332 |
| expressed genes | #7334 |
| adhesins | #7335 |
| inflammasome | #7342 |
| potential targets | #7343 |
| secreted | #7347 |
| disease specific | #7350 |
| uncontrolled | #7353 |
| metalloendopeptidases | #7355 |
| microglobulin | #7363 |
| adulthood | #7369 |
| transduction animals | #7370 |
| oxide nitric | #7377 |
| array | #7387 |
| analyses | #7391 |
| nervous | #7406 |
| transglutaminase | #7410 |
| interleukin6 | #7411 |
| chemokines | #7411 |
| proven | #7418 |
| supernatants | #7428 |
| genotyping | #7446 |
| immunocytochemistry | #7453 |
| fusion protein | #7456 |
| cells peripheral | #7461 |
| β2 | #7467 |
| airways | #7489 |
| adjuvant | #7493 |
| inhibitory factor | #7500 |
| cytotoxic cells | #7518 |
| disease incidence | #7535 |
| anchor | #7536 |
| eliminate | #7540 |
| early disease | #7541 |
| il1 beta | #7545 |
| lesser extent | #7547 |
| interleukin1beta | #7549 |
| necrotic | #7550 |
| activity relationship | #7553 |
| responder | #7562 |
| elevations | #7589 |
| interacting | #7594 |
| micrograms | #7596 |
| hydrocarbon | #7610 |
| appeared | #7610 |
| arginine | #7621 |
| evident | #7628 |
| cytometry | #7630 |
| unexplained | #7632 |
| allogeneic | #7640 |
| peripheral nervous | #7645 |
| sustain | #7654 |
| receptors immunologic | #7659 |
| graft survival | #7661 |
| component | #7661 |
| murine model | #7665 |
| considerable | #7704 |
| histone deacetylase | #7707 |
| placental | #7712 |
| differentially expressed | #7721 |
| chromosomes | #7722 |
| activators | #7728 |
| motifs | #7730 |
| critical roles | #7731 |
| bacterial toxins | #7735 |
| diagnostics | #7735 |
| initiation | #7745 |
| 325 | #7749 |
| rodent | #7751 |
| chain | #7753 |
| granulocyte | #7754 |
| leukocytes mononuclear | #7766 |
| candidate genes | #7769 |
| activates | #7772 |
| mer | #7772 |
| 37°c | #7773 |
| manuscript | #7780 |
| resolving | #7797 |
| carbonic | #7798 |
| cells tregs | #7800 |
| cell surface receptors | #7807 |
| diet fat | #7810 |
| tgf beta1 | #7831 |
| lipopolysaccharides | #7836 |
| patients levels | #7843 |
| strain | #7844 |
| cells pbmcs | #7853 |
| sirtuin | #7854 |
| retinoid | #7862 |
| interleukin1 | #7866 |
| ifnγ | #7872 |
| gene therapy | #7878 |
| amenable | #7895 |
| analyze | #7897 |
| illness | #7901 |
| lymphopenia | #7909 |
| 2nd | #7917 |
| th2 | #7918 |
| fact | #7925 |
| mann | #7929 |
| myocarditis | #7932 |
| discoveries | #7955 |
| cellular immune | #7957 |
| immunodiffusion | #7959 |
| transform infrared | #7960 |
| positive | #7982 |
| nitrites | #7983 |
| candidate gene | #7987 |
| scoring | #7989 |
| direct effects | #7991 |
| tregs | #7991 |
| unknown | #7993 |
| immune function | #7994 |
| oxidative | #7996 |
| fertilized | #8002 |
| identifies | #8007 |
| haplotypes humans | #8011 |
| polymorphisms | #8012 |
| psa | #8015 |
| essential | #8017 |
| hydroxy | #8030 |
| capacity | #8031 |
| raised | #8040 |
| lncrna | #8047 |
| macroscopic | #8049 |
| myeloid differentiation | #8054 |
| respiratory distress | #8063 |
| address | #8064 |
| drive | #8066 |
| evaluation preclinical | #8067 |
| factor signal | #8077 |
| ascertained | #8077 |
| spanning | #8085 |
| hypophyseal | #8087 |
| appearing | #8088 |
| tetramer | #8088 |
| clinical evaluation | #8089 |
| suboptimal | #8101 |
| physiological | #8105 |
| prolongation | #8108 |
| homozygosity | #8108 |
| considerably | #8109 |
| intronic | #8113 |
| prerequisite | #8120 |
| reasons | #8130 |
| nash | #8133 |
| bovine | #8133 |
| latest | #8134 |
| macrophages peritoneal | #8141 |
| definition | #8141 |
| dying | #8148 |
| trachea | #8156 |
| peripheral nerve | #8160 |
| relapses | #8166 |
| elevated | #8167 |
| conditioned | #8167 |
| harbor | #8170 |
| characterize | #8170 |
| bacterial infection | #8176 |
| expression | #8180 |
| member | #8181 |
| induced inflammation | #8186 |
| rescue | #8192 |
| sacrificed | #8197 |
| cassette | #8198 |
| analysing | #8209 |
| underlying | #8214 |
| preferential | #8216 |
| genetic associations | #8225 |
| sulphate | #8225 |
| defective | #8238 |
| ors | #8241 |
| marginal zone | #8244 |
| foster | #8245 |
| wide | #8261 |
| cultured cytokines | #8268 |
| ppar | #8274 |
| fibrinogen | #8275 |
| bone resorption | #8290 |
| clinical manifestations | #8294 |
| disease genome | #8295 |
| differ | #8295 |
| subcutaneous injection | #8300 |
| streptococcal | #8302 |
| oxygen | #8304 |
| combined treatment | #8309 |
| monoester | #8310 |
| remodeling | #8311 |
| 11 | #8316 |
| aspergillus fumigatus | #8316 |
| peptide1 | #8316 |
| genetically modified | #8320 |
| tlr | #8339 |
| cov2 infection | #8349 |
| vh | #8363 |
| boronic | #8363 |
| frequency | #8364 |
| parietal | #8367 |
| firstly | #8379 |
| fibrils | #8388 |
| migrate | #8391 |
| expressed | #8400 |
| poly | #8401 |
| residue | #8401 |
| p001 | #8404 |
| cd11b | #8408 |
| unaffected | #8411 |
| hydrophilicity | #8420 |
| advancement | #8424 |
| notion | #8424 |
| macrophage activation | #8429 |
| highlights | #8433 |
| defense | #8436 |
| viable | #8460 |
| 14 | #8468 |
| lamina | #8472 |
| manifestation | #8482 |
| protein conformation | #8485 |
| damaging | #8500 |
| promotes | #8502 |
| booster | #8512 |
| inflammatory process | #8516 |
| involves | #8520 |
| cells express | #8525 |
| mildly | #8527 |
| drug development | #8539 |
| phenotype | #8539 |
| burkholderia | #8540 |
| forkhead transcription | #8544 |
| human neutrophils | #8545 |
| estradiol | #8546 |
| copy | #8554 |
| tubule | #8558 |
| adaptive | #8568 |
| inflammatory cytokines | #8576 |
| responsive | #8580 |
| cellular functions | #8582 |
| marginal | #8600 |
| productive | #8609 |
| region | #8618 |
| stress reactive | #8622 |
| chickens | #8638 |
| xanthine | #8641 |
| positivity | #8659 |
| uncovered | #8689 |
| inducers | #8705 |
| outline | #8708 |
| experimental mice mice | #8716 |
| vigorous | #8717 |
| constitutive expression | #8717 |
| ccaat | #8720 |
| staphylococci | #8725 |
| regulatory cell | #8734 |
| cytokine | #8750 |
| recovered | #8751 |
| resorption | #8757 |
| rejection | #8759 |
| larynx | #8761 |
| subset | #8775 |
| chemokine receptor | #8777 |
| impaired | #8781 |
| highlight | #8782 |
| promoter | #8789 |
| cells human | #8790 |
| homozygous | #8792 |
| 4 weeks | #8792 |
| generate | #8799 |
| fungal infections | #8807 |
| human serum | #8808 |
| occasionally | #8808 |
| chemically | #8809 |
| parotid | #8809 |
| generates | #8811 |
| female male | #8812 |
| cytokine levels | #8825 |
| correlated | #8830 |
| kupffer | #8836 |
| cell phenotype | #8866 |
| pathway | #8867 |
| precisely | #8877 |
| bovis | #8882 |
| pathways | #8883 |
| unidentified | #8885 |
| frequencies | #8890 |
| deletion | #8893 |
| key regulator | #8903 |
| endopeptidases | #8922 |
| flow cytometric | #8932 |
| strengthen | #8941 |
| hypothalamo | #8941 |
| and or | #8942 |
| staining | #8944 |
| chemiluminescence | #8945 |
| modulate | #8948 |
| pge2 | #8966 |
| pitfalls | #8967 |
| subpopulation | #8967 |
| attack | #8975 |
| neonatal | #8981 |
| gene | #8983 |
| endosomal | #8987 |
| 129 | #8990 |
| vasculature | #9008 |
| rna long | #9017 |
| adrenocorticotropic | #9019 |
| chemoattractant | #9019 |
| discriminate | #9043 |
| thp1 | #9068 |
| leading | #9074 |
| positioned | #9075 |
| specific role | #9081 |
| glut4 | #9084 |
| hl60 | #9115 |
| cd4 cell | #9129 |
| differentially | #9131 |
| human | #9131 |
| cell surface | #9135 |
| pad | #9136 |
| ongoing | #9160 |
| reconstitution | #9166 |
| negative | #9175 |
| causative | #9182 |
| preincubation | #9186 |
| secrete | #9196 |
| tnf | #9198 |
| lethal | #9205 |
| serologic | #9213 |
| respiratory syndrome | #9222 |
| started | #9233 |
| innate immunity | #9233 |
| sequence | #9238 |
| cells isolated | #9241 |
| glomerulus | #9242 |
| immortalized | #9244 |
| severely | #9250 |
| orphan | #9255 |
| offer | #9255 |
| millions | #9268 |
| ubiquitous | #9272 |
| matrix | #9273 |
| killer | #9278 |
| crystal structures | #9313 |
| clear | #9315 |
| smoking status | #9329 |
| sdspage | #9335 |
| copolymers | #9346 |
| carbohydrate | #9368 |
| neutralizing | #9381 |
| immunoblot | #9395 |
| sweden | #9420 |
| functionality | #9425 |
| cysteine | #9458 |
| ifnα | #9459 |
| lacks | #9460 |
| treatment strategies | #9463 |
| immunomodulation | #9473 |
| luminescent | #9474 |
| molecular | #9484 |
| endotoxins | #9487 |
| tlr4 | #9501 |
| immobilized | #9505 |
| cyclosporin | #9519 |
| hormonal | #9519 |
| immunofluorescence | #9519 |
| sensitized | #9523 |
| detrimental | #9524 |
| heritable | #9530 |
| preexisting | #9543 |
| neuroinflammation | #9558 |
| factor beta1 | #9560 |
| interferon regulatory | #9572 |
| regulated | #9576 |
| culture techniques | #9577 |
| analogous | #9593 |
| entering | #9608 |
| affinities | #9614 |
| steroid hormones | #9615 |
| pretreated | #9624 |
| vaccinated | #9638 |
| gestation | #9639 |
| mammalian cells | #9643 |
| attached | #9647 |
| genetic models | #9655 |
| basement membrane | #9657 |
| key | #9658 |
| vehicle | #9670 |
| cell adhesion | #9678 |
| slight | #9694 |
| dramatic | #9694 |
| accessible | #9708 |
| snp | #9709 |
| azathioprine | #9721 |
| ear | #9723 |
| environment interaction | #9730 |
| humanized | #9753 |
| livers | #9753 |
| maintenance | #9756 |
| metabolic syndrome mets | #9758 |
| functional analysis | #9772 |
| blocked | #9776 |
| cleavage | #9781 |
| microscopic | #9784 |
| adhesion cell | #9784 |
| nasal | #9786 |
| plasminogen activator | #9788 |
| structure activity | #9789 |
| infectious | #9804 |
| lowered | #9804 |
| sterile | #9810 |
| driven | #9836 |
| fibronectin | #9846 |
| delineation | #9856 |
| rheumatology | #9870 |
| phage | #9872 |
| memory cells | #9874 |
| nonhuman primates | #9876 |
| pathogens | #9902 |
| serological | #9907 |
| coculture | #9927 |
| interleukin8 | #9936 |
| healthy control | #9938 |
| reactions | #9953 |
| monkeys | #9973 |
| anticipated | #9993 |
| nucleic acids | #10007 |
| flare | #10014 |
| inflammatory cytokine | #10023 |
| genotype | #10053 |
| serum | #10061 |
| leukocytes | #10067 |
| administered | #10070 |
| differentiation factor | #10076 |
| inflammation male | #10091 |
| generating | #10093 |
| surface receptors | #10102 |
| fibrin | #10105 |
| virulence factors | #10110 |
| cells patients | #10110 |
| activated | #10122 |
| ccl4 | #10125 |
| il1beta | #10131 |
| edge | #10132 |
| new strategy | #10136 |
| host cells | #10139 |
| mitogens | #10140 |
| cell signaling | #10143 |
| kappa | #10143 |
| th2 cells | #10147 |
| retroviridae | #10157 |
| postmenopausal | #10172 |
| traps | #10177 |
| hydrogen peroxide | #10184 |
| placenta | #10185 |
| named | #10188 |
| tlrs | #10207 |
| delta | #10218 |
| summarize | #10236 |
| day | #10244 |
| molecular biology | #10259 |
| rats spraguedawley receptors | #10277 |
| arg | #10279 |
| reproducible | #10283 |
| animals anti | #10304 |
| germ | #10305 |
| gene environment | #10307 |
| tendency | #10317 |
| scid | #10324 |
| lectins | #10329 |
| dismutase | #10332 |
| avian influenza | #10343 |
| reductive | #10347 |
| complete | #10365 |
| mediators | #10378 |
| nterminal | #10392 |
| partially | #10400 |
| lasting | #10406 |
| promote | #10424 |
| determine | #10429 |
| cterminus | #10432 |
| refined | #10437 |
| kill | #10441 |
| cattle | #10446 |
| assays | #10447 |
| indirectly | #10460 |
| mediates | #10474 |
| thioredoxin | #10475 |
| occur | #10477 |
| motif | #10479 |
| redundant | #10502 |
| receptor binding | #10504 |
| developing | #10513 |
| behavior animal | #10515 |
| promoter regions | #10545 |
| phosphate | #10548 |
| produced | #10552 |
| exception | #10554 |
| dysregulated | #10557 |
| critical | #10564 |
| influence | #10568 |
| understood | #10572 |
| converting enzyme | #10584 |
| progressive | #10597 |
| rise | #10608 |
| female | #10609 |
| shortened | #10612 |
| small molecule | #10616 |
| nf kappa | #10617 |
| extracellular matrix | #10620 |
| paralysis | #10632 |
| primers | #10636 |
| collectively | #10637 |
| underlie | #10642 |
| testosterone | #10659 |
| macrophage colony | #10664 |
| selective inhibitor | #10667 |
| aged osteoarthritis | #10675 |
| summary | #10684 |
| repeats | #10685 |
| pbs | #10702 |
| respond | #10705 |
| cerebrospinal fluid | #10708 |
| 17 | #10713 |
| disruption | #10729 |
| issue | #10762 |
| conformation | #10767 |
| il18 | #10770 |
| generation | #10781 |
| cleaved | #10800 |
| 103 | #10811 |
| conditional | #10821 |
| capture | #10822 |
| operated | #10824 |
| seropositive | #10826 |
| cellular mechanisms | #10838 |
| saline | #10857 |
| belonging | #10857 |
| restraint | #10864 |
| phosphatase | #10866 |
| immunoblotting | #10872 |
| factor1 | #10880 |
| base | #10885 |
| connective tissue | #10896 |
| phagocytosis | #10904 |
| multifunctional | #10904 |
| ineffective | #10909 |
| avoid | #10909 |
| luciferase | #10915 |
| bronchoalveolar | #10916 |
| promise | #10920 |
| secondary | #10926 |
| pivotal | #10926 |
| mulatta | #10929 |
| mannose | #10934 |
| persisted | #10939 |
| concluded | #10955 |
| methotrexate | #10967 |
| myeloid cells | #10978 |
| airway inflammation | #10982 |
| degrading | #10983 |
| immunoassay | #10984 |
| subcutaneously | #10984 |
| characterization | #10986 |
| governing | #10998 |
| ethanol | #11000 |
| septic | #11000 |
| tnfα | #11003 |
| mpo | #11010 |
| cell subsets | #11012 |
| originally | #11016 |
| 263 | #11027 |
| immunohistochemistry | #11028 |
| scid mice | #11030 |
| occurrence | #11030 |
| messenger | #11037 |
| hyper | #11040 |
| optical imaging | #11045 |
| skin | #11056 |
| establish | #11066 |
| calcitriol | #11067 |
| tumor progression | #11088 |
| paternal | #11094 |
| add | #11096 |
| freezing | #11102 |
| systemic | #11112 |
| infection animals | #11117 |
| focusing | #11144 |
| genetic polymorphism | #11161 |
| innate immune response | #11167 |
| male | #11167 |
| osteoarthritis | #11176 |
| subsequent | #11177 |
| influx | #11177 |
| receptors | #11177 |
| affinity chromatography | #11186 |
| genes involved | #11187 |
| ankylosing spondylitis | #11197 |
| article | #11201 |
| directly | #11208 |
| bsa | #11210 |
| limited | #11223 |
| sorting | #11229 |
| elicited | #11230 |
| interleukin10 | #11232 |
| disulfides | #11233 |
| contributed | #11248 |
| peptidase | #11251 |
| human blood | #11281 |
| ability | #11284 |
| extensive | #11297 |
| humans influenza | #11314 |
| genotyped | #11318 |
| compared controls | #11322 |
| depends | #11323 |
| oxidant | #11344 |
| caution | #11347 |
| addressing | #11351 |
| tissue damage | #11352 |
| correlate | #11354 |
| extra | #11356 |
| histopathologic | #11376 |
| neuroglia | #11384 |
| modifications | #11385 |
| experimental evidence | #11409 |
| increased expression | #11410 |
| pharmacology | #11413 |
| oxidative phosphorylation | #11428 |
| eosinophilic | #11432 |
| interleukin12 | #11437 |
| quantified | #11438 |
| receptor | #11445 |
| hla class | #11447 |
| cell death | #11460 |
| enhance | #11461 |
| reduces | #11466 |
| governed | #11476 |
| initiating | #11479 |
| contrasting | #11480 |
| melanoma cells | #11488 |
| compared healthy | #11489 |
| cd8 cell | #11498 |
| ankle | #11508 |
| serine | #11525 |
| cytosol | #11542 |
| recipient | #11546 |
| ca2 | #11559 |
| therapeutic interventions | #11561 |
| mets | #11566 |
| jurkat | #11569 |
| backgrounds | #11570 |
| inflammatory effects | #11595 |
| culture medium | #11599 |
| differential expression | #11606 |
| alteration | #11627 |
| frequently | #11627 |
| chicken | #11649 |
| swiss | #11652 |
| enhanced | #11661 |
| exerted | #11663 |
| immunologic memory | #11672 |
| transforming growth | #11678 |
| relief | #11691 |
| synergism | #11703 |
| controls | #11730 |
| psychotic | #11730 |
| toxin | #11735 |
| aiming | #11737 |
| innovative | #11751 |
| amyotrophic | #11769 |
| cell lineage | #11773 |
| constitutes | #11774 |
| inoculated | #11781 |
| commentary | #11785 |
| multiple | #11805 |
| selective | #11814 |
| display | #11817 |
| moderately | #11819 |
| altered | #11829 |
| insufficient | #11830 |
| sequence homology | #11840 |
| 9 | #11857 |
| graft | #11866 |
| analogues | #11871 |
| forkhead | #11888 |
| stained | #11890 |
| enzyme | #11942 |
| augmentation | #11943 |
| classic | #11944 |
| supplied | #11946 |
| gastrointestinal tract | #11958 |
| animals bone | #11966 |
| reveal | #11966 |
| maternal fetal | #11968 |
| adherent | #11980 |
| stress response | #11991 |
| contribution | #11998 |
| tgf | #12005 |
| biomarker | #12016 |
| antiserum | #12017 |
| cricetulus | #12021 |
| deacetylase | #12050 |
| encoding | #12051 |
| plasma cell | #12059 |
| aethiops | #12067 |
| propose | #12072 |
| fat diet | #12104 |
| immunologic factors | #12106 |
| protection | #12107 |
| downstream | #12107 |
| il2 | #12111 |
| tyrosine | #12113 |
| lung | #12116 |
| effectively | #12118 |
| replaced | #12144 |
| induced cell | #12147 |
| bromide | #12152 |
| humans | #12155 |
| quiescent | #12181 |
| switched | #12181 |
| genetic vectors | #12203 |
| oligodeoxyribonucleotides | #12204 |
| myd88 | #12222 |
| histologic | #12222 |
| lectin | #12223 |
| therapeutics | #12230 |
| mesenteric | #12231 |
| toxic | #12231 |
| represents | #12233 |
| receptors estrogen | #12236 |
| corticosterone | #12242 |
| noncoding | #12244 |
| diabetic mice | #12257 |
| fibroblasts humans | #12268 |
| recombinant | #12270 |
| splice | #12271 |
| involving | #12273 |
| fluorescent antibody | #12276 |
| mineral | #12297 |
| tnf alpha | #12300 |
| streptococcus | #12310 |
| harmful | #12319 |
| depending | #12361 |
| acid | #12363 |
| leukocyte count | #12369 |
| syndromes | #12371 |
| tradeoff | #12389 |
| interplay | #12412 |
| origin | #12416 |
| clonal | #12420 |
| microfilament | #12423 |
| reversed | #12439 |
| publication adaptor proteins | #12462 |
| weaker | #12464 |
| protein expression | #12503 |
| pain | #12532 |
| hydrochloride | #12535 |
| drug design | #12567 |
| functional | #12573 |
| rats treated | #12596 |
| suppressor | #12596 |
| binding site | #12597 |
| monomeric | #12605 |
| medullary | #12637 |
| cells natural | #12637 |
| explained | #12643 |
| macaca | #12645 |
| notably | #12664 |
| fetuses | #12665 |
| chronic diseases | #12665 |
| cdnas | #12679 |
| adenine | #12679 |
| p38 mitogen | #12681 |
| 6 weeks | #12681 |
| investigation | #12697 |
| instance | #12709 |
| persistent | #12729 |
| alveolar | #12729 |
| receptor alpha | #12743 |
| modulators | #12770 |
| interactions | #12785 |
| aimed | #12791 |
| nature | #12795 |
| influencing | #12800 |
| diminished | #12804 |
| tibia | #12813 |
| initiated | #12813 |
| sole | #12814 |
| metalloproteinases | #12819 |
| thought | #12823 |
| twin | #12854 |
| isolated | #12871 |
| solely | #12882 |
| disadvantages | #12886 |
| sulfhydryl | #12921 |
| sustained | #12922 |
| assay | #12926 |
| breakdown | #12984 |
| cell division | #13004 |
| embryonic development | #13020 |
| damage | #13056 |
| removing | #13067 |
| tryptophan | #13079 |
| tightly | #13087 |
| crystallography | #13101 |
| hyaluronic | #13102 |
| enabling | #13133 |
| time pcr | #13141 |
| publications | #13143 |
| receptors cell | #13145 |
| stereoisomerism | #13158 |
| distress syndrome | #13175 |
| ancestral | #13179 |
| retained | #13203 |
| valine | #13205 |
| division | #13213 |
| suffering | #13215 |
| single nucleotide polymorphisms | #13234 |
| opportunity | #13243 |
| opportunities | #13258 |
| 1 protein | #13270 |
| chemotaxis | #13279 |
| modulator | #13283 |
| lavage fluid | #13293 |
| transgene | #13297 |
| ascending | #13302 |
| regulators | #13320 |
| elucidated | #13323 |
| purity | #13330 |
| bronchoalveolar lavage | #13334 |
| nk | #13353 |
| fisher | #13357 |
| inhibitory effects | #13362 |
| lymphoproliferative | #13372 |
| amyotrophic lateral | #13377 |
| facilitating | #13380 |
| overexpressed | #13383 |
| scattered | #13389 |
| borrelia | #13393 |
| intact | #13410 |
| independently | #13433 |
| thiol | #13434 |
| fibroblast | #13447 |
| oocytes | #13463 |
| embryos | #13465 |
| marrow derived | #13484 |
| spraguedawley receptors | #13488 |
| overcome | #13489 |
| endopeptidase | #13500 |
| aspect | #13523 |
| lateral sclerosis | #13577 |
| tail | #13589 |
| selectively | #13591 |
| lipopolysaccharide | #13598 |
| elisa | #13612 |
| heritability | #13616 |
| vertebrates | #13627 |
| renal disease | #13634 |
| cure | #13674 |
| peripheral | #13689 |
| reproductive | #13755 |
| clones | #13757 |
| requires | #13783 |
| profiling gene | #13808 |
| lavage | #13811 |
| exon | #13822 |
| arising | #13831 |
| secretory | #13835 |
| techniques | #13873 |
| 6 | #13879 |
| killer cells | #13891 |
| exposed | #13917 |
| cloned | #13927 |
| iga | #13936 |
| hepatocytes | #13938 |
| tolerant | #13992 |
| lncrnas | #14002 |
| anti inflammatory | #14010 |
| killed | #14033 |
| selectin | #14034 |
| sensitization | #14035 |
| environmental | #14057 |
| insertion | #14063 |
| recombinant proteins | #14070 |
| neighboring | #14098 |
| reflects | #14102 |
| great | #14120 |
| preclinical | #14123 |
| highlighting | #14145 |
| preventing | #14148 |
| healthy individuals | #14159 |
| administration | #14164 |
| vaccination | #14176 |
| potent | #14183 |
| retroviral | #14208 |
| multigene | #14246 |
| advances | #14275 |
| amino acids | #14298 |
| ester | #14310 |
| oxidative stress | #14315 |
| cord | #14319 |
| incidence | #14322 |
| impairs | #14323 |
| domain | #14325 |
| psychosis | #14326 |
| p38 | #14329 |
| bovine serum | #14329 |
| isolation | #14334 |
| differentiation | #14342 |
| multiprotein | #14366 |
| mineral density | #14406 |
| #14414 | |
| differentiation cells | #14414 |
| resolve | #14420 |
| colony stimulating | #14421 |
| consistently | #14448 |
| paracrine | #14452 |
| kinases animals | #14452 |
| adenoviridae | #14472 |
| chlorocebus | #14481 |
| marrow transplantation | #14485 |
| targeted | #14490 |
| pathology | #14492 |
| il1 | #14500 |
| integrative | #14510 |
| cells vitro | #14537 |
| monocytes | #14540 |
| bone density | #14589 |
| infectious diseases | #14593 |
| biomedical | #14605 |
| nitrate | #14616 |
| nf kappab | #14627 |
| recombinant human | #14632 |
| divergent | #14638 |
| pathological | #14640 |
| enzyme activation | #14658 |
| lupus nephritis | #14661 |
| smoking | #14673 |
| transforming | #14675 |
| gfp | #14681 |
| inborn | #14696 |
| hand | #14698 |
| green fluorescent | #14703 |
| scarce | #14718 |
| substances | #14724 |
| risk developing | #14724 |
| nitrates | #14728 |
| oxide synthase | #14731 |
| p005 | #14732 |
| particulate | #14751 |
| oxidoreductases | #14753 |
| protein binding | #14757 |
| blood vessels | #14759 |
| human cells | #14768 |
| interferon alpha | #14780 |
| il1β | #14800 |
| degenerative | #14815 |
| proteinase | #14817 |
| originating | #14824 |
| vitro | #14829 |
| overlapping | #14835 |
| biocompatible | #14851 |
| prostaglandins | #14881 |
| controlled | #14895 |
| interaction | #14916 |
| chronically | #14923 |
| genomic dna | #14929 |
| potential therapeutic | #14939 |
| colleagues | #14950 |
| plays | #15011 |
| cross | #15041 |
| implications | #15063 |
| escape | #15078 |
| granule | #15079 |
| receptor gene | #15089 |
| phosphoric | #15090 |
| converting | #15126 |
| acute respiratory | #15173 |
| spinal cord | #15185 |
| seroepidemiologic | #15205 |
| bmd | #15213 |
| proliferation cells | #15219 |
| covalently | #15234 |
| preferentially | #15252 |
| adhesion | #15299 |
| fetus | #15300 |
| processed | #15329 |
| allografts | #15337 |
| synthase | #15339 |
| bone mineral density | #15340 |
| accelerate | #15346 |
| neurodegenerative | #15377 |
| pretreatment | #15379 |
| blood mononuclear | #15414 |
| interleukin6 il6 | #15440 |
| comparative | #15474 |
| selected | #15486 |
| antigens bacterial | #15511 |
| cells dcs | #15513 |
| locally | #15521 |
| transcriptase polymerase | #15530 |
| influenza human | #15537 |
| basis | #15540 |
| hormone | #15542 |
| central nervous | #15566 |
| estrogen receptor | #15572 |
| transduction | #15579 |
| vaccines | #15623 |
| responsiveness | #15647 |
| rna interference | #15649 |
| binds | #15651 |
| accelerator | #15673 |
| limitation | #15675 |
| pyruvate | #15682 |
| sequenced | #15696 |
| conformational | #15701 |
| cd28 | #15708 |
| connective | #15748 |
| gastric | #15775 |
| single | #15789 |
| fluorescent | #15793 |
| bone loss | #15832 |
| induced expression | #15835 |
| protein structure | #15849 |
| spinal | #15861 |
| vasculitis | #15884 |
| treating | #15887 |
| kappab | #15894 |
| gcsf | #15908 |
| competitive | #15910 |
| positron emission | #15913 |
| downregulation | #15914 |
| systemic inflammation | #15944 |
| methylated | #15945 |
| neurodegeneration | #15945 |
| involve | #15980 |
| ap1 | #15985 |
| plasmon resonance | #15986 |
| reflected | #15993 |
| chromatographic | #16019 |
| cnv | #16065 |
| oligonucleotide array | #16092 |
| 106 | #16097 |
| responding | #16105 |
| pluripotent | #16135 |
| bone mineral | #16141 |
| undetectable | #16148 |
| skeletal | #16151 |
| neurons | #16154 |
| tissue distribution | #16155 |
| disequilibrium | #16156 |
| beta1 | #16172 |
| exhibited | #16189 |
| response treatment | #16236 |
| grafted | #16238 |
| array sequence | #16239 |
| glandular | #16252 |
| functional studies | #16273 |
| responders | #16278 |
| new class | #16282 |
| subunit | #16293 |
| required | #16309 |
| animals base | #16310 |
| subclinical | #16311 |
| linkage disequilibrium | #16342 |
| receptor signaling | #16351 |
| difference | #16367 |
| remarkably | #16382 |
| molecular structure | #16391 |
| form | #16409 |
| signalling | #16414 |
| molecular mechanism | #16419 |
| publication antibodies | #16433 |
| cd40 | #16468 |
| shr | #16471 |
| capable | #16496 |
| grouped | #16512 |
| subcutaneous | #16522 |
| fibroblasts | #16525 |
| revealing | #16544 |
| targeting | #16552 |
| respiratory | #16585 |
| node | #16585 |
| organs | #16586 |
| tumor cells | #16600 |
| antibodies bacterial | #16603 |
| subunits | #16626 |
| profiling | #16651 |
| necrosis | #16655 |
| negatively | #16709 |
| establishing | #16709 |
| uric | #16743 |
| irradiated | #16757 |
| nick | #16765 |
| intramolecular | #16795 |
| deeper | #16801 |
| instrumental | #16812 |
| detected | #16851 |
| clinically | #16859 |
| immunoreactive | #16859 |
| serve | #16878 |
| inhibitory | #16881 |
| documented | #16904 |
| greatly | #16907 |
| colony | #16928 |
| turn | #16941 |
| immunosuppression | #16942 |
| mmps | #16957 |
| inhibition | #16959 |
| receptor 1 | #16964 |
| additionally | #16970 |
| humans hydrogen | #16982 |
| structurally | #16985 |
| prior | #16994 |
| additional | #17005 |
| binding protein | #17006 |
| recombinant fusion | #17013 |
| sulfate | #17069 |
| b7 | #17077 |
| count | #17083 |
| il12 | #17096 |
| sex factors | #17111 |
| consist | #17113 |
| minimal | #17116 |
| alpha subunit | #17119 |
| lysosomal | #17126 |
| unexpected | #17137 |
| tissue | #17148 |
| pluripotent stem | #17151 |
| receptors tumor | #17172 |
| csf | #17185 |
| activator | #17202 |
| lymph node | #17208 |
| underlying mechanisms | #17217 |
| stimulation | #17249 |
| starting | #17298 |
| peritoneal | #17299 |
| cell proliferation | #17318 |
| fluid | #17330 |
| propensity | #17345 |
| generations | #17377 |
| humans immunity | #17410 |
| constitute | #17425 |
| demonstrated | #17444 |
| membrane | #17466 |
| muscle skeletal | #17479 |
| allowing | #17505 |
| types | #17505 |
| transcriptase | #17515 |
| fibrous | #17515 |
| type iii | #17546 |
| localization | #17547 |
| constitutive | #17559 |
| cytometry humans | #17570 |
| discovery | #17583 |
| treatments | #17596 |
| peripheral blood | #17615 |
| variation | #17616 |
| packed | #17678 |
| differed | #17683 |
| expanded | #17687 |
| proved | #17691 |
| plasmon | #17698 |
| longitudinally | #17713 |
| pbmcs | #17728 |
| stimulating factor | #17743 |
| somatic | #17805 |
| inflammatory bowel disease | #17815 |
| dcs | #17827 |
| relating | #17861 |
| alpha tnf | #17880 |
| neuroendocrine | #17920 |
| oligonucleotide | #17954 |
| homology | #17962 |
| surface plasmon | #17971 |
| pregnancy | #17985 |
| chromosomal | #17994 |
| post | #17998 |
| inhibit | #18002 |
| labelled | #18004 |
| damaged | #18064 |
| osmolar | #18107 |
| 2 4 | #18130 |
| creating | #18142 |
| cytoplasm | #18155 |
| released | #18157 |
| trigger | #18161 |
| corticosteroids | #18164 |
| species | #18168 |
| endocrine | #18192 |
| vertebrate | #18206 |
| labeled | #18208 |
| subcellular | #18231 |
| rna messenger | #18235 |
| protein serine | #18279 |
| limiting | #18281 |
| reverse transcriptase | #18325 |
| evidenced | #18329 |
| truncated | #18336 |
| avian | #18345 |
| net | #18345 |
| males | #18375 |
| critically | #18389 |
| assumed | #18433 |
| modulated | #18444 |
| rats wistar | #18448 |
| pathogen | #18464 |
| immunogenicity | #18486 |
| acids | #18490 |
| reaching | #18494 |
| nonparametric | #18512 |
| constitutively | #18518 |
| processing | #18609 |
| hyaluronan | #18609 |
| sulfonamides | #18643 |
| investigating | #18651 |
| 15 | #18656 |
| 22 | #18658 |
| verify | #18669 |
| signal transduction | #18682 |
| agents steroidal | #18685 |
| remaining | #18721 |
| aim | #18788 |
| cerebrospinal | #18788 |
| created | #18803 |
| balanced | #18823 |
| cultured | #18823 |
| carry | #18829 |
| pathophysiological | #18830 |
| production | #18927 |
| nerve | #18943 |
| nested | #18957 |
| nfκb | #18987 |
| failed | #18988 |
| sequence analysis | #19002 |
| specific antigen | #19050 |
| observations | #19062 |
| provided | #19067 |
| bone marrow | #19084 |
| lungs | #19111 |
| stimulating | #19136 |
| protein | #19164 |
| bearing | #19167 |
| publication administration | #19185 |
| gained | #19200 |
| mitochondrial | #19260 |
| symptoms | #19288 |
| lost | #19298 |
| majority | #19304 |
| intra | #19311 |
| interacts | #19344 |
| hormones | #19441 |
| fatal | #19464 |
| interferons | #19489 |
| analyzing | #19515 |
| exogenous | #19526 |
| adrenal | #19553 |
| cytoskeletal | #19553 |
| rapidly | #19574 |
| inducible | #19616 |
| etiology | #19652 |
| environment | #19668 |
| implanted | #19680 |
| lps | #19681 |
| mice scid | #19683 |
| vesicular | #19701 |
| lineage | #19719 |
| markers | #19789 |
| histologically | #19817 |
| offers | #19826 |
| cutaneous | #19834 |
| precise | #19836 |
| pharmacological | #19854 |
| fetal | #19862 |
| shifted | #19875 |
| newly | #19892 |
| supporting | #19915 |
| vitro techniques | #19945 |
| yielded | #19948 |
| 8 | #19978 |
| 28 | #19979 |
| cns | #19979 |
| response relationship | #20014 |
| transient | #20038 |
| modify | #20055 |
| designated | #20056 |
| reverse | #20057 |
| casecontrol study | #20088 |
| mutagenesis | #20118 |
| illustrated | #20126 |
| downregulated | #20133 |
| ultimately | #20202 |
| κb | #20256 |
| 1 diabetes | #20263 |
| hypothalamic | #20285 |
| primary | #20303 |
| entered | #20310 |
| nitric | #20316 |
| gene expression | #20364 |
| markedly | #20453 |
| genotype humans | #20460 |
| mature | #20491 |
| microglia | #20561 |
| circulating | #20574 |
| overexpressing | #20593 |
| human pair | #20604 |
| polyacrylamide | #20612 |
| marrow | #20651 |
| defining | #20660 |
| pregnant | #20665 |
| equal | #20678 |
| resting | #20729 |
| injured | #20739 |
| mild | #20819 |
| local | #20825 |
| discovered | #20835 |
| cricetinae | #20839 |
| reduction | #20847 |
| illustrate | #20874 |
| lactic | #20908 |
| hypothesized | #20913 |
| tended | #20919 |
| 10 | #20952 |
| successful | #20952 |
| cell derived | #20955 |
| aberrant | #20961 |
| animals biomarkers | #21033 |
| 2 | #21085 |
| attractive | #21228 |
| acute | #21279 |
| produces | #21297 |
| transfected | #21316 |
| marked | #21340 |
| decreased | #21383 |
| maternal | #21389 |
| emerged | #21445 |
| survived | #21524 |
| confirms | #21558 |
| membrane proteins | #21585 |
| forming | #21593 |
| preserved | #21732 |
| contained | #21802 |
| previous | #21805 |
| 16 | #21813 |
| doses | #21835 |
| immunodeficiency | #21852 |
| electrophoresis | #21867 |
| mellitus type | #21871 |
| natural killer | #21877 |
| cell count | #21898 |
| prolonged | #21903 |
| heavy | #21965 |
| increasing | #21979 |
| polymeric | #22042 |
| gradually | #22067 |
| glial | #22202 |
| selecting | #22242 |
| extremely | #22248 |
| 4 | #22274 |
| opportunistic | #22307 |
| accepted | #22356 |
| emission tomography | #22395 |
| enable | #22402 |
| humans models | #22445 |
| initially | #22458 |
| microscopy confocal | #22466 |
| physiologic | #22470 |
| appears | #22488 |
| releasing | #22497 |
| suitable | #22522 |
| humans immunosuppressive | #22529 |
| confirm | #22553 |
| chemokine | #22558 |
| metabolic | #22585 |
| actins | #22597 |
| loss | #22611 |
| nf | #22756 |
| reactive protein | #22834 |
| utilizing | #22899 |
| transformed | #22917 |
| progression female | #22918 |
| detailed | #23005 |
| natural | #23089 |
| cell types | #23132 |
| sex | #23234 |
| null | #23277 |
| untranslated | #23305 |
| signaling | #23324 |
| syndrome | #23335 |
| bone | #23397 |
| necrosis factor | #23407 |
| rich | #23430 |
| cells tumor | #23467 |
| nucleic | #23501 |
| continued | #23663 |
| cellular | #23667 |
| expression gene | #23728 |
| attenuated | #23757 |
| mitogen | #23814 |
| serine threonine | #23835 |
| examine | #23864 |
| fusion proteins | #23968 |
| organ | #23990 |
| remained | #23998 |
| prevent | #24026 |
| confined | #24245 |
| oxidized | #24325 |
| called | #24330 |
| discussed | #24334 |
| genomic | #24394 |
| covering | #24485 |
| embryonic | #24490 |
| interleukin | #24583 |
| varying | #24640 |
| weeks | #24698 |
| mechanistic | #24796 |
| putative | #24897 |
| sarcoidosis | #24963 |
| detect | #24963 |
| remains | #25082 |
| controversial | #25175 |
| implies | #25192 |
| stromal | #25269 |
| type 1 diabetes | #25410 |
| enriched | #25470 |
| relation | #25543 |
| attributed | #25618 |
| 7 | #25632 |
| proteins | #25644 |
| tumor necrosis | #25683 |
| dysregulation | #25711 |
| cytoplasmic | #25732 |
| inflammatory agents | #25735 |
| energetic | #25813 |
| healthy | #25887 |
| representing | #25917 |
| challenging | #25976 |
| threonine | #25988 |
| mechanisms underlying | #26094 |
| signal | #26163 |
| tnfalpha | #26432 |
| frequent | #26487 |
| individuals | #26568 |
| antibodies viral | #26579 |
| growth factor | #26602 |
| validated | #26686 |
| lower | #26708 |
| treat | #26713 |
| 3 | #26751 |
| tolerated | #26780 |
| pathophysiology | #26782 |
| explored | #26850 |
| tumor necrosis factor | #26925 |
| comparable | #26955 |
| normal | #27016 |
| define | #27055 |
| exist | #27121 |
| presented | #27123 |
| consists | #27152 |
| intracellular | #27233 |
| invariant | #27331 |
| animals cells | #27339 |
| adaptor proteins | #27447 |
| chromosomes human | #27524 |
| associations | #27560 |
| kda | #27648 |
| tract | #27680 |
| possess | #27765 |
| exclude | #27824 |
| cell tumor | #27826 |
| attributable | #28018 |
| proteins humans | #28150 |
| heterozygote | #28266 |
| treated | #28436 |
| observe | #28472 |
| remain | #28560 |
| regulation humans | #28667 |
| threonine kinases | #28809 |
| hypothesis | #28819 |
| require | #28838 |
| examined | #29041 |
| infection | #29082 |
| 5 | #29247 |
| animals apoptosis | #29491 |
| intracellular signaling | #29517 |
| easily | #29557 |
| effective | #29656 |
| 005 | #29706 |
| fully | #29936 |
| exhibit | #29947 |
| gtp binding | #29997 |
| intravenous | #30185 |
| cell movement | #30520 |
| oxide | #30546 |
| reached | #30655 |
| active | #30908 |
| versus | #30963 |
| 1 | #31228 |
| cell differentiation | #31374 |
| vary | #31548 |
| blotting western | #31843 |
| free | #32409 |
| expression regulation | #32516 |
| needed | #32543 |
| objectives | #32805 |
| generally | #33368 |
| inhibited | #33394 |
| clinical | #33439 |
| sought | #34008 |
| reduce | #34128 |
| biological | #34247 |
| reflect | #34701 |
| separately | #34818 |
| agents | #34868 |
| assess | #34935 |
| polymerase | #35201 |
| nuclear | #35715 |
| polymerase chain | #36180 |
| formed | #36819 |
| chain reaction | #36949 |
| 001 | #36954 |
| measured | #42007 |
Rapport d'exécution | |
Prominent publications by Rikard Holmdahl
KOL-Index: 15284
The purpose of the study was to map the dominant T cell epitope of the CB11 sequence of CII in RTlu haplotype rats and to determine if, when used as a synthetic peptide, it would induce tolerance to protect against CIA. A dominant epitope corresponding to residues 184-198 included in the sequence of the CB11 fragment of bovine CII was identified in proliferation assay using peptides in an epitope scanning system using synthetic peptides of 15 amino acids, overlapping by 12 amino acids. ...
| Connu pour Mucosal Tolerance | Synthetic Peptide | Cell Epitope | Cia Cii | Collagen‐induced Arthritis |
KOL-Index: 14658
An antibody response to defined epitopes located on the triple helical portion of type II collagen (CII) is associated with the development of collagen-induced arthritis (CIA) and rheumatoid arthritis (RA). Monoclonal antibodies to epitopes associated with arthritis, but not antibodies specific for epitopes not associated with arthritis, induce arthritis in mice, the so-called collagen antibody induced arthritis (CAIA) model. We have selected monoclonal IgG antibodies specific for four ...
| Connu pour Collagen Antibody | Induced Arthritis | Monoclonal Antibodies | Mice Inbred | Specific Epitopes |
KOL-Index: 13984
The Aq major histocompatibility complex (MHC) class II molecule is associated with susceptibility to murine collagen-induced arthritis (CIA), whereas the closely related H-2Ap molecule is not. To understand the molecular basis for this difference, we have analyzed the ability of H-2Aq and H-2Ap molecules (referred to as Aq and Ap) to bind and present collagen type II (CII)-derived glycosylated and non-glycosylated peptides. T cell clones specific for the immunodominant CII 256-270 ...
| Connu pour Collagen‐induced Arthritis | Transgenic Models | Aq Molecule | Structural Basis | C3h Mice |
KOL-Index: 13727
BACKGROUND: Autoantibodies to cyclic citrullinated peptides (anti-CCP) are present in most patients with rheumatoid arthritis (RA), and associate with HLA-DRB1 shared epitope (SE) alleles.
OBJECTIVE: To investigate reactivities of anti-CCP to various citrullinated proteins/peptides, which represent potential autoantigens in RA, and to examine the relationship between such antibodies, and their association with genetic variants within HLA-DRB1 SE alleles.
METHODS: Serum samples from 291 ...
| Connu pour Citrullinated Antigens | Rheumatoid Arthritis | Drb1 Alleles | Ccp Patients | Antibody Reactivities |
Localization of a critical restriction site on the I-A beta chain that determines susceptibility to collagen-induced arthritis in mice
[ PUBLICATION ]
Type II collagen-induced arthritis (CIA) in mice is an autoimmune experimental model for rheumatoid arthritis. Susceptibility to CIA is associated with certain major histocompatibility complex class II haplotypes. The two very closely related haplotypes H-2q and H-2p differ in susceptibility to CIA. Only mice of H-2q (DBA/1, B10G strains) but not mice of H-2p-expressing strains (like strain B10P) develop CIA and an autoimmune response to type II collagen (CII) after immunization with ...
| Connu pour Mice Cia | Beta Chain | Rheumatoid Arthritis | H2q Haplotype | Type Collagen Cii |
KOL-Index: 13513
INTRODUCTION: It has previously been shown that an increased number of antibodies against citrullinated peptides/proteins (ACPA) predate the onset of rheumatoid arthritis (RA). Over time antibody positivity expands, involving more specific responses when approaching the onset of symptoms. We investigated the impact of human leukocyte antigen-shared epitope (HLA-SE) alleles and smoking on the development of ACPA, as well as in combination with ACPA during the state of quiescent ...
| Connu pour Citrullinated Peptides | Onset Symptoms | Development Rheumatoid Arthritis | Combination Acpa | Hlase Smoking |
Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients
[ PUBLICATION ]
OBJECTIVE: High titers of specific anti-citrullinated protein antibodies (ACPAs) are frequently present in the serum of rheumatoid arthritis (RA) patients, but their presence in synovial fluid is less well characterized. The purpose of this study was to compare the levels of antibody to 4 well-defined citrullinated candidate RA autoantigens in serum and synovial fluid and to determine whether antibodies to one citrullinated antigen are dominant over another. Furthermore, we studied their ...
| Connu pour Citrullinated Antigens | Synovial Fluid | Rheumatoid Arthritis Patients | Type Collagen | Antibodies Acpas |
Toll-like receptor 3 upregulation in macrophages participates in the initiation and maintenance of pristane-induced arthritis in rats
[ PUBLICATION ]
INTRODUCTION: Toll-like receptors (TLRs) are involved in both innate and adaptive immune responses and are likely to play a complex role in the pathogenesis of human rheumatoid arthritis (RA) and experimental arthritis. The objective of this study was to identify the key TLR in pristane-induced arthritis (PIA), a rat model for RA, and to clarify its roles in the initiation and maintenance of arthritis.
METHODS: Arthritis in DA rats was induced by pristane and the severity was evaluated ...
| Connu pour Induced Arthritis | Tlr3 Expression | Rats Pristane | Receptor 3 | Inbred Strains Severity |
KOL-Index: 12776
Multiple sclerosis (MS) is a complex chronic neurologic disease with a suspected autoimmune pathogenesis1,2. Although there is evidence that the development of MS is determined by both environmental influences and genes, these factors are largely undefined3,4, except for major histocompatibility (MHC) genes. Linkage analyses and association studies have shown that susceptibility to MS is associated with genes in the human histocompatibility leukocyte antigens (HLA) class II region, but ...
| Connu pour Multiple Sclerosis | Transgenic Mice | Hla Dr2 | Humanized Model | Spontaneous Disease |
KOL-Index: 12721
Polymorphism of the major histocompatibility complex (MHC) influences susceptibility to experimental autoimmune encephalomyelitis (EAE) induced by myelin basic protein (MBP) in rats. Current concepts relate such influences to the capacity of class II molecules to present relevant peptides to autoreactive T cells. We have here analyzed the MHC influence on the immune response and the development of EAE after immunization with the immunodominant peptide MBP-63-88. Analysis of MHC-congenic ...
| Connu pour Myelin Basic Protein | Experimental Autoimmune | Major Histocompatibility | Rats Eae | Immune Response |
Multiplex Analyses of Antibodies Against Citrullinated Peptides in Individuals Prior to Development of Rheumatoid Arthritis
[ PUBLICATION ]
OBJECTIVE: The presence of antibodies against cyclic citrullinated peptides has been demonstrated to precede the onset of symptoms of rheumatoid arthritis (RA) by several years. The aim of this study was to analyze antibodies against 10 citrullinated autoantigen-derived peptides for reactivity before the onset of RA symptoms.
METHODS: A case-control study was conducted within the Medical Biobank of Northern Sweden. The study was performed in 409 individuals, 386 of whom donated 717 blood ...
| Connu pour Citrullinated Peptides | Rheumatoid Arthritis | Onset Symptoms | Antibodies Cep1 | Type Collagen |
KOL-Index: 12510
Antibodies against type II collagen (anti-CII) are arthritogenic and have a crucial role in the initiation of collagen-induced arthritis. Here, we have determined the dependence of T and B cells in collagen-antibody-induced arthritis (CAIA) during different phases of arthritis. Mice deficient for B and/or T cells were susceptible to the CAIA, showing that the antibodies induce arthritis even in the absence of an adaptive immune system. To determine whether CII-reactive T cells could have ...
| Connu pour Collagen Type | Arthritis Mice | Antigen Tcell | Antibodies Cii | Adaptive Immune |
KOL-Index: 12427
The nonobese diabetic (NOD) mouse spontaneously develops autoimmune-mediated diseases such as diabetes and Sjögren's syndrome. To investigate whether NOD genes also promote autoimmune-mediated arthritis we established a NOD strain with an MHC class II fragment containing the A(q) class II gene predisposing for collagen induced arthritis (NOD.Q). However, this mouse was resistant to arthritis in contrast to other A(q) expressing strains such as B10.Q and DBA/1. To determine the major ...
| Connu pour Genetic Control | Complement Factor | Induced Arthritis | Locus Chromosome | Mice Inbred |
Des personnes clés pour Rheumatoid Arthritis
Top Kols dans le monde
Sélectionnez une phrase de recherche rheumatoid arthritis , rheumatoid arthritis patients , rheumatoid arthritis treatment , rheumatoid arthritis risk , rheumatoid arthritis study
Rikard Holmdahl:Impact expert
Concepts pour lesquelsRikard Holmdahla une influence directe:Rheumatoid arthritis, Induced arthritis, Experimental arthritis, Collagen type, Type collagen, Animal models, Reactive oxygen species, Autoimmune diseases.
Rikard Holmdahl:Impact de Kol
Concepts liés au travail d'autres auteurs pour lesquelsfor which Rikard Holmdahl a une influence:Rheumatoid arthritis, Multiple sclerosis, Autoimmune diseases, Oxidative stress, Animal models, Reactive oxygen species, Nadph oxidase.
Tools
Est-ce votre profil? Réclamez votre profil Copier le lien ENCHED LIEN À VOTRE PROFIL |